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ABSTRACT 
 
Effects of maturation, polyploidy, and nutrition on growth, composition, and gene 
expression within fatty acid metabolism in rainbow trout 
 
Meghan L. Manor 
 
 
In many cultured fish species, such as salmonids, gonadal development occurs at the expense of 
stored energy and nutrients, including lipids. Mobilization of intramuscular lipid during gonadal 
development decreases fillet quality. The aquaculture industry induces triploidy to generate sterile 
individuals; however, differences in lipid metabolism of female diploid (2N) and triploid (3N) trout may 
alter fillet quality. In addition, there is concern that genetic selection for increased growth negatively 
impacts fillet quality and muscle lipid content. Research in these areas would aid in the development of 
better management practices for efficient food-fish production that optimizes product quality.  
The goal of this research is to assess the specific impacts of sexual maturation, polyploidy, and 
nutrition on growth responses, fillet quality attributes, and fatty acid content. Additionally, changes in 
gene expression of 35 genes within the regulatory pathways governing fatty acid metabolism of various 
energy stores were investigated to elucidate mechanisms regulating nutrient repartitioning during sexual 
maturation. Four studies were conducted to assess these variables. In the first study, effects of feeding 
level and polyploidy on fatty acid composition and metabolism of energy stores were considered. This 
study showed that ploidy had greater impact on fatty acid metabolism and composition of energy stores 
than moderately restricted diets at sexual maturation. A second study investigated changes in fatty acid 
metabolism of 2N and 3N female trout throughout sexual maturation. These data showed that there are no 
physiological differences between 2N and 3N females prior to 18 M of age; however, there are dramatic 
differences in energy store compositions and gene expression beginning at 20 M of age. In general, data 
indicate 2N fish have increased fatty acid β-oxidation in white muscle that was associated with altered 
gene expression within the mTOR pathway and in visceral adipose tissue that was associated with 
increased pparβ expression. In contrast, increased expression of genes involved in fatty acid synthesis in 
3N female liver appears to be associated with increased expression of PPARγ as well as altered 
expression within the mTOR pathway, consistent with continued deposition of lipids in these fish. A 
subsequent study examined differences in fatty acid composition and gene expression between immature 
male and female rainbow trout. Females had higher muscle polyunsaturated fatty acid (PUFA) content; 
albeit, no differences were observed for other fatty acids measured. Gene expression data indicate 
possible increased fatty acid turnover in female trout muscle through increased expression of genes 
involved in both fatty acid synthesis and β-oxidation. Male livers have higher expression of genes within 
β-oxidation, which may contribute to the lower PUFA content. Lastly, to evaluate specific associations of 
fillet yield and fat content with differences in fatty acid metabolism, growth, fillet fatty acid composition, 
and gene expression were assessed for 100 fish chosen based on fillet yields and fat contents. This study 
indicated that high-yield/low-fat fish produced the highest quality fillets as measured by instrumental 
texture and composition. In addition, high-yield/low-fat fillets had the greatest long-chain, 
polyunsaturated fatty acid content. Overall, data suggests that differences in growth and fillet quality 
phenotypes may partially result from variation in the capacity for fatty acid, β-oxidation through altered 
gene expression within the mTOR signaling pathway.   
In general, sexual maturation, triploidy, and gender have profound affects on fatty acid 
composition, metabolism, and gene expression. Furthermore, the mTOR and PPAR signaling pathways 
have altered gene expression that is associated with differences in fatty acid composition and metabolism 
in rainbow trout. 
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INTRODUCTION 
The increasing world population, projected to reach over 9 billion by 2050, has resulted 
in a startling demand for food production. Currently, we do not produce enough food to feed that 
many people. Food production will have to double while reducing the environmental impact in 
order to achieve this feat. A changing demographic where people have greater income, allowing 
them to consume more protein-based diets. Additionally, the perception that fish is an excellent 
protein and essential fatty acid source is growing. These perceived and real issues perpetuate 
increased demands for aquatic foods. The captive fisheries have not been able to increase 
production since the 1980’s (FAO, 2013). Therefore, the aquaculture industry has been forced to 
rapidly expand in order to supply the increased demand. The aquaculture industry is now 
considered the fastest growing, food-animal production sector in the world with an average 
annual increase of 6.1% during the last 10 years (FAO, 2013). Aquaculture accounts for roughly 
50% of the world’s food-fish supply and 76% of the global freshwater, finfish production (FAO, 
2008). Over 77% of fish production was used for direct human consumption in 2006 (FAO, 
2006). Furthermore, production has grown from under 1.0 million tons to 62.7 million tons per 
year over the past 50 years, and it has a value of $130.2 billion dollars worldwide (FAO, 2013). 
It was reported that rainbow trout alone contributed $2.2 million (FAO, 2006).  
 
Salmonids, such as rainbow trout, are considered to be a saturated market in North and 
South America, as well as in Europe (FAO, 2013). However, the market is dynamic because 
there is an increased research interest in farmed fish that is focused on understanding fish fatty 
acid biochemical and metabolic pathways and improving the omega 3 fatty acid content of 
aquatic food products for consumer consumption (Karakatsouli, 2012). Evidence associating 
long-chain, omega 3 polyunsaturated fatty acids with a variety of human health benefits, seafood 
as the major dietary source of these fatty acids, and studies linking fish consumption to reduced 
cardiovascular disease have justified the continued interest in this research (Dyerberg et al., 
1975; Ruxton and Derbyshire, 2009; Karakatsouli, 2012). Consequently, it is important for the 
aquaculture industry to produce high-quality fish, containing high amounts of omega 3 fatty 
acids, through appropriate production practices. Therefore, research investigating the role of fatty 
acid metabolism and its regulation in animal growth, reproduction, and fillet quality is required 
in order to maintain high standards and develop more efficient food-fish production.   
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There is also an increasing demand for production of polyploid salmonids (Piferrer et al., 
2009).  Triploid (3N) fish have three sets of chromosomes as opposed to two sets of 
chromosomes in normal diploid (2N) fish. The aquaculture industry induces triploidy in a variety 
of cultured species to cause sterility, improve growth, and prevent the onset of sexual maturation. 
Female 3N rainbow trout do not undergo sexual maturation and therefore, do not develop large 
ovaries, nor experience the shift from somatic growth to gonadal growth, thereby preventing 
mobilization of lipids and deterioration of muscle quality (Piferrer et al., 2009). Triploid males 
do, however, undergo sexual maturation, but produce non-viable sperm (Piferrer et al., 2009). 
These characteristics make the culture of all female, 3N fish desirable. Nevertheless, little is 
known about differences in 2N and 3N fatty acid metabolism and fillet quality or the regulation 
of these processes during maturation.  
 
It was the goal of this research to investigate possible roles of fatty acid metabolism, and 
its regulation, in altering nutrient partitioning during growth and reproduction. Additional 
investigations into metabolic differences in 2N and 3N females and differences between male 
and female trout, as well as associations between gene expression and fillet quality attributes, are 
included in this work. There are a total of four separate projects that examine the same set of 
responses, including growth variables, fillet quality attributes, proximate and fatty acid 
compositions of energy stores, and gene expression of 35 genes within fatty acid metabolism. 
The first project examines the effects of ration and ploidy on these parameters at two time points 
during rapid gonadogenesis (Chapters 1 and 2). The second project follows changes in fatty acid 
metabolism throughout sexual maturation in 2N and 3N females from 16 to 24 months of age 
(Chapter 3). The third project looks at differences between immature male and female rainbow 
trout because most marketed products are from immature fish (Chapter 4). Lastly, the fourth 
project investigates associations between fillet quality attributes in immature female trout and 
gene expression profiles (Chapter 5).  This research enhances our understanding of changes in 
fillet quality and fatty acid metabolism as affected by sexual maturation, polyploidy, gender 
specification, and growth. Furthermore, understanding differences in lipid utilization allows for 
the development of better management strategies for more efficient, food-fish production.       
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LITERATURE REVIEW 
 
Fatty Acid Metabolism: 
Lipoproteins: Triacylglycerol (TAG) consists of three fatty acids esterified to a glycerol 
backbone. TAGs are hydrophobic in nature and therefore must be transported through the 
circulatory system. They are transported as components of globular micelle particles that consist 
of a nonpolar core of TAGs and cholesterol esters surrounded by an amphiphilic coating of 
protein, phospholipid, and cholesterol called lipoproteins (Voet and Voet, 2004). Lipoproteins 
have apoproteins that are distributed on the outside of the molecules to disguise the hydrophobic 
contents as hydrophilic. There are nine main apoproteins that are found on human lipoproteins. 
They are water-soluble proteins that weakly associate with lipoproteins allowing for easy transfer 
among the various lipoproteins. The nine apoproteins are A-I, A-II, B-48, B-100, C-I, C-II, C-III, 
D, and E, and are they summarized in Table 1 (Voet and Voet, 2004).  
 
There are five categories of lipoproteins, each with unique combinations of apoproteins, 
functions, and physical properties (Table 2 and Figure1). The least dense category is the 
chylomicrons. They are the largest lipoprotein and carry exogenous, or dietary TAGs from the 
intestine to other tissues. Chylomicrons consist of 90% TAGs, 4% cholesterol esters, 2% 
cholesterol, and 2% protein. Chylomicrons have apoproteins A-I, A-II, B-48, C-I, C-II, C-III, 
and E (Voet and Voet, 2004). Since chylomicrons’ function is to transport dietary TAGs from 
the intestine to tissues, they are synthesized in intestinal cells, but their remnants are taken up by 
the liver (Chow, 2008). The next dense lipoprotein is very low density lipoprotein (VLDL). 
VLDL carries endogenous TAG and cholesterol from the liver to other tissues. VLDL consists of 
65% TAGs, 15% cholesterol esters, 10% free cholesterol, and 10% protein. VLDL carries 
apoproteins B-100, C-I, C-II, C-III, and E, and this lipoprotein is synthesized in the liver (Voet 
and Voet, 2004). As VLDL circulates and loses its TAGs, it becomes smaller and denser. VLDL 
is then considered intermediate density lipoprotein (IDL). IDL contains 22% TAGs, 30% 
cholesterol esters, 8% free cholesterol, and 20% protein. IDL carries the same apoproteins as 
VLDL (B-100, C-I, C-II, C-III, and E) (Voet and Voet, 2004). As IDL continues to circulate and 
lose its TAGs, it becomes smaller and denser until it is considered the densest lipoprotein 
involved in TAG transport, low density lipoprotein (LDL). LDL consists primarily of cholesterol 
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esters (40%), and contains 10% free cholesterol, 10% TAG, and 25% protein. LDL loses most of 
the apoproteins, but still has apoprotein B-100 attached (Voet and Voet, 2004). The fifth 
lipoprotein is high density lipoprotein (HDL); its primary role is in the reverse transport of 
excess cholesterol from tissues back to the liver for removal through bile synthesis and excretion. 
HDL contains very little TAGs and therefore has no main role in TAG transport (Voet and Voet, 
2004).  
 
Dietary Fatty Acid Absorption: Dietary lipids, such as TAGs, must pass across the 
intestinal membrane for absorption. There are four events that must occur for TAGs to be 
assimilated: 1) secretion of bile and lipases, 2) emulsification, 3) enzymatic hydrolysis of ester 
linkages, and 4) solubilization of lipolytic products within bile salt micelles (Figure 2) (Johnson, 
2001). Lipid digestion begins in the stomach; this process consists primarily of absorption of 
short chain fatty acids that are membrane permeable and water soluble. Cholecystokinin (CCK) 
is released when lipids are detected in the small intestine. CCK causes gastric motility to slow, 
secretion of lipases, and contraction of the gallbladder. Gastric lipases are secreted by the fundus 
portion of the stomach; these lipases hydrolyze TAGs to diacylglycerides (DAG) (Johnson, 
2001).  
 
In addition, several pancreatic lipases function within the intestinal lumen. Pancreatic 
lipase-colipase cleaves R1 and R3 ester linkages of TAGs. Phospholipase A2 cleaves R2 fatty 
acid and yields a free fatty acid and lysophospholipid (Voet and Voet, 2004). TAG digestion is 
completed by the time the bolus reaches the mid-jejunum (Johnson, 2001). Since TAGs and fatty 
acids are hydrophobic, they coalesce into lipid droplets with hydrophobic tails in the center and 
hydrophilic heads towards the outside forming a micelle. Micelle formation is important in 
absorption (Voet and Voet, 2004). Bile salts aid in emulsification and micelle formation. 
Micelles diffuse across the unstirred water layer at the intestinal lumen-membrane interface, 
increasing the fatty acid concentrations at the apical membrane by 100 to 1000 fold. However, 
medium and short chain fatty acids are not dependent on micelle formation for absorption 
because they are water soluble (Johnson, 2001). Once fatty acids and monoacylglycerides 
(MAG) are in enterocytes of the intestine, TAGs are reformed and incorporated into 
chylomicrons.  
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Although triglyceride digestion is considered to be highly conserved among species, there 
are marked anatomical differences in fish that have made it challenging to study metabolic and 
enzymatic processes (Tocher, 2005). In fish, lipolyic processes occur mainly in the proximal 
region of the intestine and the pyloric caeca with little lipolytic activity in the stomach (Tocher, 
2005). Many fish, including salmonids, lack a pancreas so they have a hepatopancreas that serves 
as the primary source of lipase enzymes. Fish also may secrete lipases from the intestinal mucosa 
(Tocher, 2005). There is evidence of a bile salt-activated lipase in fish that has high homology 
with its mammalian counterpart (Tocher, 2005). However, evidence for a pancreatic-lipase 
colipase system in fish is inconsistent.  An enzyme similar to mammalian pancreatic lipase has 
been identified in rainbow trout, but it has low specific activity, low colipase activation, and 
requires bile salt for full activation (Tocher, 2005). In general, data suggests that lipolytic 
activity is primarily carried out by bile salt-activated lipases, but there could be a pancreatic-
colipase system in some fish species as well. Nevertheless, the primary products of lipid 
digestion are free fatty acids and MAGs (Tocher, 2005). Lipid absorption, on the other hand, has 
not been well characterized in fish, but processes are assumed to be similar to that in mammals. 
Absorption proceeds at lower rates in fish compared to mammals because of lower body 
temperatures (Tocher, 2005). Transport of dietary lipids by chylomicrons, as described below, is 
considered to be the same in fish and in mammals. Likewise, fatty acid transport by lipoproteins, 
as described above, is similar between fish and mammals (Tocher, 2005).          
 
Chylomicrons are synthesized in intestinal cells. The ApoB gene is transcribed in the 
nucleus. ApoB editing complex (APOBEC) then changes a CAA codon to UAA codon, a stop 
codon, causing the gene to be shortened creating a protein that is only 48% of the original length. 
ApoB48 is then translated in the rough endoplasmic reticulum (ER). Next, ApoB48 is added to 
the TAG and cholesterol droplet in the Golgi apparatus (Chow, 2008). ApoB48 transcription rate 
is constitutive and the rate of chylomicron formation is determined by the amount TAG present 
to be packaged. The primary role of ApoB48 is to make TAGs and cholesterol water soluble for 
transport. Chylomicrons are then released into the lymphatic system. Chylomicrons slowly move 
through the lymphatic system and enter the blood stream through the thoracic duct (Voet and 
Voet, 2004). It takes roughly three hours for dietary fat in chylomicrons to reach the blood 
stream. Once chylomicrons are in the blood stream, they bump into other molecules such as 
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HDL. When chylomicrons bump into HDL molecules, ApoCII/CIII and ApoE are transferred 
from HDL to the chylomicron (Chow, 2008).  ApoE is required for interactions of chylomicrons 
with lipoprotein lipase (LPL); it tethers chylomicrons to endothelial cells through its interaction 
with heparin sulfate proteoglycan (HSPG). ApoE’s interaction with HSPG holds the chylomicron 
in place while LPL hydrolyzes the TAGs (Lindberg and Olivecrona, 2002). The concentration of 
ApoCII/CIII determines the rate at which LPL hydrolyzes TAGs of chylomicrons. ApoCII 
stimulates LPL while ApoCIII inhibits LPL. The concentrations of ApoCII/CIII are determined 
by the liver because HDL, ApoCII, and ApoCIII are synthesized in the liver (Voet and Voet, 
2004).  With all of the apoproteins attached, the chylomicron becomes a substrate for LPL. LPL 
hydrolyzes TAGs of chylomicrons to free fatty acids and MAG. MAGs are then further 
hydrolyzed by MAG lipase (MAGL) into free fatty acids and glycerol.  Free fatty acids are taken 
up by tissues and are used for energy or are stored; glycerol is taken up by the liver. Only TAGs 
are removed from chylomicrons (Chow, 2008). Once 85% of the TAGs have been hydrolyzed by 
LPL, ApoCII and CIII are recycled and are transferred back to HDL that the chylomicron comes 
into contact with. The chylomicron remnant now contains primarily dietary cholesterol, 
phospholipid, some TAG, ApoE, and ApoB48. The chylomicron remnant is taken up by the liver 
through receptor-mediated endocytosis (Chow, 2008).  ApoE is required for endocytosis of the 
chylomicron. ApoE tethers chylomicron remnants through its interaction with HSPG to liver so 
hepatic lipase can hydrolyze the remaining fatty acids (Gibbons et al., 2000). The remnant is then 
transferred to the coated pit for endocytosis. There can also be LDL-receptor dependent 
endocytosis of the chylomicron remnant (Gibbons et al., 2000). The remnant binds LDL 
receptor-like protein and ApoE tethers the molecule through its interaction with HSPG. The 
remnant then undergoes receptor-mediated endocytosis. Cholesterol and remaining TAGs that 
were in the chylomicron are then packaged into VLDLs for further circulation through the blood 
stream. The cholesterol can also be used in bile synthesis while TAGs can be used for energy in 
the liver if necessary (Voet and Voet, 2004).  
 
Receptor-mediated endocytosis requires multiple steps. First, the lipoprotein binds the 
receptor. Next, the chylomicron and receptor bud into the cell to form coated vesicles (Voet and 
Voet, 2004). The clathrin coats depolymerize as triskelions forming uncoated vesicles. The 
uncoated vesicles fuse with endosomes, which have an internal pH of 5.0. The acidity induces 
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the chylomicron to disassociate from the receptor (Voet and Voet, 2004). The receptors and 
chylomicrons accumulate in separate sections of the endosome and the receptor portion 
disassociates and recycles to the cell membrane. The remaining portion of the endosome fuses 
with a lysosome yielding a secondary lysosome wherein the lipoproteins are degraded into its 
component cholesterol esters, and amino acids (Voet and Voet, 2004). Cholesterol esters then are 
hydrolyzed to yield free cholesterol and fatty acids. This process is the same for all lipoproteins 
that undergo receptor-mediated endocytosis (chylomicrons, LDL, IDL) (Voet and Voet, 2004).       
 
De novo Fatty Acid Synthesis: Fatty acid synthesis is considered to be highly conserved 
among and between species; the major difference is in the amount of synthesis. Fish generally 
undergo less de novo fatty acid synthesis because their diets are rich in fatty acids. Most of the 
lipid accumulated in fish is, therefore, mainly derived from the diet. However, fish are capable of 
modifying dietary fatty acids by further elongating or desaturating them (Tocher, 2005). 
Nevertheless, the de novo fatty acid synthesis pathway is essentially the same in fish and 
mammals.  De novo fatty acid synthesis (Figure 3a) involves two main enzymes, acetyl-CoA 
carboxylase (ACC) and fatty acid synthase (FAS). ACC is the rate determining step (Voet and 
Voet, 2004). ACC catalyzes the cytosolic reaction that converts acetyl-CoA to malonyl-CoA. 
However, acetyl-CoA is produced in the mitochondria of the cell and cannot pass through the 
mitochondrial membrane; therefore acetyl-CoA is converted to citrate in the first step of the 
citric acid cycle (TCA) catalyzed by citrate synthase (Voet and Voet, 2004; Chow 2008). Citrate 
is transported into the cytoplasm and converted back to acetyl-CoA by ATP-citrate lyase which 
produces acetyl-CoA and oxaloacetate. The shuttle system is completed with two additional 
steps where oxaloacetate is converted to malate by malate dehydrogenase; malate is subsequently 
converted to pyruvate by malic enzyme (Voet and Voet, 2004). Pyruvate can pass through the 
mitochondrial membrane, back into the matrix. In the cytosol, acetyl-CoA is then converted to 
malonyl-CoA by ACC. ACC exists in two forms, the activated dephosphorylated form and the 
inactive phosphorylated form. Its hormonal regulation is described below.  
 
FAS is the second enzyme involved in fatty acid synthesis. FAS catalyzes the formation 
of palmitic acid from seven acetyl-CoA molecules and malonyl-CoA (Voet and Voet, 2004; 
Chow, 2008; Ratnayake and Galli, 2009).  FAS is a multifunctional enzyme that catalyzes seven 
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enzymatic reactions. Mammalian FAS functions as a dimer with an acyl carrier protein (ACP) 
phosphpantetheine chain that transports substrates between the various enzymatic domains (Voet 
and Voet, 2004). The first step of FAS is a priming step that transfers an acetyl group from 
acetyl-CoA to ACP to yield acetyl-ACP catalyzed by malonyl/acetyl-CoA-ACP transacylase 
(MAT). MAT also catalyzes the second step where malonyl-CoA replaces acetyl-CoA (Voet and 
Voet, 2004). The third step is the coupling of the acetyl group to the malonyl group forming 
acetoacetyl-ACP. The β carbon is then reduced with NADPH producing carbon dioxide and 
butyryl-ACP (Voet and Voet, 2004). Next, butyryl-ACP is reduced by β-ketoacyl-ACP reductase 
(KR), then dehydrated by β-hyrdoxyacyl-ACP dehydrase (DH), and then reduced again by 
enoyl-ACP reductase (EAR). The butyryl group from butyryl-ACP is transferred to the cysteine 
of ketosynthase (KS), elongating the initial priming acetyl-CoA molecule by two carbons (Voet 
and Voet, 2004). The ACP then binds another malonyl-CoA, and another cycle is repeated to add 
the next two carbon units to the chain. These steps (3-7) are repeated seven times to produce 
palmitoyl-ACP (Voet and Voet, 2004). The palmitoyl-ACP thioester bond is hydrolyzed by 
palmitoyl thioesterase (TE) producing palmitate, the final product of fatty acid biosynthesis 
(Voet and Voet, 2004).  
 
Elongation and Desaturation: The end product of FAS, C16:0, is subject to elongation 
and desaturation (Figure 3a). There are two types of elongases, mitochondrial and ER-based. 
Both types extend the carbon chain by two carbons per reaction (Voet and Voet, 2004). 
Mitochondrial elongation is the reverse reaction of β-oxidation with successive addition and 
reduction of acetyl units (Voet and Voet, 2004). The difference is that the final reduction step 
involves NADPH as the terminal redox coenzyme instead of FADH2.  Elongation in the ER, on 
the other hand, condenses malonyl-CoA with acyl-CoA. The difference between this elongation 
and the FAS reaction is that the fatty acid is elongated as its CoA derivative, rather than its ACP 
derivative (Voet and Voet, 2004). There are several desaturases that insert double bonds into the 
carbon chain with no chain-length specificities. The major desaturases in animals are ∆9-, ∆6-, 
∆5-, ∆4-fatty acyl-CoA desaturases (Ratnayake and Galli, 2009). In de novo fatty acid synthesis 
the first and most active desaturase is ∆9-desaturase (stearoyl-CoA desaturase; SCD1). SCD1 
inserts a double bond between carbons nine and ten to produce 16:1n-9 or 18:1n-9 (Ratnayake 
and Galli, 2009). These products can be further elongated into other monounsaturated fatty acids 
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(MUFA). The other desaturases have more of a role in synthesizing highly unsaturated fatty 
acids (HUFA) such as 20:4n-6 (ARA), 20:5n-3 (EPA), and 22:6n-3 (DHA) from 18:2n-6 
(linoleic) and 18:3n-3 (α-linolenic) (Ratnayake and Galli, 2009).  Most animals do not have ∆12- 
or ∆15-desaturases, but plants do. Therefore, animals are not able to synthesize 18:2n-6 or 18:3n-
3 making them essential fatty acids that must be consumed in the diet (Ratnayake and Galli, 
2009). In addition, 18:2n-6 and 18:3n-3 are important because they are required precursors for 
long-chain, n-6 and n-3 PUFAs. Both n-6 and n-3 PUFAs synthesis pathways are distinct with no 
cross reactions, but they do undergo the same alternating reactions employing the same enzymes 
to desaturate and elongate (Ratnayake and Galli, 2009) (Figure 3b). The first step employs ∆6-
desaturase followed by elongation and subsequent desaturation with ∆5-desaturase to form 
20:4n-6 and 20:5n-3. ∆6-desaturase is the rate limiting step, and it has a higher affinity for 18:3n-
3 compared to 18:2n-6 (Ratnayake and Galli, 2009). The next step involves two successive 
elongation steps and desaturation with ∆6-desaturase to form 24:6n-3 (Ratnayake and Galli, 
2009). The fatty acids then undergo one round of β-oxidation to yield 22:6n-3 (Ratnayake and 
Galli, 2009).   
 
Triglyceride Synthesis: Triglycerides consist of three fatty acids and a glycerol backbone 
synthesized from fatty acyl-CoA esters and glycerol-3-phophate (G3P) (Voet and Voet, 2004). 
The first step in TAG synthesis is catalyzed by glycerol-3-phosphate acyltransferase (GPAT) in 
the mitochondria or ER (Figure 3c) (Voet and Voet, 2004). The G3P used in the first step of 
TAG synthesis is derived from glucose via the glycolytic pathway or from oxaloacetate via 
gluconeogenesis (Voet and Voet, 2004). Freed glycerol from fatty acid β-oxidation is recycled 
and converted back to G3P by glycerol kinase; however, this reaction can only occur in the liver. 
GPAT converts G3P to a lysophosphatidic acid by adding a fatty acid to the R1 position (Voet 
and Voet, 2004). The lysophosphatidic acid is then converted to phosphatidic acid by 1-
acylglycerol-3-phosphate acyltransferase, which adds a fatty acid in the R2 position. 
Phosphatidic acid can be converted to phospholipids or DAG; the latter reaction is catalyzed by 
phosphatidic acid phosphatase (Lipin1) which removes the phosphate group in the R3 position 
(Voet and Voet, 2004). Monoacylglycerol acyltransferase converts MAG to DAG by adding a 
fatty acid to the R2 position. DAG is then converted to TAG by diacylglycerol acyltransferase 
which adds a third fatty acid in the R3 position (Voet and Voet, 2004). DAG can also be 
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synthesized from MAG absorbed during intestinal lipid digestion. In general, the acyltransferases 
are not specific to particular fatty acids (Voet and Voet, 2004).  
 
De novo Synthesized Fatty Acid Transport: Transport of de novo synthesized fatty acids 
and TAGs involves mainly the liver; synthesized TAGs are packaged in VLDL in the liver 
(Chow, 2008). VLDL synthesis is much like that of chylomicrons. ApoB is transcribed in the 
nucleus of cells in the liver and translated in the rough ER. The liver lacks ApoBEC that cuts 
ApoB down to ApoB48 in the intestine; therefore the liver produces lipoproteins with ApoB100 
(Voet and Voet, 2004). The TAGs and cholesterol are added through the actions of the smooth 
ER. ApoB100 surrounds the TAG/cholesterol package in the Golgi apparatus. The resulting 
VLDL is then released directly into the blood stream (Figure 1) (Voet and Voet, 2004). The rate 
of VLDL synthesis is directly related to the amount of TAG available for packaging. Once in the 
bloodstream, VLDL bumps into HDL molecules, and ApoCII/CIII and ApoE are transferred 
from HDL to the VLDL (Voet and Voet, 2004).  ApoE is required for the interaction of VLDL 
with LPL. ApoE tethers VLDL to endothelial cells through its interaction with HSPG. ApoE’s 
interaction with HSPG holds VLDL in place while LPL hydrolyzes TAGs. The ratio of 
ApoCII/CIII determines the rate at which LPL hydrolyzes TAGs of the VLDL. ApoCII 
stimulates LPL while ApoCIII inhibits LPL (Voet and Voet, 2004). The concentrations of 
ApoCII/CIII are determined by the liver because HDL and ApoCII and ApoCIII are synthesized 
in the liver.  With all apoproteins attached, VLDL becomes a substrate of LPL. LPL hydrolyzes 
TAGs to free fatty acids and MAG (Voet and Voet, 2004). As TAGs are hydrolyzed, the VLDL 
molecule becomes smaller and denser and becomes considered IDL. The apoproteins remain 
attached allowing IDL to be a substrate of LPL as well (Voet and Voet, 2004). As more TAGs 
are hydrolyzed, IDL becomes even denser and is then considered LDL. Once the molecule has 
lost enough of its TAGs to be considered LDL ApoCII/CIII and ApoE are recycled and are 
transferred to HDL (Voet and Voet, 2004). The resulting LDL only has ApoB100 along with its 
remaining TAG, cholesterol, and phospholipids. LDL is then cleared by the liver through 
receptor-mediated endocytosis with the LDL receptors binding LDL.  If sufficient TAGs are 
removed from VLDL by LPL, VLDL can become LDL directly, skipping IDL.   
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Uptake of LDL is primarily dependent on the number of LDL receptors. The number of 
receptors is controlled transcriptionally by sterol regulatory element-binding protein (SREBP). 
There are two isoforms involved in lipid metabolism. SREBP1c is involved in the transcription 
of fatty acid synthesis genes such as ACC, FAS, and SCD1 (Voet and Voet, 2004). SREBP2 is 
involved in cholesterol synthesis and LDL receptor expression. SREBP1c is activated by insulin 
and inhibited by polyunsaturated fatty acids (PUFA) while SREBP2 is activated by sterols, 
especially cholesterol (Voet and Voet, 2004). Regardless of the isoform, the model for eliciting 
transcriptional regulation is the same and is illustrated in Figure 4. During basal conditions, when 
insulin is low and cholesterol is high, SREBP is in the membrane of the ER bound to SREBP 
cleavage-activating protein (SCAP). SCAP is the sensing portion of the complex. When 
cholesterol levels fall or insulin levels rise, SCAP transports SREBP to the Golgi apparatus 
where SREBP undergoes sequential proteolytic cleavage by site-1 protease (S1P) and site-2 
protease (S2P) (Voet and Voet, 2004). This releases SCREP’s dHLH/Zip-containing N-terminal 
domain. The dHLH portion then translocates into the nucleus of the cell, binds the sterol 
regulatory element (SRE), and increases transcription of its target genes (Voet and Voet, 2004). 
This process allows cholesterol or PUFA concentrations to depict the amount of LDL receptors 
on the cell’s surface. Once the gene is transcribed and the protein is translated in the ER, the 
receptor is tranlocated to the cell membrane. Therefore, the number of LDL receptors increases 
when cholesterol or PUFA levels are low allowing for increased uptake of LDL. The LDL 
receptor-like protein, that is involved in the uptake of chylomicron remnants and some IDL 
molecules functions in much the same way. The rate of uptake is dependent on receptor 
availability, which is controlled transcriptionally through the SREBP/SCAP pathway (Voet and 
Voet, 2004). In addition, the transcription of several lipogenic genes is regulated through this 
same pathway.    
 
Fatty Acid β-Oxidation: Like fatty acid synthesis, lipolysis and β-oxidation are highly 
conserved among speices and are considered to be the same in fish and mammals (Tocher, 
2005). β-oxidation occurs in the mitochondria and is simply the breakdown of fatty acids into 
acetyl-CoA (Figure 5). In order for β-oxidation to occur, the fatty acid must first be primed by 
acyl-CoA synthetase, which forms a fatty acyl-CoA. The fatty acyl-CoA must then be 
transported into the mitochondria by carnitine palmitoyltransferase I (CPT1), the rate limiting 
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step in β-oxidation (Voet and Voet, 2004). CPT1 is located on the internal and external surfaces 
of the mitochondrial membrane. Translocation of the fatty acyl-CoA is mediated by a protein 
carrier that transports acyl-carnitine into the mitochondria while transporting free carnitine out 
(Voet and Voet, 2004). In this process CPT1 transfers the fatty-acyl group to carnitine releasing 
CoA.  Fatty-acyl carnitine is then transported into the mitochondria by CP translocase as it 
subsequently transfers free carnitine out. Fatty-acyl carnitine is then converted back to fatty acyl-
CoA and free carnitine by CPT2 located on the inner mitochondrial membrane. Free carnitine is 
transported out of the mitochondria by CP translocase, and the fatty acyl-CoA can enter the β-
oxidation pathway (Voet and Voet, 2004).  
 
β-oxidation breaks fatty acids down into two-carbon units of acetyl-CoA, much like fatty 
acid synthesis builds fatty acids by adding two-carbon units from acetyl-CoA. There are four 
steps that are repeated until the fatty acid is completely broken down into acetyl-CoA. 
Mammalian-derived fatty acids have an even number of carbons, while some plant-derived fatty 
acids have odd-chain lengths. Odd-chain fatty acids undergo the same β-oxidation process, but 
the final product is propinyl-CoA, made of three carbons, which must enter another pathway to 
be further broken down (Voet and Voet, 2004). The first step of β-oxidation involves 
dehydration by acyl-CoA dehydrogenase (ACDH) that inserts a trans-double bond between α 
and β carbons. The double bond is then hydrated by enoyl-CoA hydratase to form 3-L-
hydroxyacyl-CoA (Voet and Voet, 2004). The third step is the NAD
+
-dependent 
dehydrogenation by 3-L-hydroxyacyl-CoA dehydrogenase to form the corresponding β-ketoacyl-
CoA. The fourth step is the cleavage of the Cα-Cβ bond by β-ketoacyl-CoA thiolase forming 
acetyl-CoA and a new fatty acyl-CoA with two less carbons (Voet and Voet, 2004). These four 
steps are repeated until all of the carbons have been broken down to acetyl-CoA.  
 
Long-chained fatty acids undergo peroxisomal β-oxidation which is basically the same 
process, but it occurs in the peroxisome of the cell. There are, however, distinct differences in the 
enzymes involved in the two fatty acid oxidation pathways. The first enzymatic reaction is 
carried out by acyl-CoA oxidase (ACO) (Voet and Voet, 2004). It requires a FAD cofactor but it 
transfers electrons directly to oxygen rather than passing them through the electron transport 
chain. This mechanism makes peroxisomal β-oxidation less efficient than mitochondrial β-
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oxidation because it produces two less ATPs per two-carbon cycle (Voet and Voet, 2004). The 
resulting H2O2 is deprotonated by peroxisomal catalase producing H2O and O2. The remaining β-
oxidation reactions are identical to the mitochondrial reactions, but are catalyzed by a 
peroxisomal bifunctional protein, enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase 
enzyme (EHHADH) (Voet and Voet, 2004). The acyl-CoA dehydrogenases used in β-oxidation 
vary depending on the length of the fatty acid chain. There are medium-chain acyl-CoA 
dehydrogenase (ACDHM) and very long-chain acyl-CoA dehydrogenase (ACDHVL) 
(Ratnayake and Galli, 2009). Peroxisomes, therefore, do not completely oxidize fatty acids 
because they cannot oxidize fatty acids with fewer than eight carbons. The shorter-chained fatty 
acids are transported to the mitochondria for complete oxidation and the resulting acetyl-CoA 
can then enter the TCA cycle;  resulting NADH + H
+ 
donates its electrons to the electron 
transport chain for oxidative phosphorylation (Voet and Voet, 2004).  For odd chain fatty acids, 
the resulting propionyl-CoA is converted to succinyl-CoA which is an intermediate of the TCA 
cycle (Voet and Voet, 2004).  
 
Fatty acid β-oxidation is regulated in two ways: 1) regulation of CPT1 and 2) the rate of 
lipolysis. CPT1 is primarily regulated by malonyl-CoA. Malonyl-CoA is the product of the ACC 
reaction converting acetyl-CoA to malonyl-CoA, the rate limiting step of fatty acid biosynthesis 
(Voet and Voet, 2004). When malonyl-CoA levels are high because of stimulated fatty acid 
synthesis, CPT1 is allosterically inhibited to prevent β-oxidation from occurring at the same time 
as fatty acid synthesis (Voet and Voet, 2004). The rate of malonyl-CoA formation is controlled 
by insulin. When blood glucose levels are high and insulin is in circulation, insulin causes 
dephosphorylation of ACC through its actions via its tyrosine kinase receptors. Therefore, insulin 
indirectly inhibits β-oxidation by stimulating the formation of its rate limiting enzyme’s 
inhibitor. When malonyl-CoA is not present, β-oxidation is not inhibited (Voet and Voet, 2004).  
 
Lipolysis: The second way β-oxidation is regulated is through its supply of fatty acids 
provided by lipolysis (Figure 5). To mobilize TAGs and fatty acids from an adipocyte lipid 
droplet, a series of phosphorylations of several proteins must occur. First, the lipid droplet is 
surrounded by a protein called perilipin that protects the TAG from lipases. During the fasted 
state, glucagon causes the phosphorylation of perilipin through its activation of cAMP (Voet and 
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Voet, 2004; Carmen and Victor, 2006). Once phosphorylated, perilipin allows the translocation 
of lipases to begin, hydrolyzing TAGs to free fatty acids (Voet and Voet, 2004). Insulin, on the 
other hand, stimulates dephosphorylation of perilipin by phosphatases and therefore prevents 
lipolysis and β-oxidation. The rate limiting enzyme of lipolysis is hormone sensitive lipase 
(HSL) (Voet and Voet, 2004). HSL is inactive when dephosphorylated and active when 
phosphorylated. Insulin stimulates the dephosphorylation of HSL by activating phosphatases 
(Voet and Voet, 2004). This therefore prevents lipolysis from occurring and thereby prevents β-
oxidation. During the fasted state glucagon stimulates the phosphorylation of HSL through the 
activation of its kinases (Carmen and Victor, 2006). This activation of HSL along with the 
phosphorylation of perilipin allows for lipolysis and therefore increases β-oxidation in order to 
supply energy (Voet and Voet, 2004). Once lipases translocate into the lipid droplet, adipose 
TAG lipase (ATGL) and HSL reduce TAGs to MAGs, and two free fatty acids are then released 
into the cytosol (Carmen and Victor, 2006). TAG lipase hydrolyzes the fatty acid in the R3 
position. HSL then hydrolyzes the fatty acid in the R1 position (Voet and Voet, 2004). The 
resulting MAG is released into the cytosol where MAGL removes the final fatty acid in the R2 
position yielding the glycerol backbone (Voet and Voet, 2004). Glycerol is readily diffusible and 
goes to the liver to be converted to G3P by glycerol kinase. This reaction cannot occur in adipose 
tissue because it does not have the glycerol kinase enzyme (Voet and Voet, 2004).  
 
Non-Esterified Fatty Acid Transport: Very little fatty acid oxidation occurs in adipose 
tissue because it requires little energy, therefore freed fatty acids must be transported to tissues 
with mitochondria for β-oxidation and energy production. Since fatty acids are insoluble, they 
must be transported. During lipolysis, fatty acids are transported through the blood by albumin, 
not lipoproteins (Figure 5) (Voet and Voet, 2004). Each albumin molecule can carry eight fatty 
acids. Once albumin reaches a target cell, fatty acids are transported into the cell by fatty acid 
translocase/cluster of differentiation 36 (FAT/CD36 ), but these fatty acids must be bound to 
fatty acid binding proteins (FABP) or be metabolized immediately because micelles cannot be 
allowed to form in the cell (Ratnayake and Galli, 2009). There are several types of FABPs that 
are tissue dependent. The main ones of concern are FABP1 in the liver, FABP2 in the intestine, 
FABP3 in muscle and heart, and FABP4 in adipocytes (Chmurzynska, 2006).  
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Acetyl-CoA as a Metabolic Intermediate: Acetyl-CoA is a metabolic intermediate that is 
an important branch point. Acetyl-CoA can feed into three pathways: 1) TCA cycle, 2) fatty acid 
synthesis, and 3) ketone body formation. Acetyl-CoA enters the TCA cycle at the citrate synthase 
step where oxaloacetate (OAA) is converted to citrate (Voet and Voet, 2004). The rate limiting 
step in the TCA cycle is the conversion of isocitrate to α-ketoglutarate by isocitrate dehydrogenase. 
The TCA cycle is responsible for creating 28 ADP, 10 NADH, 2 FADH2 and 34 Pi molecules that 
feed into the electron transport chain for oxidative phosphorylation (Voet and Voet, 2004). 
Oxidative phosphorylation converts those molecules to 28 ATP, 10 NAD
+
, and 2 FAD molecules. 
These processes occur under aerobic conditions (Voet and Voet, 2004). Acetyl-CoA is also used in 
the fatty acid biosynthesis pathway; which was previously discussed. A third pathway acetyl-CoA 
can enter is ketone body formation. This pathway is activated when acetyl-CoA is being produced 
from β-oxidation faster than the TCA cycle and oxidative phosphorylation can use it (Voet and 
Voet, 2004). Ketogenesis primarily occurs in liver mitochondria where acetyl-CoA is converted to 
acetoacetate, D-β-hydroxybutyrate, or acetone. These compounds serve as metabolic fuels for 
peripheral tissues during bouts of starvation (Voet and Voet, 2004). Ketone bodies are synthesized 
in three enzymatically catalyzed reactions. The first reaction is catalyzed by acetyl-CoA 
acetlytransferase (ACAT) which catalyzes the reverse reaction of the final step in β-oxidation 
combining two acetyl-CoA molecules to form acetoacetyl-CoA (Voet and Voet, 2004). A third 
acetyl-CoA is added by HMG-CoA synthase to form β-hydroxy-β-methylglutaryl-CoA (HMG-
CoA). The cleavage of HMG-CoA into acetyl-CoA and acetoacetate is then catalyzed by HMG-
CoA lyase (Voet and Voet, 2004).   
 
 
Hormonal Control of Fatty Acid Metabolism: 
Insulin and Glucagon: Most mammals eat meals and go hours between meals. To 
prevent alternation of feast and famine at the cellular level, there are mechanisms in place to help 
balance nutrient availability. These mechanisms ensure storage of nutrients directly after a meal 
and mobilization of nutrient stores between meals. There are two primary hormones that elicit 
these effects on nutrient metabolism, insulin and glucagon. Both hormones respond to blood 
glucose levels; insulin is released when glucose levels are high, while glucagon is released when 
blood glucose levels are low. In general, insulin decreases blood glucose levels through 
16 
 
activating storage of carbohydrates, lipids, and amino acids by increasing their synthesis and 
uptake in muscle and adipose tissue (Voet and Voet, 2004).   
 
Insulin is the only hormone in the body that can stimulate the uptake of glucose. Glucose 
uptake in muscle and adipose tissue cells is insulin-dependent, whereas glucose uptake in the 
brain and liver is insulin-independent.  In insulin-dependent cells insulin lowers blood glucose by 
directly acting on cells to increase glucose uptake by increasing the number of type 4 glucose 
transports (GLUT4) present on the cell membranes. Insulin also increases glucose-using 
pathways while decreasing endogenous fuel-producing pathways to help lower blood glucose 
concentrations (Voet and Voet, 2004). Insulin elicits its effects on these pathways in a receptor-
mediated manner through a tyrosine kinase receptor. The insulin receptor acts as an α2β2 tetramer 
(Figure 6a). The α subunits contain the extracellular binding site and the β subunits anchor the 
receptor in the membrane of the cell and contains the tyrosine kinase domain that elicits the 
enzymatic activity of the receptor (Voet and Voet, 2004). When insulin binds the α subunits it 
activates the tyrosine kinase activity of the β subunit which auto-phosphorylates the tyrosine 
residues of the β subunits. The activated tyrosine kinase then phosphorylates second messenger 
proteins such as insulin receptor substrate-1 (IRS-1). Once IRS-1 is phosphorylated it acts as a 
docking protein for other protein messengers that mediate the actions of insulin (Voet and Voet, 
2004). One protein that is activated by its phosphorylation is phosphatidylinositol-3-kinase 
(PI3K). IRS-1 causes reactions that convert phosphatodylinosityl-4,5-diphosphate (PIP2) to 
become phosphatodylinosityl-3,4,5-triphosphate (PIP3). This activates Akt.  Akt stimulates the 
movement of GLUT4 transporters to the cell’s membrane. It also activates protein phosphatase-1 
(PP-1) which dephosphorylates proteins in nutrient utilization pathways regulated by 
phosphorylation, such as fatty acid synthesis and β-oxidation.  Lastly, it inactivates glycogen 
synthase kinase-3 (GSK3) through the activation of protein kinase c (PKC). This decreases 
GSK3 activity by increasing its phosphorylation (Voet and Voet, 2004). Another group of 
second messengers activated by insulin tyrosine-kinase receptors are in the Cbl-P messenger 
system. This system facilitates the movement of GLUT4 transporters into the plasma membrane 
as well (Voet and Voet, 2004). Gene expression can also be altered by insulin through the 
activation of the RAS/Mek pathway that activates a series of MAP kinase cascade reactions that 
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controls gene expression of target genes (Voet and Voet, 2004). Overall, this signalling pathway 
results in increased glucose uptake and increased glycogen, lipid, and protein synthesis. 
 
Glucagon acts through stimulating a Gs receptor (Figure 6b). The Gs receptor is a G-
protein receptor that has seven trans-membrane helices and three subunits, α, β, and γ. When not 
stimulated, the α, β, and γ subunits are bound together and the α-subunit has GDP attached (Voet 
and Voet, 2004). Upon stimulation of the Gs receptor by glucagon, the α-subunit hydrolyzes a 
GTP to GDP, and its attached GDP becomes GTP. This conversion of GDP to GTP causes the α-
subunit to disassociate from the β/γ-subunit complex (Voet and Voet, 2004). The activated α-
subunit then activates adenylate cyclase (AC). AC then increases cyclic AMP (cAMP) 
concentrations which activates phosphoprotein kinases. The activated kinases then phosphorylate 
proteins and enzymes (Voet and Voet, 2004). The increased phosphorylation generally activates 
enzymes involved in gluconeogenesis as well as regulated enzymes within the lipolysis, β-
oxidation, protein degradation, amino acid deamination, and glycogen degradation pathways. 
Conversely, phosphorylation will inhibit the regulated enzymes within glycolysis, fatty acid 
synthesis, protein synthesis, and glycogen synthesis pathways (Voet and Voet, 2004).  
 
De novo fatty acid synthesis involves two main enzymes, ACC and FAS; both enzymes 
are regulated by insulin (Voet and Voet, 2004). ACC catalyzes the cytosolic reaction that 
converts acetyl-CoA to malonyl-CoA. ACC exists in two forms, the active dephosphorylated 
form and the inactive phosphorylated form. Insulin’s activation of phosphoprotein phosphatase 
2A (PP2A) causes ACC to be dephosphorylated and activated (Voet and Voet, 2004). Glucagon, 
on the other hand, activates AMP-dependent protein kinase (AMPK) which phosphorylates 
ACC, deactivating it (Voet and Voet, 2004). Phosphorylation is catalyzed differently in the liver 
than in other tissues. In the liver only AMPK phosphorylates ACC while in other tissues ACC is 
phosphorylated by AMPK and PKA. Both kinases are activated through glucagon’s interaction 
with its receptor (Voet and Voet, 2004). ACC also exists in two mammalian isoforms, α-ACC 
and β-ACC. The α-ACC isoform only exists in adipose tissue and β-ACC is found in tissues that 
oxidize but do not synthesize fatty acids. The liver contains both isoforms. The β-ACC isoform’s 
main function in non-synthesizing tissues is to produce malonyl-CoA because malonyl-CoA is a 
primary inhibitor of fatty acyl-CoA transport into the mitochondria, the rate limiting step for 
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fatty acid β-oxidation.  Therefore β-ACC has a regulatory function in fatty acid oxidation (Voet 
and Voet, 2004).  
 
Fatty acid synthase is the second enzyme involved in fatty acid synthesis. FAS catalyzes 
the formation of palmitic acid from acetyl-CoA and malonyl-CoA.  Like several other enzymes 
involved in synthesis pathways that synthesize energy storage molecules, insulin controls FAS 
gene transcription, and therefore controls the amount of the enzyme available to catalyze fatty 
acid synthesis (Voet and Voet, 2004). Like the other genes, there is an insulin response unit 
(IRU) on the FAS gene. The IRU is subject to regulation by phosphorylation or 
dephosphorylation caused by downstream effectors of the insulin signally pathway (Voet and 
Voet, 2004). For FAS, insulin activates PI3K which in turn activates PKB. PKB and its 
downstream effectors are responsible for activating the IRU of the FAS gene. Therefore, when 
insulin is present FAS gene transcription is increased (Voet and Voet, 2004). When fasting, 
glucagon has opposite effects on FAS gene transcription by inhibiting the IRU activation. There 
is evidence the presence of glucose at high levels further enhances increases of FAS gene 
transcription increased by insulin (Voet and Voet, 2004). In general, when animals are fasted and 
then re-fed with a high carbohydrate diet, blood glucose concentrations are high and there is at 
least a four-fold increase in FAS gene transcription and a subsequent increase in the flux through 
the fatty acid biosynthesis pathway.   
 
Fatty acid β-oxidation is regulated in two ways: 1) regulation of CPT1 and 2) the rate of 
lipolysis. Insulin indirectly inhibits β-oxidation by stimulating the formation of malonyl-CoA, 
CPT1’s inhibitor. CPT1, the rate limiting enzyme of β-oxidation, is primarily regulated by 
malonyl-CoA. Malonyl-CoA is the product of the ACC reaction converting acetyl-CoA to 
malonyl-CoA, the rate limiting step of fatty acid biosynthesis (Voet and Voet, 2004). Insulin’s 
and glucagon’s actions on ACC, therefore, regulate CPT1 activity through allosteric regulation. 
The second way β-oxidation is regulated is through its supply of fatty acids provided by 
lipolysis. Glucagon regulates lipolysis through phosphorylating and activating perilipin and HSL. 
Perilipin must be phosphorylated in order to allow lipase’s to enter the lipid droplet and HSL 
must be phosphorylated to hydrolyze fatty acids (Voet and Voet, 2004). 
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Overall, regulation of nutrient metabolism by insulin is complex. In general, after a high 
carbohydrate diet when blood glucose levels are high, insulin becomes the governing hormone. 
Insulin’s main goal is to lower blood glucose concentrations. Under the direction of insulin, 
metabolic pathways that synthesize molecules for energy storage are activated. These activated 
pathways include glycolysis, glycogen synthesis, protein synthesis, and fatty acid synthesis. 
These pathways are activated by dephosphorylation of their regulatory enzymes which is caused 
by insulin’s interaction with tyrosine kinase receptors (Voet and Voet, 2004). In contrast, 
pathways that breakdown energy storage molecules into glucose are inhibited by insulin. These 
inhibited pathways include gluconeogenesis, glycogen breakdown, and fatty acid β-oxidation. 
These pathways are therefore inhibited by dephosphorylation (Voet and Voet, 2004). This 
complex regulation of these pathways by insulin, along with its counterpart glucagon, is vital to 
maintaining healthy blood glucose concentrations. When there is a malfunction within these 
pathways, it can be detrimental to the cell’s and organism’s life.  A list of regulated enzymes is 
provided in Table 3. The specific actions of insulin on metabolism are illustrated in Figure 6. 
 
Growth Hormone and IGF-1: In all vertebrates, growth hormone (GH) is synthesized in 
the anterior pituitary, but its release is controlled by tropic factors released by the hypothalamus. 
Also, GH actions are not all direct, most of its actions on peripheral tissues are indirect through 
growth factors produced and released by the liver (Voet and Voet, 2004). Upon stimulation, the 
hypothalamus releases growth hormone releasing hormone (GHRH). GHRH then acts on the 
anterior pituitary, stimulating it to release GH. GH, in turn, acts on tissues (primarily the liver) 
causing them to synthesize and release insulin-like growth factor-1 (IGF1; somatomedin). IGF1 
acts to maintain appropriate levels of circulating GH by participating in negative feedback loops 
to the pituitary and hypothalamus (Voet and Voet, 2004). Similarly, GH and GHRH act through 
negative feedback loops on the hypothalamus to inhibit GH release. When IGF1, GH, or GHRH 
levels are high, the hypothalamus releases somatostatin which inhibits the pituitary from 
producing more GH (Gerrard and Grant, 2006). Moreover, IGF1 mediates many of GH’s effects 
on other tissues including bone, muscle, and adipose tissue. In the bone, IGF1 increases 
chondrocyte proliferation and osteoblast differentiation leading to increased bone lengthening 
prior to epiphyseal closure and increased bone mass through periosteal growth (Gerrard and 
Grant, 2006). GH and IGF1 increase lean muscle growth by increasing protein synthesis while 
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decreasing protein degradation. GH can act either directly by stimulating myogenic cells to 
release IGF1 or through IGF1 release from the liver (Gerrard and Grant, 2006).  In addition, GH 
and IGF1 increase lipolysis and decrease lipogenesis in adipose tissue. 
 
GH secretion is influenced by a number of factors including exercise, stress, low levels of 
glucose and fatty acids, and high levels of amino acids in the blood (Gerrard and Grant, 2006). 
One of the most influential factors is the circadian rhythm. GH levels are relatively low and 
constant. GH levels rise during the night in mammals and in rainbow trout (Gelineau et al., 
1996). In salmonids, such as rainbow trout, GH and IGF1 levels rise during increased day-length 
hours (summer months) and elevated water temperatures. Additionally, elevated levels of 
cortisol during bouts of stress will increase the release of GH (Flores et al., 2012). GH levels also 
rise just after a feeding event and remain elevated for roughly 8 hours after feeding in juvenile 
rainbow trout (Gelineau et al., 1996). There is a rise in corresponding IGF1 levels during the 
summer months (June-October) in rainbow trout (Taylor et al., 2008). Conversely, there does 
appear to be a positive correlation between pituitary GH, mRNA concentrations or plasma GH 
levels and gonadogenesis (Gomez et al., 1998). Sex steroids are known to increase the release of 
GH and IGF1. During sexual maturation in female rainbow trout, there is an increase in estrogen 
that increases the release of GH. In turn, GH stimulates lipolysis and energy production to 
support increased energy demands of gonadogenesis and vitellogenesis. In general, GH mRNA 
levels in the pituitary remain constant during vitellogenesis, but there is a significant increase in 
GH mRNA concentrations during oocyte maturation (stage 5). GH levels within the pituitary 
increased during exogenous vitellogeneis throughout oocyte maturation (stage 3-stage 5). 
Although plasma GH levels were not significantly different throughout the stages of oogenesis 
(P<0.05), there was a trend for plasma GH levels to decrease during oogenesis (P=0.053) 
(Gomez et al., 1998). These findings suggest that GH release is stimulated when sex steroid 
levels reach their highest concentrations during late oogenesis. This hormonal relationship is also 
consistent with trout limiting their feed intake during sexual maturation; increased GH 
concentrations during and after ovulation suggest a role for GH in redirecting energy toward 
somatic growth from gonadal growth. This rise in GH concentrations after ovulation also occurs 
during the transition into summer when day length becomes longer. 
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Growth hormone also acts as an antagonist to insulin signaling, especially in adipose 
tissue. Growth hormone reduces the number of GLUT4 transporters in adipose tissue and 
decreases lipogenesis while increasing lipolysis. These effects cause muscle metabolism to shift 
and rely more on non-esterfied fatty acids (NEFA) rather than glucose for energy (Hocquette et 
al., 1998). In fish, growth hormone is believed to be involved in the shift in development from 
somatic tissue accretion to gonadal growth which leads to a reduction in body weight and 
condition (Sumpter et al., 1991). Sumpter et al. (1991) reported that the onset of gonadal growth 
leads to nutritional insufficiency resulting in lower condition and cessation of somatic growth. 
These changes during spawning season cause plasma growth hormone concentrations to 
increase. Increased plasma growth hormone concentration allows fish to regain somatic growth 
and increase condition after spawning (Sumpter et al., 1991).  In 1991, Sumpter et al. determined 
that plasma growth hormone does not trigger maturation or gamete release, nor is growth 
hormone required for rapid somatic or gonadal growth. Triploid females maintain a low plasma 
growth hormone concentration and high condition throughout development (Sumpter et al., 
1991). Most changes in adipose tissue during spawning are thought to be associated with 
nutritional insufficiency because they eat less while undergoing gonad development and 
maturation. Furthermore, Sumpter et al. (1991) suggested that nutritional insufficiency during 
reproduction causes decreases in condition factor associated with depleted intramuscular fat as 
the fat is mobilized from the muscle to support egg growth. 
 
Estrogen: Estrogen elicits its effects on lipid metabolism through estrogen receptor α 
(ERα). Estrogen administration decreases adipocyte size and number in cultured mouse 
adipocytes. The decreased size of adipocytes is a result of estrogen inducing lipolysis. Estrogen 
acts through ERα receptor to increase gene expression of adipose triglyceride lipase (ATGL) and 
perilipin (Wend et al., 2013). Expression of ATGL in ERα knockout mice is decreased relative to 
the wild type expression and estrogen administration does not induce changes in ATGL 
expression in ERα knockout mice (Wend et al., 2013). Estrogen administration decreases 
perilipin protein content in wild type and ERα knockout mice. ERα knockout mice did maintain 
a higher level of perilipin protein when compared to the wild type mice regardless of treatment 
(Wend et al., 2013). Perilipin gene expression was, however, significantly lower in ERα 
knockout mice compared to wild type mice. Furthermore, estrogen treatment increased perilipin 
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mRNA, but had no effect in ERα knockout mice (Wend et al., 2013). These findings suggest 
estrogen regulates perilipin post-transcriptionally while regulating ATGL through altered gene 
expression, through ERα. Increased expression of ATGL facilitates increased lipolysis. ATGL is 
the first step in lipolysis, catalyzing the hydrolysis of TAG to DAG (Voet and Voet, 2004). 
Increased hydrolysis of TAG reduces lipid droplet size within adipocytes. Altered expression of 
perilipin can also affect the amount of lipid within adipocytes because it regulates lipolysis by 
controlling translocation and activation of lipases, mainly HSL (Voet and Voet, 2004).    
 
Testosterone: Testosterone is a hormone with numerous physiological functions. Several 
studies have shown that testosterone’s effects on fat-free mass are directly correlated to serum 
testosterone concentrations; whereas, changes in whole-body and regional fat mass are inversely 
correlated with testosterone levels in mammals (De Maddalena et al., 2012). There is an 
increased visceral adipose tissue deposition in hypogonadal individuals. Increased adipose tissue 
causes a further decrease in circulating testosterone levels through conversion of testosterone to 
estrogen by aromatase (De Maddalena et al., 2012). Testosterone inhibits adipogenic 
differentiation of preadipocytes by activating AR/β-catenin interaction leading to its 
translocation into the nucleus and subsequent down-regulation of adipogenic transcription factors 
(De Maddalena et al., 2012). Furthermore, serum concentrations of leptin are inversely related to 
testosterone levels. Leptin is primarily expressed in adipose tissue and acts to reduce appetite and 
increase energy expenditure. Testosterone decreases expression of leptin in cultured adipocytes 
(De Maddalena et al., 2012). Additionally, low testosterone levels are correlated with reduced 
levels of circulating ghrelin. Ghrelin is a gastric hormone that increases appetite and slows down 
metabolism (De Maddalena et al., 2012). In general, testosterone decreases adipogenesis by 
inhibiting adipocyte differentiation and reduces adipocyte size by decreasing lipogenesis and 
energy consumption.             
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Peroxisome Proliferator-Activated Receptor Signaling Pathway:   
Lipids serve as primary sources of energy as well as potent regulators of metabolism by 
controlling metabolism through transcription regulation. One signaling pathway lipids induce to 
elicit control over transcription is the peroxisome proliferator-activated receptors (PPAR) 
pathway. PPARs are members of the nuclear receptor superfamily of ligand-activated 
transcription factors (Poulsen et al., 2012). PPARs alter transcription of genes involved in a 
variety of biological processes including development, reproduction, inflammation, immune 
function, metabolism, apoptosis, growth, and cancer (Poulsen et al., 2012).  There are three 
subtypes of PPARs that have been identified: PPARα, PPARβ/δ, and PPARγ.  The three 
isoforms have a high degree of amino acid homology in the molecular domains that bind DNA 
and ligands; however, they display distinct ligand specificity and DNA-binding sites (Abbott, 
2009).  Each receptor has an N-terminal “A/B” domain that has a ligand-independent activation 
function and it is poorly conserved between the various isoforms. The “C” domain encodes for 
the DNA binding region of the receptor and is highly conserved among the isoforms (Varga et 
al., 2011). The C-terminal ligand binding domain, the “E/F” domain, is responsible for ligand-
dependent activation and is important for RXR (retinoid X receptor) heterodimerization (Varga 
et al., 2011).  In general, all isoforms act through the same general mechanisms to elicit their 
individual effects. PPAR forms a heterodimer with RXR, another member of the nuclear receptor 
super family. The complex then binds a specific DNA sequence, peroxisome proliferator 
response element (PPRE), in the promoter region of target genes. In order for RXR to 
heterodimerize it must be activated by its ligand 9-cis-retinoic acid (Hausman et al., 2008). Once 
the complex interacts with the PPRE a series of co-activators are recruited to induce transcription 
of the target gene. Co-repressors may also be bound to prevent transcription of the target gene 
(Varga et al., 2011).  An outline of PPARs actions on gene regulation is in Figure 7. 
 
PPARα: All three PPAR subtypes are highly expressed in tissues involved in lipid 
metabolism; however, they have distinct expression profiles and biochemical properties resulting 
in subtype-specific activation of target genes (Poulsen et al., 2012). PPARα induces fatty acid 
oxidation and is highly expressed in tissues with substantial mitochondrial and peroxisomal β-
oxidation, such as brown adipose tissue, liver, kidney, and heart (Poulsen et al., 2012). However, 
PPARα has low expression in white adipose tissue (Varga et al., 2011). Disruption of PPARα 
24 
 
prevents β-oxidation; however, adipose tissue develops normally (Hossner, 2006). In muscle, 
PPARα activation not only causes increased fatty acid oxidation, it decreases glucose uptake and 
induces mild insulin resistance. In the liver, PPARα is activated during the fasting state to 
increase expression of genes involved in fatty acid catabolism and ketogenesis. There is also 
evidence it decreases expression of genes associated with lipogenesis and fatty acid elongation in 
a sterol regulatory element binding protein (SREBP) manner. In general, PPARα induces fatty 
acid handling within the liver to either catabolize or store fatty acids, thereby diminishing 
cytotoxic effects of free fatty acids (Paulsen et al., 2012). PPARα increases expression of β-
oxidation genes such as cpt1, cpt2, acdh, ehhadh, acat2, magl, and aco as well as transporters 
such as cd36, lpl, and fabp (Mandard et al., 2004; Labar et al., 2010). PPARα’s primary function 
within adipose tissue appears to be activation of thermogeneic programs including activation of 
uncoupling protein-1 and PPARγ co-activator 1α gene expression (Pouslen et al., 2012). 
 
PPARβ: PPARβ is ubiquitously expressed and has a general role is activating β-
oxidation. It is known to increase endurance, oxidative myofiber switch, and glycogen storage 
along with increasing β-oxidation when activated in skeletal muscle (Poulsen et al., 2012). 
PPARβ primarily governs hepatic glucose utilization and lipoprotein metabolism in liver by 
mainly altering the gene expression of VLDL (Pouslen et al., 2012). PPARβ is expressed in 
many different tissues, but is not highly expressed in adipose tissue (Varga et al., 2011). It does, 
however, appear to play a role in priming preadipocytes for differentiation (Pouslen et al., 2012).  
PPARβ has also been linked to colon cancer and is known to down regulate the expression of 
PPARγ (Zuo et al., 2007).   
 
PPARγ: PPARγ is highly expressed in adipose tissue, but has low expression in other 
tissues. PPARγ signals lipid accumulation and it is a key regulator of gene expression for adipose 
tissue development and adipocyte differentiation (Pouslen et al., 2012; Varga et al., 2011; 
Hossner, 2006). Activation of PPARγ leads to increased TAG accumulation in muscle and liver 
(Pouslen et al., 2012). It is the most abundant of the PPAR, occurring in adipose tissue at levels 
30-fold higher than levels found in other tissues (Varga et al., 2011). PPARγ also increases 
insulin sensitivity, but is primarily considered the master regulator of adipocyte differentiation 
and adipocyte metabolism (Hossner, 2006). In general, PPARγ activation induces adipocyte 
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differentiation for both brown and white adipose tissue. There are two main variants of PPARγ, 
PPARγ1 and PPARγ2 in mammals. These isoforms are a result of alternative splicing of mRNA 
and alternate promoter sites of the PPARγ gene (Varga et al., 2011). PPARγ2 has 30 additional 
N-terminal amino acids distinguishing it from PPARγ1 (Hossner, 2006). There is also a third 
promoter in the human sequence coding for a third protein, PPARγ3 (Varga et al., 2011). Co-
activators known to interact with the PPARγ complex include: steroid receptor co-activator 1 
(SRC-1), CREB binding protein (CBP/p300), PPARγ co-activator-1 (PGC-1) and PGC-2, PPAR 
binding protein (PBP/TRAP220/DRIP230), and androgen receptor associated with protein 70 
(ARA70). PPARγ elicits effects on a variety of target genes such as fabps, cd36, lpl, leptin, fas, 
acc, and scd1 (Hossner 2006). The ligand binding domains are highly conserved, with rat and 
mouse PPARγ1 and γ2 having 95-98% homology with the human receptors (Varga et al., 2011).   
 
  Several ligands are known to interact with PPARγ. Hormones and growth factors such 
as insulin, growth hormone, and thyroid hormones are known to interact with PPARγ (Chung 
and Johnson, 2008). A variety of fatty acids and fatty acid derivatives (such as conjugated-
linoleic acid (CLA), eicosanoids and prostaglandins) are known to elicit effects through the 
PPARγ signaling pathway (Smith et al., 2009; Duplus et al., 2000; Dodson et al., 2010; Hausman 
et al., 2009). In addition, micronutrients, such as vitamins A, C, and D, zinc, chromium, and 
magnesium are known to elicit effects on adipogenesis through the PPARγ signaling pathway 
(Kawachi, 2006; Gorocica-Buenfil et al., 2007). These ligands have varying effects on 
adipocytes and adipogenesis. Fatty acids can either up-regulate or down-regulate gene 
expression. Polyunsaturated fatty acids (PUFA), such as linoleate (C18:2n-6), down regulate 
expression of fas. me, and glucose-6-phosphate (g6p) dehydrogenase (Duplus et al., 2000). Both 
saturated (SFA) and unsaturated fatty acids are known to stimulate expression of acyl-CoA 
oxidase (aco), L-fatty acid binding protein (l-fabp), and cpt1 (Duplus et al., 2000). SFA increases 
transcription of ldl and enzymes involved in fatty acid chain elongation (Viscarra and Ortiz, 
2013). A low MUFA:SFA ratio would maintain lipolysis without increasing oxidation, allowing 
for preservation of energy stores to support energetic demands associated with food deprivation 
(Viscarra and Ortiz, 2013). CLA administration to weanling pigs reduces adipocyte volume and 
depresses scd1 gene expression causing a decrease in monounsaturated fatty acids (MUFA) 
synthesis (Hausman et al., 2009). In rodents, CLA prevents lipid filling of adipocytes by 
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decreasing pparγ gene expression in preadipocytes (Brown et al., 2003).  Vitamin A and D 
supplementation depresses adipogenesis while vitamin C supplementation increases adipocyte 
differentiation in beef cattle through interactions with PPARγ (Smith et al., 2009).  
 
Ligands that affect adipogenesis can be used in meat-animal production to improve 
carcass quality (Hausman et al., 2009; Gorocica-Buenfil et al., 2007; Smith et al., 2009; Dodson 
et al., 2010). In the United States there has been a downward trend in cattle that grade Choice 
(Smith et al., 2009). This trend is largely due to loss of corn and other grains to the production of 
ethanol (Smith et al., 2009). Feed manipulation, hormone supplementation, and selective 
breeding have been primary methods used to improve animal growth, but these methods decrease 
muscle quality by decreasing the amount of fat on the carcass (Dodson et al., 2010). These 
decreases in muscle quality have stimulated an interest in developing alternative technologies to 
alter lipid deposition and selectively enhance intramuscular fat deposition in meat animals 
(Dodson et al., 2010). However, mechanisms leading to differential lipid accumulation in 
visceral, subcutaneous, intermuscular, and intramuscular fat depots remain unclear (Dodson et 
al., 2010).  PPAR ligands, especially PPARγ, show the most promise in manipulating adipose 
tissue development by altering adipogenesis.  
 
Post-translational Modifications:   In addition to PPAR ligand-mediated activation, 
PPAR activity is also modified by phosphorylation, which affects their action in both a ligand-
dependent and ligand-independent manner (Diradourian et al., 2004). Phosphorylation, therefore, 
provides a mechanism to alter the activity of PPARs that is dependent on other signaling 
pathways providing a mechanism for crosstalk between pathways. Phosphorylation of PPARs 
has varying affects dependent on the serine phosphorylated and PPAR subtype. PPARα and 
PPARγ A/B domains are phosphorylated, but PPARβ is not (Diradourian et al., 2004; Bugge and 
Mandrup, 2010). The ERK/MAPK pathway is the primary pathway leading to serine 
phosphorylations altering PPAR transcriptional activity. MAPK-phosphorylation of serine 12 
and 21 of PPARα increases transcriptional activity by increasing receptor stability through 
decreased ubiquitination. Increased PPARα activity by phosphorylation in rat hepatocytes 
increases subsequent expression of genes within the β-oxidation pathway. On the other hand, 
phosphorylation of seine 76 of PPARα by glycogen synthase kinase increases ubiquitination and 
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degradation (Buggie and Mandrup, 2010).  MAPK-phosphorylation of serine 82 of PPARγ1 
inhibits its activity by decreasing the ligand-binding affinity of the receptor (Diradourian et al., 
2004; Bugge and Mandrup, 2010). Whereas MAPK-phosphorylation of serine 112 (the 
corresponding serine to serine 82 of PPARα) of PPARγ2 increases transcriptional activity of 
PPARγ. This suggests that the cellular and molecular context determines the transcriptional 
effects of PPARγ, A/B domain phosphorylation. Furthermore, serine 16 or 21 phosphorylation of 
PPARγ by casein-kinase II promotes shuttling of PPARγ from the nucleus to the cytosol, 
inhibiting PPARγ actions on lipogeneic gene transcription (Bugge and Mandrup, 2010).  In 
general, phosphorylation of PPARβ has been less studied; however, there is evidence that cAMP 
and PKA are involved in inhibition of PPARβ actions either through phosphorylation of PPARβ 
directly or by affecting interaction of PPARβ with its coactivators or corepressors (Diradourian 
et al., 2004).  
 
Phosphorylation can alter actions of PPARs through several different mechanisms. First, 
phosphorylation can alter PPAR’s affinity for ligands even if the phosphorylation site is far from 
the ligand binding site through interdomain communications and conformational changes. 
Secondly, phosphorylation can modify PPAR’s interactions with coactivators and corepressors. 
Phosphorylation-induced inhibition of transcriptional activity of PPARs provides a mechanism to 
switch off responses to ligand binding (Diradourian et al., 2004). PPAR phosphorylation could 
also modulate binding to PPRE. In addition, phosphorylation is a signal for ubiquitination and 
proteasomal catabolism of many proteins as well as a determinant of nuclear translocation with 
phosphorylation inhibiting translocation (Diradourian et al., 2004).  However, it is important to 
remember that activities of PPARs are not only dependent on phosphorylation; they also require 
heterodimerization, cofactors, and ligands to elicit their effects, which further allude to their 
complex regulation.  
 
PPARs in Salmonids: PPARs are widely studied in mammals, but little is known about 
fish PPARs. In brown trout, PPARα is highly expressed in white muscle, heart, and liver, while 
PPARβ predominates in testis, heart, liver, white muscle, and trunk kidney. PPARγ, however, 
was only quantified in the trunk kidney and liver (Batista-Pinto et al., 2009). PPARγ was first 
characterized in Atlantic salmon by Ruyter et al. (1997), with the full-length cDNA encoding for 
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PPARγ being reported by Andersen et al. (2000). There appears to be a more diverse expression 
of PPARγ in salmon where it is found not only in adipose tissue, but is also highly expressed in 
liver (Ruyter et al., 1997). Conversely, PPARγ was only quantifiable in the trunk kidney and 
very slightly in liver of brown trout (Batista-Pinto et al., 2009). Furthermore, Andersen et al. 
(2000) found three variants of PPARγ; two differing in 3’UTR length and the third has a 
truncated C-terminal.  Batista-Pinto et al. (2009) determined that PPARβ was the dominant 
PPAR expressed in all tissues investigated (heart, liver, head kidney, trunk kidney, spleen, testis, 
blood, and white muscle). Furthermore, gender and stage of life cycle are known to influence 
expression levels of all PPARs in brown trout; estrogen appears to play an important role in 
differential expression of PPARs (Batista-Pinto et al., 2009).  PPARα differences in gender were 
only during early vitellogenesis. There is also an increased expression of PPARβ in males pre-
spawning. However, PPARγ expression was the same in male and female brown trout, increasing 
post-spawning (Batista-Pinto et al., 2009).  
 
 
Target of Rapamycin (mTOR): 
The TOR pathway is a central signaling pathway that plays a role in integrating energy-
sensing pathways. Regulation of TOR provides a mechanism for cells to transition between 
anabolic and catabolic states in response to nutrient and energy availability (Laplante and 
Sabatini, 2011). TOR is a well-conserved serine/threonine kinase that regulates cell proliferation, 
growth, and metabolism (Hay and Sonenberg, 2004). TOR is a target of rapamycin, an anti-
fungal macrolide produced by Streptomyces hygroscopicus isolated from soil (Vezina et al., 
1975). Rapamycin is a highly specific inhibitor of TOR (Hay and Sonenberg, 2004). TOR was 
first identified through genetic screens of yeast, later mammalian TOR was characterized. The 
official name is now mechanistic TOR (mTOR) (Laplante and Sabatini, 2011).   
 
Signaling Cascade: mTOR associates into two distinct protein complexes, TORC1 
(target of rapamycin complex 1) and TORC2 (target of rapamycin complex 2; Figure 8). TORC1 
integrates four major signals: growth factors, energy status, oxygen, and amino acids to promote 
cell growth and metabolism (Laplante and Sabatini, 2009). TORC2 is activated by growth 
factors and regulates cell survival, metabolism, and cytoskeletal organization (Laplante and 
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Sabatini, 2009). Both complexes act to alter gene transcription of a variety of metabolic 
pathways including protein synthesis, lipid synthesis, adipogenesis, mitochondrial proliferation, 
oxidative metabolism, stress resistance, apoptosis, and inflammation (Lapanate and Sabatini, 
2009; Caron et al., 2010; Laplante and Sabatini, 2011). TORC1 promotes protein synthesis 
through phosphorylation of S6K1 and 4EBPs (Caron et al., 2010). Whereas, TORC1 activates 
lipid biosynthesis through a separate signaling pathway than that used to up regulate protein 
biosynthesis.  
 
The mTOR-activated lipid synthesis begins with growth factors activating Akt, Erk, and 
Rsk through tyrosine-kinase receptors activating PI3K (Caron et al., 2010). The receptor acts as 
an α2β2 tetramer (Voet and Voet, 2004). The α subunits contain the extracellular binding site; β 
subunits anchor the receptor in the cell membrane, and contain the tyrosine kinase domain that 
elicits enzymatic activity of the receptor. When insulin or another growth factor binds the α 
subunits, it activates the tyrosine kinase activity of the β subunit which auto-phosphorylates 
tyrosine residues of the β subunits (Voet and Voet, 2004). Activated tyrosine kinase then 
phosphorylates second messenger proteins such as insulin receptor substrate-1 (IRS-1). Once 
IRS-1 is phosphorylated it acts as a docking protein for other protein messengers that mediate 
actions of growth factors (Voet and Voet, 2004). One protein that is activated by its 
phosphorylation is phosphatidylinositol-3-kinase (PI3K). IRS-1 causes reactions that convert 
phosphatodylinosityl-4,5-diphosphate (PIP2) to become phosphatodylinosityl-3,4,5-triphosphate 
(PIP3) (Voet and Voet, 2004). This activates Akt.  Akt stimulates the movement of GLUT4 
transporters to the cell’s membrane. It also activates protein phosphatase-1 (PP-1) which 
dephosphorylates proteins in nutrient utilization pathways regulated by phosphorylation (Voet 
and Voet, 2004).  Another group of second messengers activated by tyrosine-kinase receptors are 
in the Cbl-P messenger system. This system facilitates the movement of GLUT4 transporters into 
the plasma membrane as well (Voet and Voet, 2004). Gene expression can also be altered by 
growth factors through the activation of the RAS/Mek pathway that activates a series of MAP 
kinase cascade reactions that controls gene expression of target genes (Voet and Voet, 2004). 
Overall, this signaling pathway results in increased glucose uptake and increased glycogen, lipid, 
and protein synthesis. 
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TORC1: Lipogenic gene transcription is primarily increased by downstream effects of 
Akt, Erk, and Rsk on TORC1. The mTOR protein is regulated by several proteins involved in the 
formation of TORC1. These proteins include PRAS40, mLST8, FKBP38, and deptor. TORC1 
cannot elicit its effects if one of these proteins associates with the complex. Raptor, however, is a 
positive regulator of TORC1, activating it (Caron et al., 2010). Additionally, there are four 
phosphorylation sites on TOR that also regulate its actions. They are Ser1261, Ser2448, Ser2481, 
and Thr2446. Ser2481 is an autophosphorylation site. Ser2481 is the only site that has shown 
affects of TOR activity via phosphorylation (Caron et al., 2010). PIP3 activates Akt through 
phosphorylation; Akt, in turn, phosphorylates and inhibits PRAS40 allowing Raptor to activate 
TORC1. Akt also phosphorylates and inhibits TSC1/2 allowing for activation of TORC1 
(Laplante and Sabatini, 2009). Additionally, Akt, Ras, and ERK phosphorylate TSC1/2 
inhibiting its actions allowing for the activation of TORC1 (Caron et al., 2004). TORC1 is also 
sensitive to hypoxia through the action of REDD1 (regulated in development and DNA damage 
responses), a hypoxia-induced protein that inhibits the actions of TORC1.  Another protein that 
alters TORC1 activity is MO25, which is activated during bouts of energy stress and inhibits the 
actions of TORC1 by activating TSC1/2 (Caron et al., 2010). 
 
Gene expression profiling experiments have shown that over 5% of the transcriptome is 
differentially expressed in response to rapamycin-mediated mTOR inhibition (Caron et al., 
2010). TORC1 has several downstream affects that alter lipid synthesis. First, it facilitates 
cleavage of SREBP1 through a mechanism that is not yet established (Laplante and Sabatini, 
2009).  When cleaved, SREBP1 translocates into the nucleus and induces the transcription of 
several lipogenic genes including acc, fas, gpat, and scd1 (Voet and Voet, 2004). In addition, it 
appears that Akt increases the transcription of SREBP1 (Laplante and Sabatini, 2009). Another 
transcription factor affected by TORC1 signaling is PPARγ. There is evidence that PPARγ 
expression and activation is dependent on TORC1. C/EBPα appears to be under similar TORC1 
regulation (Laplante and Sabatini, 2009).  Interestingly, SREBP1 activation increases synthesis 
of PPARγ ligands promoting the transactivation of PPARγ as a transcription factor (Laplante and 
Sabatini, 2009). A third downstream effect of TORC1 involving lipid synthesis is its effects on 
Lipin1. Lipin1 is a phosphatase that facilitates conversion of phosphatidic acid to DAG. Lipin1 
also acts as a transcriptional co-activator for PPARγ (Laplante and Sabatini, 2009). Lipin1 is 
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regulated through phosphorylation; however, it remains unclear how mTORC1 affects its 
activity. There is evidence that Lipin1 is phosphorylated in response to insulin and amino acids 
in a rapamycin-sensitive fashion, suggesting that mTOR signaling may directly regulate 
adipogenesis and lipogenesis through control of Lipin1 activity (Laplante and Sabatini, 2009).   
 
TORC2: The second mTOR complex, TORC2, is involved in cell survival, metabolism, 
and proliferation, but its signaling pathways and role in lipid metabolism are less understood 
than TORC1. TORC2 is comprised of mTOR, Rictor, mSin1, mLST8, and Deptor (Caron et al., 
2010). Deptor is an inhibitor of TORC2 while Rictor, mSin1, and mLST8 help facilitate complex 
formation (Caron et al., 2010). There is little known about the role of TORC2 in lipid 
metabolism. There has been some evidence in lower organisms that suggest TORC2 acts as a 
negative regulator of lipid deposition in Rictor null worms (Jones et al., 2009). It is unclear if this 
same association is present in mammals. However, there is evidence that TORC2 phosphorylates 
and activates Akt. Activation of Akt allows it to elicit its effects on TSC1/2 and TORC1 (Caron 
et al., 2010).  
 
Pathway Integration with β-Oxidation: Most studies are focused on mTOR’s roles in 
facilitating synthesis pathways such as protein, lipid, and amino acid synthesis. There is also an 
appreciation for mTOR’s role in facilitating the switch between glucose, amino-acid, and fatty 
acid metabolism through mTOR’s signaling relationship with AMPK (Tokunaga et al., 2004). 
However, a few studies have shown that mTOR has effects on energy breakdown pathways such 
as fatty acid β-oxidation as well. Both studies investigating mTOR’s role in β-oxidation used 
rapamycin as an mTOR inhibitor to elucidate mTOR’s role in β-oxidation (Brown et al., 2007; 
Sipula et al., 2006).  Brown et al. (2007) used primary rat hepatocytes in culture and found that 
inhibition of mTOR by rapamycin increased β-oxidation of exogenous fatty acids by 46% at 18 
hours and 100% at 48 hours. They went on to show esterification of exogenous fatty acids and de 
novo lipid synthesis were reduced by 40% and 60%, respectively (Brown et al., 2007). 
Rapamycin-inhibition of mTOR also decreased gene expression of acc and gpat. These findings 
further suggest mTOR not only plays an important role in energy sensing, but also plays a role in 
regulating energy production (Brown et al., 2007). Sipula et al. (2006) showed β-oxidation is 
also increased in L6 myotubes and in vivo in S6K1-deficient mice when mTOR is inhibited by 
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rapamycin. These authors saw significant increases in activities of CPT1 and CPT2 in culture 
with subsequent increases in their mRNA levels in vivo (Sipula et al., 2006). The mechanism by 
which mTOR elicits its effects on fatty acid β-oxidation remains unclear. Sipula et al. (2006) 
suggested that mTOR directly acts on key oxidative genes and proteins and causes a flux through 
the β-oxidation pathway. Brown et al. (2007), however, suggested that decreased expression of 
acc during rapamycin-inhibition of mTOR causes a decrease in its product, malonyl-CoA. 
Malonyl-CoA is the first intermediate in the fatty acid synthesis pathway and acts to inhibit 
CPT1. In the absence of malonyl-CoA, CPT1 is active. These authors suggest that it is the 
decreased ACC activity producing less malonyl-CoA that allows for CPT1 activity to increase; 
therefore, increasing the flux of fatty acids through β-oxidation (Brown et al., 2007). Both 
authors do, however, admit that further clarification of the mTOR pathway and its role in β-
oxidation is necessary.  
 
 mTOR in Fish:  The TOR signaling pathway in fish is less characterized than that of 
mammals, however the consensus has been that the mTOR signaling pathway is highly 
conserved among species through limited in vitro and in vivo studies (Plagnes-Juan et al., 2008; 
Seiliez et al., 2008; Lansard et al., 2009; Lansard et al., 2010; Seiliez et al., 2011).  Most studies 
involving salmonids are focused on effects of insulin (Plagnes-Juan et al., 2008; Lansard et al., 
2010) or feeding regimen (Lansard et al., 2009; Seiliez et al., 2011) on energy, mostly protein, 
metabolism. There was some assessment of the lipid synthesis pathway by investigating gene 
expression of fas, srebp1, and cpt1. However, one study focused on differences in lipid 
deposition between two divergent bred lines of rainbow trout (lean and fat) and the role mTOR 
signaling plays in developing those phenotypes (Skiba-Cassy et al., 2009).  
 
Dietary studies determined that feeding a high protein diet activates the mTOR signaling 
pathway and shows a subsequent increase in fas and srebp1gene expression and a decreased cpt1 
mRNA content (Seiliez et al., 2011). Lansard et al. (2009) determined feeding a plant-based diet 
verses a fishmeal-based diet does not alter mTOR signaling, but there were significant increases 
in fatty acid synthesis genes with partial and full fishmeal and fish oil replacement. An in vitro 
study using rainbow trout primary hepatocytes determined amino acids alone did not activate the 
mTOR pathway; however, insulin activated the mTOR signaling pathway confirmed by an up-
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regulation of lipogenic (fas, acyl,and srebp1) and glycolytic (glucokinase, 6-phosphofructo-
kinase, and pyruvate kinase) genes (Lansard et al., 2010). Subsequently, another study tested 
effects of insulin injections on mTOR signaling in vivo in fasted rainbow trout and subjected 
primary hepatocytes to glucose and insulin stimulation (Plagnes-Juan et al., 2008). These authors 
determined that insulin is required for mTOR activation through the PI3-kinase/Akt pathway as 
observed in mammals. Glucose is required for the insulin-induced up-regulation of fas gene 
expression. They also reported a decreased expression of cpt1, but this response was only 
observed in vivo as cpt1 was undetectable in the primary hepatocytes (Plagnes-Juan et al., 2008).  
 
Skiba-Cassy et al. (2009) took a different approach to investigating the role mTOR plays 
in controlling lipid synthesis. These authors wanted to determine if divergent selection for high 
and low muscle fat altered nutrient utilization through changes in mTOR signaling of rainbow 
trout. They also fasted fish and subsequently measured changes in gene expression and mTOR 
activation during refeeding (Skiba-Cassy et al., 2009). Body weight or feed intake was not 
different between the two groups. All data further suggest insulin regulation of the mTOR 
signaling pathway is similar to that in mammals. Refeeding increased expression of lipogenic 
genes and srebp1. They also determined mtor was more abundant in the liver of the fat line fish. 
In addition, they found cpt1 expression was low in the fat line fish compared to that of the lean 
line fish, suggesting a decreased ability for β-oxidation (Skiba-Cassy et al., 2009). Combining 
these findings and those of Corraze et al. (1999) who determined that de novo synthesized lipids 
are preferentially incorporated in muscle rather than adipose tissue, Skiba-Cassy et al. (2009) 
concluded genetic selection for increased muscle fat content results in over activation of the 
mTOR signaling pathway and increased expression of lipogenic genes.  The aforementioned 
responses suggest there are metabolic differences in nutrient utilization between the lines 
resulting in different phenotypes (Skiba-Cassy et al., 2009). 
 
Overview: 
 Many metabolic pathways, including those within fatty acid metabolism, are highly 
conserved across terrestrial and aquatic species. Unfortunately, there has been limited research 
on specific regulatory pathways in aquatic species. Investigating how fatty acid metabolism is 
regulated in fish will improve our understanding of lipid metabolism in aquatic species. Research 
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to characterize regulatory pathways and changes in fatty acid metabolism during various life 
stages would be beneficial in developing more standard protocols in fish culture and processing. 
Standard protocols for fish husbandry, similar to terrestrial food-animal species, will improve 
consistency of fillet quality. Fillet yields and quality are highly variable, making mechanical 
processing very difficult and wasteful. In general, investigations of lipid synthesis, mobilization, 
and oxidation throughout several life stages in fish will increase our understanding of fatty acid 
metabolism and how its regulation affects fillet quality in rainbow trout. 
 
 
 
TABLES and FIGURES 
Table 1: Apoprotein Summary Table 
This table summarizes the 9 apoproteins involved in lipid metabolism and their functions. 
LCAT—lecithin-cholestrol acyltransferase; LPL—lipoprotein lipase; HSPG-- heparin sulfate 
proteoglycan 
 
  
Apoprotein # of Residues Molecular Mass (kD) Function 
AI 243 29 Activates LCAT 
AII 77 17 Inhibits LCAT, activates hepatic lipase 
B48 2152 241 Cholesterol clearance 
B100 4536 513 Cholesterol clearance 
CI 56 6.6 Activates LCAT 
CII 79 8.9 Activates LPL 
CIII 79 8.8 Inhibits LPL 
D 169 19 Unknown 
E 299 34 Cholesterol Clearance, tethers to HSPG 
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Table 2: Lipoprotein Summary Table                                                                                                                                                                          
This table summarizes properties and functions of lipoproteins.  
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Figure 1: Fatty Acid and Triglyceride Synthesis Pathways 
a.) Illustrates the fatty acid synthesis pathway; b.) Illustrates the omega-3 and omega-6 synthesis 
pathways from 18:2n-6 and 18:3n-3; c.) Illustrates the triglyceride synthesis pathway 
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Figure 2: Lipolysis and β-Oxidation 
Lipolysis: To mobilize TAGs and fatty acids from an adipocyte lipid droplet perilipin becomes 
phosphorylated to allow the translocation of lipases. ATGL hydrolyzes the fatty acid in the R3 
position. HSL then hydrolyzes the fatty acid in the R1 position. The resulting MAG is released 
into the cytosol where MAGL removes the final fatty acid in the R2 position yielding the 
glycerol backbone. Glycerol is readily diffusible and goes to the liver to be converted to G3P by 
glycerol kinase. Free fatty acids are transported through the blood by albumin. Once albumin 
reaches a target cell, fatty acids are transported into the cell by fatty acid translocase/cluster of 
differentiation 36 (FAT/CD36), but must be bound to fatty acid binding proteins (FABP) or be 
metabolized immediately. Fatty Acid Oxidation: Acyl-CoA synthetase forms a fatty acyl-CoA. 
The fatty acyl-CoA must then be transported into the mitochondria by carnitine 
palmitoyltransferase I (CPT1). Translocation of the fatty acyl-CoA is mediated by a protein 
carrier that transports acyl-carnitine into the mitochondria while transporting free carnitine out. 
In this process CPT1 transfers the fatty-acyl group to carnitine releasing CoA.  Fatty-acyl 
carnitine is then transported into the mitochondria by CP translocase as it subsequently transfers 
free carnitine out. Fatty-acyl carnitine is then converted back to fatty acyl-CoA and free carnitine 
by CPT2 located on the inner mitochondrial membrane. Free carnitine is transported out of the 
mitochondria by CP translocase and the fatty acyl-CoA can enter the β-oxidation pathway. There 
are four steps that are repeated until the fatty acid is completely broken down into acetyl-CoA. 
These steps are carried out by acyl-CoA dehydrogenase (ACDH),  enoyl-CoA hydratase, 3-L-
hydroxyacyl-CoA dehydrogenase (EHHADH), β-ketoacyl-CoA thiolase These four steps are 
repeated until all of the carbons have been broken down to acetyl-CoA. Long-chained fatty acids 
undergo peroxisomal β-oxidation which is basically the same process, but it occurs in the 
peroxisome of the cell.  
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Table 3: Insulin Actions on Fatty Acid Metabolism 
This table summarizes insulin’s effects of regulated enzymes within fatty acid metabolism 
pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Perixosome Proliferator-Activated Receptor (PPAR) Signaling  
This figure illustrates various effects of PPAR signaling on gene transcription (KEGG 
Pathways). 
 
 
Enzyme Reaction Activated by 
Insulin 
Action 
Fatty Acid Synthesis    
Acetyl-CoA Carboxylase (ACC) Acetyl-CoA           Malonyl-CoA    Dephosphorylation + 
Fatty Acid Synthase (FAS) Malonyl-CoA           Palmitate Dephosphorylation + 
    
Fatty Acid β-Oxidation    
Carnitinepalmitolytransferase (CPT1) Fatty-Acyl CoA Transport Malonyl-CoA - 
    
Lipolysis    
Perilipin Lipases translocation  Phosphorylation - 
Hormone Sensitive Lipase (HSL) DAG          MAG Phosphorylation - 
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Figure 4: Mechanistic Target of Rapamycin (mTOR) Signaling Pathway 
This figure illustrates the mTOR signaling cascade and its downstream effects on fatty acid 
metabolism (Laplante and Sabatini, 2009).  
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ABSTRACT 
Sexual maturation is an energy demanding, physiological process that alters growth 
efficiency and compromises muscle quality in many food-fish species. Lipid mobilization 
supplies energy required for this process. To study the effect of ration level on fatty acid 
composition, diploid (2N) rainbow trout, approaching ovulation, were fed at 0.25 and 0.50% of 
tank biomass/day and to apparent satiation (~0.75% of tank biomass/day). In addition, triploid 
(3N) female trout, which exhibit only minimal ovarian development, were fed at 0.50% of tank 
biomass/day. The primary objective of this study was to determine effects of ration level on fatty 
acid composition in different lipid compartments (muscle, visceral adipose tissue, liver, and 
gonad) during sexual maturation.  Lower feeding levels produced smaller fish, but did not affect 
the onset of sexual maturation. Higher feeding levels resulted in fish muscle with higher relative 
amounts of saturated fatty acids (SFA), but monounsaturated fatty acids (MUFA) and 
polyunsaturated fatty acids (PUFA) were not affected by ration level. While ration level affected 
the fatty acid profile of each of the four tissues analyzed, the number of fatty acids affected was 
greatest in white muscle. An additional objective was to determine differences in the fatty acid 
composition of energy stores during maturation in female rainbow trout that were fed at a 
moderately restricted feeding level (0.50% of tank biomass/day). These differences were 
determined by comparing mature 2N to sterile 3N females of the same age. Diploid muscle 
contained higher amounts of PUFA (44.4±1.0%) than 3N muscle (39.7±0.8%). Saturated fatty 
acids were in the highest concentrations in muscle and visceral adipose tissue, and 2N liver 
contained more PUFAs and fewer MUFAs than 3N liver; however these values are relative 
values. In general, fatty acids affected by ration level were not the same as fatty acids affected by 
ploidy. Triploid fatty acid profiles did not mimic those of the satiation fed group; which was 
expected if 3N fish were simply consuming excess energy. Both 2N and 3N muscle fatty acid 
profiles were similar to that of the diet, except muscle had lower amounts of PUFA precursors 
(18:3n-3 and 20:5n-3) and higher relative amounts of their product (22:6n-3). Also, 2N muscle 
had higher 16:1 and 3N muscle had higher 16:0 compared to the diet. It is unclear if these 
differences are hormonally driven or if there are other physiological dissimilarities between 2N 
and 3N trout causing these differences. Overall, our data suggest that 2N and 3N fatty acid 
metabolism is regulated differently.  
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INTRODUCTION 
 
Sexual maturation is a dominant physiological process that causes a shift from somatic 
growth to gonadal growth (Taranger et al., 2010). In many cultured fish species, including 
salmonids, gonadal development occurs at the expense of stored energy and nutrients, including 
lipids. During this time period, females cannot assimilate enough nutrients from the diet to 
support gonadal development (Nassour and Legar, 1989; Shearer, 1994; Jonsson et al., 1997; 
Kiessling et al., 2001; Memis and Gun, 2004; Salem et al., 2006; Gorgun and Akpinar, 2007; 
Aussanasuwannakul et al., 2011; Riberio et al., 2011; Aussanasuwannakul et al., 2012; and 
Manor et al., 2012).  This repartitioning alters body composition, in general, and muscle lipid 
content, specifically.  Depletion of intramuscular fat and protein catabolism in cultured rainbow 
trout results in a reduction in muscle quality; softer fillets with minimal fat are less desirable for 
food products (Rasmussen 2001; Salem et al., 2006; Salem et al., 2007; Cleveland et al., 2012), 
particularly in a species where a fillet with more oil is a standard of identity.  During sexual 
maturation lipid is mobilized initially from visceral adipose tissue; although, in the long term, 
lipid will be mobilized from secondary storage sites such as muscle (Tocher 2003; Manor et al., 
2012). In disagreement, Kiessling et al. (1991a) suggest that intramuscular fat acts as a short-
term fat depot and is mobilized first.  However, effects of sexual maturation on composition will 
likely depend on the size and composition of nutrient reserves, diet composition, and ration 
levels.  
 
One method that can be used to avoid deterioration of muscle quality during sexual 
maturation is induction of triploidy. Triploid (3N) fish have three sets of chromosomes as 
opposed to two sets of chromosomes in normal diploid (2N) fish. The aquaculture industry 
induces triploidy in a variety of cultured species to cause sterility and prevent the onset of sexual 
maturation. In salmonids, such as rainbow trout, 3N females do not undergo sexual maturation 
and therefore do not develop large ovaries (Piferrer et al., 2009). Triploid females do not 
experience the shift from somatic growth to gonadal growth, thus preventing mobilization of 
lipids and deterioration of muscle quality. Triploid males do, however, undergo sexual 
maturation, but produce non-viable sperm (Piferrer et al., 2009). These characteristics make the 
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production of all female, 3N fish desirable within the aquaculture industry. Nevertheless, little is 
known about the differences in 2N and 3N fatty acid metabolism.  
 
Since total lipid and specific fatty acid contents are important attributes of fillet quality, 
regulation of fatty acid profiles has received much attention.  Considering variables that impact 
fatty acid composition, studies have addressed: 1) cultured versus wild fish, 2) seasonal 
variations, 3) altered diet composition, 4) fasting, and 5) basic physiology (Kiessling et al., 1989; 
Kiessling et al., 1991b; Kiessling et al., 2001; Regost et al., 2001; Memis and Gun, 2004; 
Menoyo et al., 2004; Haugen et al., 2006; Gorgun and Akpinar, 2007; Kandemir and Polat, 2007; 
Turchini and Francis, 2008).  Of these variables, diet is the major contributor to muscle fatty acid 
composition. In general, white muscle saturated fat (SFA) and omega 6 (ω6) fatty acids are 
relatively stable while muscle monounsaturated (MUFA) and omega 3 (ω3) fatty acids exhibit 
greater sensitivity to changes in ration level. However, information on the responses of various 
lipid stores in fish to various ration levels is limited (Kiessling et al., 2001). In addition, little is 
known about differences in lipid metabolism between 2N and 3N rainbow trout. Our previous 
study, Manor et al. (2012), investigated fatty acid and proximate compositions of lipid stores in 
2N and 3N rainbow trout on a high nutritional plane throughout sexual maturation and ovulation. 
We found that female rainbow trout on a high nutritional plane, with large visceral adipose tissue 
energy stores, did not mobilize lipid from muscle energy stores during sexual maturation. These 
findings are in contrast to studies using fish on lower nutritional planes (Kiessling et al., 1989; 
Kiessling et al., 1991a; Kiessling et al., 2001; Memis and Gun, 2004; Gorgun and Akpinar, 2007; 
Salem et al., 2007). Most research has focused on muscle fatty acid composition, with less 
emphasis on other lipid stores (ie. visceral adipose tissue). This follow-up study investigates 
effects of ration level on carcass characteristics and fatty acid composition of energy stores in 
female rainbow trout.  Additionally, effects of sexual maturation on the fatty acid profiles were 
determined by comparing maturing 2N to sterile 3N, female rainbow trout on a moderately 
restricted feeding level (0.50% of tank biomass/day). Additional data from this study on growth, 
fillet quality, and indices of protein degradation are reported in Cleveland et al. (2012). The 
objective of this paper is to determine the effects of sexual maturation and ration level on fatty 
acid composition of four distinct tissues (white muscle, visceral fat, liver, and gonad) 
representing primary fat depots that are central to lipid metabolism, redistribution, and storage.  
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MATERIALS and METHODS 
 
Experimental Design 
 Fish care and experimentation followed guidelines outlined by the US Department of 
Agriculture (USDA) and the National Center for Cool and Cold Water Aquaculture (NCCCWA; 
U.S. Department of Agriculture, Agricultural Research Service) Animal Care and Use 
Committee, which are in line with the National Research Council publication Guide for Care 
and Use of Laboratory Animals. Diploid and triploid female rainbow trout from 4 families 
(family A, B, C, and D) were generated and maintained at the NCCCWA.  At the fingerling 
stage (~50g) and for individual identification, fish were implanted with passive integrated 
transponders (PIT-tags; Avid Identification Systems Inc., Norco, CA, U.S.A.) in the dorsal 
musculature.  Fish were confirmed 2N or 3N by flow cytometry (Allen, 1983; Hershberger and 
Hostuttler, 2007). Multiple families were used to ensure genetic diversity. Fish were maintained 
indoors, under simulated ambient photoperiod, and supplied with partially-recirculated and 
treated spring water throughout the study.  Water temperatures ranged from 12.4
o
C to 14.0
o
C. 
  
One month prior to onset of this study, fish were fed at 0.75% of tank biomass/day.  
Initial ration levels for 2N females were: 1) 0.50% of tank biomass/day, 2) 0.75% of tank 
biomass/day, and 3) apparent satiation, and 3N females were fed at 0.75% of tank biomass/day.  
Two, 1000L tanks were assigned to each of the four treatments, with a total of 7 fish per family 
per treatment.  Families were split between two tanks, with the first tank containing 4 fish from 
families A and B, and 3 fish from families C and D.  The second tank contained 3 fish from 
families A and B, and 4 fish each from families C and D. Therefore, each tank contained an 
equal number of fish (n=14). Two weeks into the 12 week study, it was calculated that fish fed to 
satiation were consuming feed equivalent to 0.80-0.90% of tank biomass/day.  At this time, 2N 
feeding levels were adjusted to: 1) 0.25% tank biomass/day, 2) 0.50% of tank biomass/day, and 
3) apparent satiation (~0.75% of tank biomass/day) for the remaining 10 weeks to increase 
potential differences between the satiation and the next-lowest feeding level. The 3N fish feeding 
level was also decreased from 0.75% tank biomass/day to 0.50% tank biomass/day. Triploid fish 
were only fed at 0.50% of tank biomass/day, a moderately restricted feeding level, because our 
previous study (Manor et al., 2012) examined 3N females fed to satiation. Moreover, the 
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moderately restricted feeding level employed in the 2N portion of this study was applied to 3N 
fish in order to test for the effect of ploidy. Although all fish were expected to be female, males 
were found in two families.  In family C, 8 of the 28 fish were males, and in family D, 13 of the 
28 fish were males.  Since there were not enough females in family D to allow for sampling, this 
family was excluded from the study. Only data from female fish were included in the analysis of 
this study. This criterion resulted in 2 fish per family per tank per ration (48 total fish) sampled 
in January at 22 M of age.   
  
Fish were fed Zeigler G, floating, 5.0mm (3/16”) pelleted feed (42% protein, 16% fat, 2% 
fiber; Zeigler Brothers, Inc.; Gardners, PA, U.S.A.) dispensed by automatic feeders (Arvotec, 
Huutokoski, Finland) that adjust feed released daily based on the predicted mass of the fish in the 
tank. The fatty acid profile of the feed is provided in Table 1. Feeders dispensed feed in multiple 
feeding events between 7am and 2pm.  Fish from each tank were weighed monthly to maintain 
the accuracy of the feeding regimen.  Feeders for those tanks fed to satiation dispensed feed at 
0.50% of tank biomass/day, followed by hand-feeding at the end of day to apparent satiation.  
Feeding procedures were modified one month after the start of the experiment to reduce the 
number of feeding events; these modifications reduced competition for available feed by 
increasing the amount of feed provided per feeding.  This approach promotes a more even feed 
consumption among individuals, especially in those tanks assigned to the lower ration levels.  To 
collect dispensed feed, buckets were placed under the feeders for tanks receiving 0.25 and 0.50% 
rations.  Collected feed was then hand-fed to the fish at 8am the next day, with a second feeding 
at 2pm, if during the first feeding event the fish reached satiation before all the collected feed 
was dispensed. 
 
Sample Collection   
Fish were weighed in November at 20 M of age. November data are reported in 
Cleveland et al. (2012). In January fish were harvested using an overdose of tricaine 
methanesulfonate (MS-222, Western Chemicals, Ferndale, CA, U.S.A.) at 300 mg/L.  Body 
weights and lengths were recorded along with standard gravimetric measurements as reported in 
Cleveland et al. (2012).  Subsamples of dorsal muscle, liver, and visceral adipose tissue were 
immediately frozen in liquid nitrogen and stored at -80
o
C for gene expression, proximate 
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composition, and fatty acid analyses. The dorsal muscle sample was taken from the epaxial 
muscle just caudal to the pectoral girdle and subcutaneous fat was removed. Fish were processed 
the following day at West Virginia University’s Muscle Foods Laboratory (Morgantown, WV, 
U.S.A.). Boneless, skinless fillets were removed from each fish and weighed.  
 
Proximate analyses   
Epaxial muscle subsamples were frozen in liquid nitrogen, powdered using a Waring 
commercial grade blender (Model 51BL31; Waring Commercial; Torrington, CT, U.S.A.), and 
stored at -80C until analysis. Liver, visceral adipose tissue, and gonad samples were minced at 
the time of analysis. Moisture and lipid analyses were completed using AOAC approved 
methods (AOAC, 2000).  Moisture content was determined by weighing the sample before and 
after an 18h drying period at 110C.  Crude lipid content was determined indirectly using 
petroleum ether, Soxhlet extraction.  Sample weight was recorded before and after extraction, 
and the difference was expressed as a percent of the original weight. Whole fillet proximate 
analysis was reported in Cleveland et al. (2012). 
 
Fatty Acid Analysis 
 Total lipids were extracted from epaxial muscle, liver, visceral adipose tissue, and 
gonads, according to Bligh and Dyer (1959), using a chloroform-methanol mixture (2:1 v/v). A 
0.05g sample of minced visceral adipose tissue was used for fatty acid analysis. Fatty acids were 
methylated using the method described by Fritshe and Johnston (1990). Nonadecanoic acid 
(19:0) was used as an internal standard. Fatty acid, methyl esters (FAMEs) were quantified using 
a Varian CP-3800 Gas Chromatograph (Varian Analytical Instruments; Walnut Creek, CA, 
U.S.A.) equipped with a flame ionization detector. A wall-coated, open-tubular fused silica 
capillary column (100m length, 0.25mm inside diameter; Varian Analytical Instruments) was 
used to separate FAMEs. The stationary phase was CP-Sil 88, and nitrogen was the carrier gas at 
a flow of 0.3mL/min. A 10 to 1 split ratio was applied for all samples. An oven temperature of 
140
o
C for 5 min, followed by a temperature ramp of 3
o
C/min to 235
o
C, was used; 235
o
C was 
held for 15 min. The total separation time per sample was 68.5 min. Injector (11-77 injector, 
Varian Analytical Instruments) and detector (Flame Ionization Detector-FID, Varian Analytical 
Instruments) temperatures were maintained at 270
o
C and 300
o
C, respectively. Sample FAMEs 
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were identified based on comparison to retention times of standard FAMEs (SupelcoTM 
quantitative standard FAME 37; Sigma-Aldrich, St. Louis, MO, U.S.A.). Peak area counts were 
computed by an integrator using the Star GC workstation version 6 software (Varian Analytical 
Instruments). Fatty acids were reported as percent of total fatty acids.  
  
Statistical analysis  
Data were analyzed using analysis of variance to test for main effects of ration level and 
family with the general linear models procedure (PC-SAS Version 9.1; 2004).  A 2x3x3x2 (fish 
x family x ration x tank) design, equaling 36 treatment combinations, was used to test ration 
main effects; accounting for mortalities and excluding males, 32 fish were sampled. A 2x3x2x2 
(fish x family x ploidy x tank) design was used to test the main effects of ploidy, equaling 24 
treatment combinations; accounting for mortalities and excluding males, 22 fish were sampled. 
Effects were considered significant at P≤0.05.  There were no significant effects of fish or tank. 
Differences between 2N and 3N fish at the 0.50% ration level were detected with a t-test 
analysis.  Data are presented as LSMeans  SEM (standard error of the mean). 
 
 
 
RESULTS 
 
Growth  
Family Effects:  Because there were no family-by-ration interactions for growth 
responses (Table 2), the main effects of family and ration level were considered separately. The 
only growth parameter affected by family was gonadosomatic index (GSI; P=0.0485). Percent 
separable muscle and whole body weight (WBW) were not significantly affected by family. 
 
Ration Effects:   The highest rations levels produced the heaviest fish (P<0.05). Percent 
separable muscle was not affected (P>0.05) by ration level. Those fish at the highest feeding 
level, the satiation group, had the highest muscle, percent crude fat (Table 2) followed by the 
moderately restricted feeding level, 0.50% of tank biomass/day. Visceral adipose tissue, 
proximate composition (Table 2) followed the same pattern as muscle proximate composition; 
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visceral adipose of the satiation group contained the highest percent crude fat, and the 0.25% of 
tank biomass/day ration group contained the lowest percent crude fat. Moisture content, but not 
crude fat, was affected by ration in liver and 2N gonad tissues with the higher ration levels 
having lower moisture contents (Table 2).  
  
Ploidy Effects: Ploidy was used to determine the effects of sexual maturation on growth 
and adipose tissue metabolism by comparing gravid (2N) and sterile (3N) female trout of the 
same age. There were no family-by-ploidy interactions for growth responses (Table 2).  The 2N 
females had the largest WBW (P≤0.05) compared to 3N females.  Fertile, 2N females also had a 
higher GSI (P≤0.05) than sterile, 3N females, as expected.  Percent separable muscle was greater 
(P≤0.05) in 3N than in 2N females.  The crude fat content of 3N muscle, liver, and visceral 
adipose tissue was higher than in 2N females (Table 2). The moisture content of 3N muscle, 
liver, and visceral adipose tissue was lower than equivalent 2N tissues. 
 
Fatty Acid Content 
Muscle—There were no significant differences in fatty acid content between 0.50% of 
tank biomass and satiation ration levels; whereas, 10 of 23 fatty acids differed between 0.25% 
and 0.50% of tank biomass ration levels (Table 3; P≤0.05).  Overall, SFA and ω6 fatty acids 
were reduced, while ω3 and ω3:ω6 ratios were greater for the 0.25% tank biomass ration level 
compared to the 0.50% of tank biomass and satiation groups.  In general, muscle was composed, 
primarily, of 22:6n-3 and 18:1n-9. In addition, 11 of 23 fatty acids differed between 2N and 3N 
fish fed the 0.50% ration, but not all affected fatty acids were the same, and values were not 
consistent with trends observed for the effect of ration. Some 3N fatty acid values were altered in 
the direction of the satiation fed fish and others in the direction of the 0.25% of tank biomass 
ration fed group. It is assumed that, if 3N females were simply consuming excess energy, their 
fatty acid profile would mimic that of the 2N satiation group. Overall, SFAs were lower and 
PUFAs were higher in 2N fish than the 3N fish fed at 0.50% of tank biomass. Variation observed 
in PUFAs is explained by changes in the ω6 fatty acids; 2N fish had more ω6 fatty acids in the 
muscle. 
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Liver—The satiation ration level resulted in the lowest 14:0 and 18:3n-6 concentrations, 
while the lowest ration level resulted in the lowest 20:1 and 20:2 concentrations. 
Eicosapentaenoic acid (EPA; 20:5n-3) was highest at the 0.25% of tank biomass/day feeding 
level and lowest at the 0.50% of tank biomass/day ration level. The liver was primarily 
comprised of 22:6n-3 and 16:0. Increased levels of 16:0 in the liver indicate fatty acid synthesis 
because this fatty acid is the end product of fatty acid synthase. There were no effects of ration 
level on any of the fatty acid categories (SFA, MUFA, PUFA, ω3, ω6). Ploidy had greater 
effects on liver fatty acids than ration level (Table 4). Overall, 2N livers contained more PUFA 
and ω6 fatty acids, while 3N livers contained more MUFAs.  
 
Visceral Adipose Tissue—Only 20:1 was different (P≤0.05; Table 5) between fish fed to 
0.50% of tank biomass and to satiation. Overall, there were no differences in SFAs, MUFAs, 
PUFAs, ω3 fatty acids, or ω6 fatty acids between the 0.50% of tank biomass and satiation ration 
levels. The most restricted feeding level resulted in the highest relative level of MUFAs and the 
lowest level of PUFAs and ω6 fatty acids. Visceral adipose tissue is comprised of MUFAs and 
PUFAs, with the primary fatty acid being 18:2n-6. Ploidy affected, primarily, the long chain, 
SFAs and MUFAs; 2N visceral adipose tissue had lower amounts of these fatty acids than 3N 
visceral adipose tissue. However, ω6 fatty acids, 18:2n-6 and 20:3n-6, were higher in 2N than in 
3N visceral adipose tissue. Lower (P≤0.05) amounts of PUFAs and ω6 fatty acids along with a 
higher ω3:ω6 ratio were observed in 3N adipose tissue 
  
Diploid Gonads—The effect of ration level on 2N gonads was analyzed because 3N 
females do not develop sufficient gonadal tissue for analysis. There were no differences between 
0.50% tank biomass and satiation ration level. In addition, there were no effects of ration level 
on total SFAs, MUFAs, PUFAs, ω3 and ω6 fatty acids, or ω3:ω6 ratio (Table 6). Diploid gonads 
were mainly comprised of 16:0 and 22:6n-3. Interestingly, a significant family effect was 
observed in all but 9 of the 23 fatty acids measured suggesting that genetics has a larger effect on 
gonad fatty acid composition than ration level.  
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DISUCSSION 
 
This study is a follow-up experiment to our previous work. Manor et al. (2012) examined 
maturing female 2N and 3N rainbow trout on a high plane of nutrition throughout sexual 
maturation from 16 M to 24 M of age. They focused on animal growth and fatty acid 
composition of muscle, liver, visceral adipose tissue, and gonads. Fish employed in that study 
did not mobilize muscle fat in response to sexual maturation because of the high plane of 
nutrition; we therefore wanted to investigate the energy stores during sexual maturation when 
fish are on a lower plane of nutrition. The primary objective of the current study was to 
determine the effects of ration level on fatty acid composition of different energy stores during 
sexual maturation.  We have published the effects of ration level and triploidy on growth metrics 
and protein regulation in muscle from this same study (Cleveland et al., 2012). The current paper 
presents the effects of ration and triploidy on muscle, liver, visceral adipose tissue, and gonad 
proximate composition and fatty acid profiles in maturing female rainbow trout.  
 
The lowest ration level, 0.25% of tank biomass/day, produced lower weight fish.  Ration 
level did not affect the onset of sexual maturation, but reduced ration levels did produce mature 
females with smaller eggs (Cleveland et al., 2012). A secondary objective was to determine 
differences in the fatty acid composition of energy stores between 2N and 3N female rainbow 
trout under moderate nutrient restriction. Our previous study found no differences in growth or 
separable muscle between 2N and 3N females at 22 M (in January) when fish were on a high 
nutritional plane (Aussanasuwannakul et al., 2011; and Manor et al., 2012). However, in the 
current study, WBW and separable muscle were affected by ploidy. Diploid females were 
heavier and yielded lower percent separable muscle than 3N females fed at 0.50% of tank 
biomass/day. A higher WBW with less separable muscle is likely attributable to gonad 
development in 2N fish.   A larger gonadal mass increased processing losses associated with the 
viscera.  Additionally, some muscle atrophy may have occurred as a result of protein catabolism 
to support egg development. 
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Although triploidy results in a higher quality fillet than fillets from fish whose muscle is 
deteriorated by maturation, there is concern that differences in metabolism and energy uses will 
result in altered fillet composition in 3N females (Piferrer et al., 2009). Triploid epaxial muscle 
had higher amounts of total SFAs and lower amounts of PUFAs, but there was no difference in 
the ω3:ω6 ratio between 2N and 3N fish fed at the same rate (0.50% of tank biomass/day). In 
general, the fatty acid profile of 2N and 3N muscle was similar to that found in the diet. The 
exceptions were the PUFA precursors (18:3n-3 and 20:5n-3) being higher in the diet than in the 
muscle and their product 22:6n-3 (DHA) being higher in the muscle than in the feed. In addition, 
3N muscle had higher amounts of 16:0 but similar amounts of 16:1 compared to the diet. 
Diploids, on the other hand, had similar amounts of 16:0 but higher amounts of 16:1 compared to 
the diet. These data suggest that sexual maturation in diploid females alters fatty acid deposition 
within muscle.   
 
The impetus behind changes in fatty acid mobilization during female sexual maturation is 
ovarian development. Ration level affected relative amounts of several individual fatty acids, but 
did not affect total SFAs, MUFAs, or PUFAs in 2N gonads. Salze et al. (2005) determined that 
fatty acids impact egg quality, particularly the highly unsaturated fatty acids such as 20:5n-3, 
22:6n-3, and 20:4n-6. They determined that 20:4n-6 was the most important unsaturated fatty 
acid affecting egg quality (Salze et al., 2005). Interestingly, 20:4n-6 and 22:6n-3 were not 
affected by ration level in our study, and 20:5n-3 was highest in 2N gonads at the most restricted 
ration level. This observation supports Tocher (2003) who reported that 20:5n-3 is preferentially 
mobilized from muscle and visceral adipose tissue and is deposited in 2N gonads during 
gonadogenesis.  Potentially, greater mobilization of fat from muscle and visceral adipose tissue 
at the most restricted feeding level enabled more 20:5n-3 to move into the oocytes.  Furthermore, 
the smaller volume of these oocytes, compared to oocytes from animals on 0.50% of tank 
biomass or satiation rations (Cleveland et al., 2012), may affect the fatty acid profile in favor of 
increasing concentrations of critical lipids because these measurements are relative values.  
Although only approximately 30% percent of the individual fatty acids measured in this study 
were significantly affected by ration, over 50% were affected by family. This observation 
suggests that fatty acid composition and egg quality can be altered to some degree by diet, but 
may be primarily determined by genetics.  Only three rainbow trout families were represented in 
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this study, and this low number limits what we can definitively conclude about the relative 
significance of ration versus genetics on the fatty acid profile of the oocytes.   Nevertheless, 
previous studies in fish suggest that maternal genetics significantly affect egg quality (Brooks et 
al., 1997).     
 
The primary adipose tissue stores that support gonadogenesis in salmonids include 
visceral fat, dorsal fat, and intramuscular fat associated with red and white muscle (Kiessling et 
al., 1991).  Adipose tissue can be separated from visceral and dorsal adipose tissue, while white 
epaxial muscle and red muscle contain the myofibrillar component and intramuscular adipose 
tissue; red muscle contains more lipid than white muscle (Kiessling, 1989).  Previous studies 
indicate that lipid content in adipose tissue and white epaxial muscle decrease (Nassour and 
Legar, 1989; Shearer, 1994; Jonsson et al., 1997; Kiessling et al., 2001; Aussanasuwannakul et 
al., 2011; Riberio et al., 2011; Aussanasuwannakul et al., 2012; and Manor et al., 2012) as fish 
progress through sexual maturation.  Whereas, dorsal adipose tissue and red muscle lipid content 
remains fairly stable across this period (Kiessling et al., 1989).   Because visceral fat and 
intramuscular fat associated with epaxial muscle represent the primary energy stores with the 
most responsive fatty acid profiles, we chose to investigate effects of ration and maturation 
within these tissues.   
 
Our data supports findings of Kiessling et al. (2001) that white muscle is the most 
responsive tissue to changes in ration level. Kiessling et al. (2001) suggested that SFAs and ω3 
fatty acids are the most stable fatty acids while MUFAs and ω3 fatty acids are most responsive to 
changes in ration level. We, however, did not observe this trend in our study. Ration level altered 
SFAs, ω3 and ω6 fatty acids, and the ω3:ω6 ratio and did not affect the total MUFA or PUFA 
content of white muscle. For epaxial muscle from 2N females, higher ration levels increased 
SFA and ω6 fatty acids while the lower ration level resulted in more PUFAs and ω3 fatty acids. 
This effect of ration on epaxial muscle, crude lipid was not observed in immature rainbow trout 
(Kiessling et al., 1989); nonetheless, this effect in maturing 2N fish from the current study likely 
resulted from increased energy demands of sexual maturation and subsequent mobilization of 
epaxial muscle and fillet lipid stores (Cleveland et al., 2012).  It is expected that as ration level 
increased, deposition of SFAs increased, thus reducing the relative percentage of ω3 fatty acids.  
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Our data indicate that feeding at 0.50% of tank biomass/day will yield 2N female rainbow trout 
with growth and epaxial muscle fatty acid composition similar to that of fish fed to apparent 
satiation. This finding is in agreement with previous data also indicating that fatty acid profiles 
of the epaxial muscle are not affected as ration levels approach satiation (Kiessling et al., 1989).   
 
The other primary energy store is visceral adipose tissue. Several studies have shown that 
visceral fat is mobilized first to supply energy for gonadogenesis (Nassour and Leger, 1989; 
Jonsson et al., 1997; Manor et al., 2012). Fish will also mobilize intramuscular fat as a secondary 
energy source to support gonadogenesis when visceral reserves are low. Ration levels in this 
study required maturing fish to mobilize visceral and muscle fat. This effect of gonadogenesis is 
evidenced by lower muscle crude fat content and less visceral adipose tissue.  Although we did 
not separate and quantify changes in visceral adipose tissue,  a lower percent gastrointestinal 
tract (GtSI) of 2N compared to 3N females fed at the 0.50% of tank biomass/day indicates there 
was mobilization of visceral lipids shown through the reduction in this adipose tissue 
compartment as a proportion of the viscera (Cleveland et al., 2012). Differences in muscle fat 
content between 2N and 3N females were not observed in Manor et al. (2012) where fish had 
accumulated large amounts of fat in the various depots. In that study, mature 2N female rainbow 
trout had a GtSI of 7.5±1.5% and fillet crude fat content of 7.5±2.3%, and 3N females of the 
same age had a GtSI of 14.7±1.5% and fillet crude fat content of 11.7±2.3% 
(Aussanasuwannakul et al., 2011; Manor et al., 2012).  To compare, 2N females in the current 
study had a GtSI of 3.97±0.24% and fillet crude fat content of 6.67±0.47% while 3N females had 
a GtSI of 8.08±0.23% and fillet crude fat content of 7.25±0.32% (Cleveland et al., 2012). The 
GtSI is used as a proxy to compare amounts of visceral adipose tissue by assuming little effect of 
ration or ploidy on the other organs of the gastrointestinal tract.  The reduced muscle fat content 
and GtSI indicates that feeding at 0.50% tank biomass/day did not supply enough energy to 
prevent mobilization of endogenous lipid stores.  Furthermore, GtSI and muscle fat content were 
not significantly improved with satiation feeding, suggesting that maximal levels of feed intake 
are still not sufficient to overcome the energy demands of reproduction in this study. This finding 
contradicts findings in Manor et al. (2012) which only had changes in visceral fat content with 
no effect of ploidy or sexual maturation on muscle fat content, albeit, Manor et al. (2012) had 
fish with much larger energy stores.   
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Effects of ration level on the fatty acid composition of visceral adipose tissue were not as 
dramatic as observed in the muscle, in agreement with Kiessling et al. (1991b) who determined 
that white muscle shows the largest changes in fatty acid composition with ration level when 
compared to other fat depots. Furthermore, 2N fish did not mobilize SFAs from visceral fat for 
energy during gonadogenesis as previously seen in Manor et al. (2012). Moreover, the current 
study supports Kiessling et al. (2001) in that muscle fat is used first as an energy store followed 
by visceral fat. Conversely, Manor et al. (2012) showed that visceral fat was the first energy 
store to be used to support gonadogenesis. These differences in findings could be a result of 
variances in the plane of nutrition and the accumulation of energy stores prior to the onset of 
sexual maturation.  
 
In this study, and our previous study (Manor et al., 2012), SFAs were mobilized from 2N 
muscle and visceral adipose tissue in support of gonadogenesis. In the previous study (Manor et 
al., 2012), highly unsaturated fatty acids were also mobilized from visceral fat and muscle in 
support of gonadogenesis, but we did not observe this response in the current study. There is a 
selective catabolism of 20:5n-3, relative to 22:6n-3 in muscle, to produce energy for 
gonadogenesis which results in the selective transfer of 22:6n-3 to the eggs (Tocher, 2003). 
Kiessling et al. (2001) also showed an increased mobilization of 20:5n-3 during maturation, 
which was observed independent of ration level and only in visceral adipose tissue. However, in 
our study, 20:5n-3 and 22:6n-3 were not different between 2N and 3N fish in any of the tissues; 
this observation suggests that there was not preferential mobilization of either fatty acid to 
support gonadogenesis at the 0.50% ration level. In general, Kiessling et al. (2001) and Ribeiro 
et al. (2011) showed much lower levels of the PUFAs and much higher levels of MUFAs than 
our study for muscle and visceral adipose tissue, which could be attributed to variation in dietary 
lipid composition between the studies.  Lower relative levels of PUFAs in 3N fish can be caused 
by increased amounts of SFAs stored as neutral triglycerides.  
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The liver is an important organ in fatty acid metabolism, but does not function as a 
significant fat store (Jonsson et al., 1997; Peragon et al., 2000). Few aspects of lipid metabolism 
are unique to the liver, but many are carried out predominantly by the liver. The liver is the 
primary site of fatty acid oxidation to produce acetoacetate for use by other tissues as energy.  
The liver also converts excess carbohydrates and proteins into fatty acids and triglycerides which 
are transported to adipose tissue depots for storage (Vemuri and Kelley, 2008). In addition, the 
liver is important in gonad development due to its role in vitellogenin synthesis (Memis and Gun, 
2004). Ration level did not exert broad affects on the fatty acid profile of liver tissue indicating 
that the fatty acid profile of the liver is relatively unaffected by ration level during sexual 
maturation. Liver fatty acid composition was, however, significantly affected by ploidy. In 
general, 2N livers had less total MUFAs and more PUFAs and ω6 fatty acids than 3N livers. 
More frequent differences in liver fatty acid composition between 2N and 3N females indicate 
that sexual maturation (ploidy) had a stronger effect on liver fatty acid metabolism than 
differences in ration.  These differences suggest that sexual maturation alters hepatic synthesis of 
specific fatty acids, mainly MUFAs and PUFAs. Alternatively, there can be inherent differences 
in fatty acid metabolism between 2N and 3N fish that contribute to differences in the fatty acid 
profile of other somatic tissues.  Alterations in hepatic synthesis thus changes fatty acid 
deposition and mobilization in 2N and 3N white muscle and visceral adipose tissue.  
 
 
CONCLUSION 
 
 Data from this study provides information about mobilization of lipid stores during 
moderate feed restriction at an important life stage.  In general, restricting the ration level affects 
total SFAs, PUFAs, and ω3 and ω6 fatty acids in 2N muscle. It appears that fatty acids are 
mobilized to a greater extent from muscle of fish on more restricted diets. Our data indicate that 
feeding at 0.50% of tank biomass/day will allow optimal growth of 2N female rainbow trout, and 
feeding above that level will not affect growth or muscle and egg composition. Furthermore, our 
data suggests that fatty acid metabolism is differentially regulated in 2N and 3N females fed on a 
moderately restricted ration level.  
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TABLES 
Fatty Acid 
Percent Fatty Acid 
(%) 
14:0 7.1±0.8 
16:0 19.8±0.5 
16:1 7.1±0.1 
18:0 3.7±0.2 
18:1n-9 16.8±0.2 
18:2n-6 21.5±0.1 
18:3n-6 0.1±0.1 
20:1 9.1±0.1 
18:3n-3 3.0±0.1 
20:4n-6 0.8±0.1 
20:5n-3 6.5±1.0 
22:6n-3 5.3±0.2 
TABLE 1.  FATTY ACID PROFILE OF THE DIET 
Percent fatty acid of all measured fatty acids. All measurements were conducted in duplicate. 
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TABLE 2: GROWTH AND PROXIMATE COMPOSITION—RATION EFFECTS 
LSMean ± SEM for Whole Body Weight (WBW), Gonadosomatic Index (GSI), Percent 
Separable Muscle, and proximate composition of 2N female rainbow trout fed three ration levels 
(0.25% and 0.50% of tank biomass/day and satiation) and 3N female rainbow trout fed 0.50% of 
tank biomass/day. GSI was calculated by representing gonad weight as a present of WBW. 
Separable muscle was calculated by representing the boneless-skinless fillet weight as a percent 
of WBW. Moisture and crude fat contents of epaxial muscle, liver, visceral adipose tissue (Vis 
AT), and 2N gonad were measured using AOAC approved methods (AOAC, 2000). Superscripts 
(
ab
) indicate ration main effects. Means with the same letters are not significantly difference 
(p>0.05). Asterisks (*) represent significant differences between 2N and 3N fish fed 0.5% tank 
biomass/day (P≤0.05). 
 
 
 
 
 
 
  
 Ration Level Ploidy  P-values  
 0.25% 0.5% Satiation 3N (0.5%)  Ration Ploidy Family 
Growth Parameters         
WBW (g) 1584±71
a
 1888±89
b
 2015±76
b
 1331±43*   0.0018  <0.0001  0.1843  
GSI (%) 13.7±0.7  12.6±0.9  13.9±0.8  0.04±0.40*   0.5598  <0.0001  0.0485  
Separable Muscle (%) 40.6±2.1  43.9±2.6  44.5±2.2  51.2±3.2*   0.3979 0.0089 0.3779 
         
Muscle Composition         
Moisture (%) 76.7±0.2
 b
 75.3±0.2
 a
 75.1±0.2
 a
 74.3±0.3  <0.0001 0.0557 <0.0001 
Crude Fat (%) 2.5±0.2
 a
 3.0±0.3
 b
 3.2±0.2
 b
 4.2±0.3*  0.0549 0.0369 0.0557 
         
Liver Composition         
Moisture (%) 78.1±0.3
b
 76.9±0.3
 a
 76.8±0.3
 a
 73.7±0.2*  0.0054 0.0054 0.7520 
Crude Fat (%) 2.0±0.4 2.9±0.5 2.4±0.4 3.6±0.4*  0.4088 <0.0001 0.9937 
         
Vis AT Composition         
Moisture (%) 16.2±0.9
 b
 15.1±1.1
 b
 11.8±1.0
 a
 8.6±1.0*  0.0022 0.0022 0.2626 
Crude Fat (%) 80.9±1.1
 a
 82.4±1.3
 a
 86.2±1.1
 b
 90.3±1.1*  0.0016 0.0010 0.2331 
         
2N Gonad Composition        
Moisture (%) 63.3±0.6
b
 60.0±0.8
a
 61.8±0.7
 ab
 ---  0.0114 --- 0.0286 
Crude Fat (%) 1.6±0.3 2.4±0.4 2.1±0.3 ---  0.1998 --- 0.6129 
         
n 12 10 11 12     
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TABLE 3: EPAXIAL MUSCLE FATTY ACID COMPOSITION 
Percent fatty acid of all measured fatty acids. LSMean±SEM for 23 individual fatty acids and the total 
saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), 
omega-3 fatty acids (ω3), omega-6 fatty acids (ω6), and omega-3 to omega-6 ratio (ω3:ω6). Table shows 
means of 2N female rainbow trout fed three ration levels (0.25% and 0.50% of tank biomass/day and 
satiation). Superscripts indicate significant effects of ration. Table also shows the means of 2N and 3N 
female rainbow trout fed 0.50% of tank biomass/day. Asterisks (*) indicate ploidy main effects. Means 
without an asterisk are not significantly different (p≤0.05). 
 Ration Effects 
Fatty 
Acid 0.25 % 0.5 % Satiation 
Ration 
P-value 
Family  
P-value 3N 
Ploidy 
P-value 
12:0 0.02±0.01 0.02±0.01 0.02±0.01 0.8344 0.1056 0.05±0.01* 0.0232 
14:0 3.24±0.10
a
 3.62±0.12
b
 3.56±0.11
b
 0.0438 0.2511 4.17±0.10* 0.0040 
14:1 0.06±0.01 0.04±0.01 0.05±0.01 0.3915 0.5138 0.08±0.01* 0.0025 
15:0 0.26±0.01
a
 0.28±0.01
ab
 0.29±0.01
b
 0.0307 0.7859 0.29±0.01 0.3259 
16:0 19.92±0.24 20.49±0.30 20.51±0.26 0.2016 0.6333 22.75±0.46* 0.0105 
16:1 5.14±0.16 5.37±0.20 5.46±0.17 0.3737 0.0113 6.62±0.19* 0.0014 
17:0 0.24±0.01
a
 0.26±0.01
b
 0.27±0.01
b
 0.0102 0.0662 0.25±0.01 0.0905 
18:0 3.50±0.07
a
 3.76±0.08
b
 3.78±0.07
b
 0.0213 0.3935 4.06±0.08 0.0657 
18:1n-9 16.26±0.30
a
 17.4±0.37
b
 17.24±0.31
b
 0.0376 0.0321 17.18±1.09 0.6641 
18:2n-6 13.71±0.30
a
 14.81±0.37
b
 14.90±0.32
b
 0.0243 0.7166 13.44±0.29* 0.0212 
20:0 0.13±0.004 0.14±0.01 0.14±0.005 0.4262 0.3309 0.15±0.03* 0.0414 
18:3n-6 0.28±0.03 0.35±0.04 0.33±0.03 0.3196 0.0301 0.36±0.03 0.9268 
20:1 5.12±0.21 4.79±0.26 4.96±0.22 0.6188 0.0959 5.00±0.26 0.4040 
18:3n-3 1.49±0.04
a
 1.62±0.05
b
 1.73±0.05
b
 0.0037 0.3014 1.51±0.04 0.2295 
20:2 1.38±0.11
a
 1.93±0.14
b
 1.80±0.12
b
 0.0136 0.3922 1.49±0.13* 0.0343 
22:0 0.09±0.03 0.14±0.04 0.11±0.03 0.6174 0.5520 0.09±0.04 0.3529 
20:3n-6 1.22±0.07 1.28±0.09 1.26±0.08 0.8677 <0.0001 1.05±0.06* 0.0354 
22:1n-9 0.37±0.02 0.37±0.03 0.34±0.02 0.5421 <0.0001 0.45±0.03* 0.0316 
20:3n-3 0.23±0.03 0.22±0.04 0.18±0.03 0.5889 0.3941 0.16±0.01* 0.0269 
20:4n-6 1.65±0.07
b
 1.33±0.08
a
 1.40±0.07
a
 0.0124 0.0090 1.32±0.06 0.9320 
20:5n-3 4.53±0.15
b
 3.51±0.20
a
 3.79±0.16
a
 0.0008 0.0488 3.17±0.10 0.0849 
24:1 0.56±0.02 0.49±0.03 0.50±0.02 0.1497 0.2059 0.48±0.03 0.6864 
22:6n-3 20.57±0.69
b
 17.76±0.86
a
 17.37±0.74
a
 0.0096 0.0623 15.87±0.65 0.1513 
        
SFA 27.25±0.39
a
 28.74±0.45
b
 28.70±0.39
b
 0.0259 0.8976 31.8±0.6* 0.0117 
MUFA 27.5±0.6 28.5±0.7 28.6±0.5 0.3743 0.0085 29.8±1.1 0.5673 
PUFA 46.5±0.6 44.8±0.7 44.6±0.6 0.0689 0.0230 39.7±0.8* 0.0027 
ω3 26.8±0.8b 23.1±1.0a 23.1±0.9a 0.0060 0.0504 20.7±0.7 0.0963 
ω6 18.3±0.3a 19.7±0.4b 19.7±0.3b 0.0074 0.1943 17.7±0.4* 0.0057 
ω3: ω6 1.47±0.06b 1.19±0.07a 1.18±0.06a 0.0046 0.0911 1.17±0.05 0.9606 
n 12 10 11   12  
Ploidy Effects 
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 Ration Effects Ploidy Effects 
Fatty 
Acid 0.25 0.5 Satiation 
Ration 
P-value 
Family   
P-value 3N 
Ploidy  
P-value 
12:0 ND ND ND ND ND ND ND 
14:0 2.08±0.13b 2.06±0.16b 1.63±0.13a 0.0494 0.2839 1.70±0.09 0.9012 
14:1 ND ND ND ND ND ND ND 
15:0 0.27±0.02 0.26±0.02 0.24±0.02 0.5524 0.2121 0.11±0.01* <0.0001 
16:0 20.06±1.19 20.66±1.47 21.75±1.26 0.6229 0.0960 21.51±0.78 0.1961 
16:1 2.41±0.22 2.14±0.27 2.48±0.23 0.6261 0.2131 4.51±0.29* 0.0004 
17:0 0.48±0.04 0.36±0.05 0.41±0.04 0.1668 0.0239 0.15±0.03* 0.0006 
18:0 10.12±0.54 11.28±0.68 9.47±0.58 0.1543 0.6657 7.27±0.29* <0.0001 
18:1n-9 11.18±0.73 10.96±0.91 12.34±0.78 0.4450 0.6939 17.58±0.72* <0.0001 
18:2n-6 6.68±0.28 6.31±0.35 6.57±0.30 0.7110 0.3783 6.32±0.16 0.5638 
20:0 0.08±0.02 0.10±0.02 0.09±0.02 0.7109 0.3390 0.24±0.02* <0.0001 
18:3n-6 0.21±0.02b 0.14±0.03ab 0.12±0.02a 0.0313 0.0199 0.25±0.02* 0.0080 
20:1 3.75±0.26a 4.98±0.32b 3.54±0.27a 0.0069 0.0173 4.20±0.28 0.1208 
18:3n-3 0.46±0.05 0.30±0.07 0.47±0.06 0.1191 0.0882 0.31±0.06 0.8688 
20:2 2.68±0.27a 4.11±0.33b 3.36±0.29ab 0.0114 0.0006 2.63±0.26* 0.0121 
22:0 ND ND ND ND ND ND ND 
20:3n-6 3.29±0.42 4.14±0.52 2.81±0.45 0.1806 0.0983 2.92±0.28* 0.0153 
22:1n-9 ND ND ND ND ND ND ND 
20:3n-3 0.23±0.02 0.27±0.03 0.25±0.02 0.5166 0.1666 0.35±0.02* 0.0053 
20:4n-6 5.23±0.64 4.68±0.80 4.74±0.68 0.8197 0.1126 3.15±0.23* 0.0003 
20:5n-3 5.10±0.39b 3.35±0.48a 4.52±0.41ab 0.0358 0.6793 3.15±0.28 0.4224 
24:1 1.44±0.13 1.54±0.16 1.89±0.14 0.0758 0.0100 2.12±0.16* 0.0355 
22:6n-3 24.27±1.63 22.37±2.02 23.31±1.73 0.7635 0.4655 21.53±1.27 0.3905 
        
SFA 33.08±1.72 34.72±2.14 33.60±1.83 0.8801 0.3185 30.98±1.10 0.1985 
MUFA 18.78±1.09 19.61±1.35 20.25±1.16 0.6527 0.3714 28.41±0.93* <0.0001 
PUFA 48.14±2.78 45.66±2.83 46.15±2.42 0.7498 0.3918 40.61±1.59* 0.0310 
ω3 30.05±1.96 26.28±2.43 28.56±2.08 0.4958 0.5164 25.34±1.52 0.4107 
ω6 18.09±0.79 19.38±0.98 17.59±0.84 0.3920 0.2935 15.27±0.41* <0.0001 
ω3: ω6 1.71±0.13 1.39±0.16 1.63±0.14 0.3153 0.7513 1.66±0.10 0.2054 
n 12 10 11   12  
 
TABLE 4: LIVER FATTY ACID COMPOSITION 
Percent fatty acid of all measured fatty acids. LSMean±SEM for 23 individual fatty acids and the 
total saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty 
acids (PUFA), omega-3 fatty acids (ω3), omega-6 fatty acids (ω6), and omega-3 to omega-6 ratio 
(ω3:ω6). Table shows means of 2N female rainbow trout fed three ration levels (0.25% and 
0.50% of tank biomass/day and satiation). Superscripts indicate significant effects of ration. 
Table also shows the means of 2N and 3N female rainbow trout fed 0.50% of tank biomass/day. 
Asterisks (*) indicate ploidy main effects. Means without an asterisk are not significantly 
different (p≤0.05). 
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 Ration Effects Ploidy Effects 
Fatty 
Acid 0.25 0.5 Satiation 
Ration 
P-value 
Family  
P-value 3N 
Ploidy 
P-value 
12:0 0.05±0.002 0.06±0.003 0.06±0.002 0.0763 0.3895 0.07±0.002* 0.0434 
14:0 3.93±0.05 4.09±0.07 4.01±0.06 0.2287 0.0604 4.24±0.07 0.1238 
14:1 0.11±0.004 0.12±0.005 0.12±0.004 0.5169 0.3601 0.15±0.004* 0.0027 
15:0 0.46±0.01
a
 0.49±0.01
b
 0.50±0.01
b
 0.0026 0.2473 0.52±0.01* 0.0231 
16:0 6.75±0.17
a
 7.40±0.22
b
 7.44±0.18
b
 0.0231 0.6610 9.48±0.20* <0.0001 
16:1 10.82±0.26
a
 11.61±0.32
ab
 11.75±0.27
b
 0.0468 0.9277 12.97±0.25* 0.0158 
17:0 0.37±0.01 0.36±0.02 0.38±0.02 0.7729 0.8158 0.41±0.02 0.1269 
18:0 2.32±0.05 2.18±0.06 2.24±0.05 0.2027 0.0355 2.75±0.05* <0.0001 
18:1n-9 17.93±0.23 17.72±0.28 17.81±0.24 0.8418 0.0645 17.84±0.16 0.6042 
18:2n-6 30.19±0.43
a
 32.09±0.54
b
 31.27±0.46
ab
 0.0345 0.0005 26.86±0.43* <0.0001 
20:0 0.13±0.75 2.03±0.93 0.02±0.80 0.2244 0.2697 0.11±0.95 0.3380 
18:3n-6 0.50±0.03 0.52±0.04 0.51±0.03 0.9268 0.2390 0.59±0.04 0.5086 
20:1 12.01±1.01
c
 6.12±1.25
a
 8.73±1.07
b
 0.0044 0.3695 8.13±1.14 0.2239 
18:3n-3 3.27±0.17 3.73±0.21 3.85±0.18 0.0662 0.0382 3.83±0.20 0.8308 
20:2 1.92±0.11 1.93±0.14 1.76±0.12 0.5641 0.4821 1.70±0.11 0.2859 
22:0 ND ND ND ND ND ND ND 
20:3n-6 1.19±0.06 1.19±0.08 1.08±0.07 0.4743 <0.0001 0.90±0.06* 0.0194 
22:1n-9 ND ND ND ND ND ND ND 
20:3n-3 ND ND ND ND ND ND ND 
20:4n-6 0.79±0.05 0.93±0.07 0.78±0.06 0.1960 0.8006 0.86±0.05 0.5784 
20:5n-3 1.76±0.11 1.94±0.14 2.01±0.12 0.2980 0.2127 2.33±0.10 0.0947 
24:1 0.38±0.08 0.43±0.11 0.30±0.09 0.6491 0.2739 0.31±0.11 0.6662 
22:6n-3 5.05±0.36 5.05±0.44 5.39±0.38 0.7795 0.5970 5.94±0.41 0.3500 
        
SFA 14.01±0.73 16.62±0.90 14.64±0.77 0.0983 0.4136 17.59±0.87 0.3685 
MUFA 41.33±0.81
b
 36.00±1.00
a
 38.70±0.86
a
 0.0019 0.1512 39.40±0.97 0.0559 
PUFA 44.66±0.69
a
 47.38±0.85
b
 46.65±0.73
ab
 0.0460 0.0103 43.01±0.67* 0.0011 
ω3 10.08±0.57 10.72±0.70 11.25±0.60 0.3844 0.4215 12.10±0.65 0.3491 
ω6 34.58±0.49a 36.66±0.61b 35.41±0.52ab 0.0499 0.0056 30.92±0.57* <0.0001 
ω3: ω6 0.29±0.02 0.30±0.02 0.32±0.02 0.5434 0.6410 0.39±0.02* 0.0227 
n 12 10 11   12  
 
TABLE 5: VISCERAL ADIPOSE TISSUE FATTY ACID COMPOSITION 
Percent fatty acid of all measured fatty acids. LSMean±SEM for 23 individual fatty acids and the 
total saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty 
acids (PUFA), omega-3 fatty acids (ω3), omega-6 fatty acids (ω6), and omega-3 to omega-6 ratio 
(ω3:ω6). Table shows means of 2N female rainbow trout fed three ration levels (0.25% and 
0.50% of tank biomass/day and satiation). Superscripts indicate significant effects of ration. 
Table also shows the means of 2N and 3N female rainbow trout fed 0.50% of tank biomass/day. 
Asterisks (*) indicate ploidy main effects. Means without an asterisk are not significantly 
different (p≤0.05). 
67 
 
 Ration Effects                                                           P-values 
Fatty 
Acid 0.25 0.5 Satiation Ration  Family   
12:0 0.03±0.002
a
 0.04±0.003
ab
 0.04±0.002
b
 0.0239 0.0007 
14:0 3.2±0.1 3.3±0.1 3.3±0.1 0.5268 0.0959 
14:1 0.047±0.002
a
 0.050±0.003
ab
 0.059±0.003
b
 0.0147 0.0242 
15:0 0.36±0.007 0.36±0.009 0.34±0.008 0.3480 0.9648 
16:0 20.4±0.2 20.1±0.3 19.7±0.3 0.1221 0.0254 
16:1 5.6±0.1 5.4±0.2 5.7±0.2 0.5683 0.0493 
17:0 0.32±0.01
b
 0.30±0.01
ab
 0.23±0.01
a
 0.0131 0.1312 
18:0 5.6±0.1 6.0±0.2 6.1±0.2 0.1109 0.0524 
18:1n-9 0.26±0.04 0.34±0.06 0.22±0.05 0.2716 0.4167 
18:2n-6 11.7±0.2 11.6±0.3 11.5±0.3 0.8494 0.0056 
20:0 0.05±0.002 0.05±0.003 0.05±0.002 0.5819 0.5976 
18:3n-6 0.47±0.02
b
 0.31±0.03
a
 0.26±0.03
a
 <0.0001 0.0011 
20:1 2.9±0.07 3.1±0.09 3.1±0.07 0.0290 0.0645 
18:3n-3 1.4±0.04 1.4±0.06 1.5±0.05 0.5884 0.1111 
20:2 1.8±0.1 2.3±0.1 2.3±0.1 0.0009 0.0202 
22:0 ND ND ND ND ND 
20:3n-6 2.2±0.4 2.4±0.2 2.3±0.2 0.8088 <0.0001 
22:1n-9 0.13±0.01 0.15±0.01 0.14±0.01 0.1622 0.1333 
20:3n-3 0.20±0.01 0.22±0.01 0.21±0.01 0.3243 0.9785 
20:4n-6 2.8±0.1 2.4±0.2 2.5±0.1 0.1255 0.0024 
20:5n-3 4.2±0.1
b
 3.5±0.1
a
 3.6±0.1
a
 <0.0001 0.0110 
24:1 0.33±0.01 0.34±0.02 0.35±0.01 0.5556 0.5616 
22:6n-3 18.1±0.4 18.2±0.5 18.8±0.5 0.5126 0.0064 
      
SFA 30.0±0.3 30.1±0.4 29.7±0.3 0.7836 0.0445 
MUFA 27.0±0.3 27.5±0.4 27.2±0.4 0.6699 0.0002 
PUFA 43.0±0.4 42.4±0.5 43.1±0.5 0.6229 0.1177 
ω3 24.0±0.4 23.4±0.6 24.1±0.5 0.6173 0.0054 
ω6 19.0±0.2 19.1±0.3 19.0±0.2 0.9800 0.0058 
ω3: ω6 1.26±0.03 1.23±0.04 1.28±0.04 0.7108 0.0013 
n 12 10 11   
 
TABLE 6: DIPLOID GONAD FATTY ACID COMPOSITION 
 Percent fatty acid of all measured fatty acids. LSMean ± SEM for 23 individual fatty acids and 
the total saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty 
acids (PUFA), omega-3 fatty acids (ω3), omega-6 fatty acids (ω6), and omega-3 to omega-6 ratio 
(ω3:ω6). Table shows means of 2N female rainbow trout fed three ration levels (0.25% and 
0.50% of tank biomass/day and satiation). Superscripts indicate significant effects of ration. 
Means with the same letters are not significantly different (p≤0.05). 
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ABSTRACT 
 
 In many cultured fish species, such as salmonids, gonadal development occurs at the 
expense of stored energy and nutrients, including lipids. However, mechanisms regulating 
nutrient repartitioning during sexual maturation are not well understood. This study investigated 
effects of ration level and sexual maturation on expression of 35 genes involved in fatty acid 
metabolism, including genes within fatty acid synthesis, β-oxidation, and cofactors of the mTOR 
and PPAR signaling pathways.  Gene expression profiles were assessed in liver, white muscle, 
and visceral adipose tissue of sexually maturing, diploid (2N) female rainbow trout fed at 0.25 
and 0.50% of tank biomass/day and to apparent satiation. Additionally, sterile triploid (3N) 
female trout were fed at 0.50% of tank biomass/day for comparison to 2N females fed at the 
same ration level. Gene expression was affected by ration level only in white muscle; erk and 
acat2 were increased in fish fed higher rations. On the other hand, sexual maturation affected 
gene expression across all three tissue types. Data indicate 2N fish have increased expression of 
β-oxidation genes within white muscle and within visceral adipose tissue. These findings support 
enhanced fatty acid mobilization within these tissues during sexual maturation. Increased 
expression of fatty acid synthesis genes in 3N female liver is associated with increased 
expression of mTOR cofactors and pparγ, which reflects continued deposition of lipids in these 
fish. Furthermore, increased expression of genes involved in β-oxidation pathways across ration 
levels in 2N females suggests that maturation-associated hormonal signals, such as estrogen, may 
regulate these effects. 
 
 
 
INTRODUCTION 
 
Sexual maturation is a dominant physiological process that causes a shift from somatic 
growth to gonadal growth (Taranger et al., 2010). In many cultured fish species, including 
salmonids, gonadal development occurs at the expense of stored energy and nutrients, including 
lipids. During this time period, female rainbow trout develop ovaries that account for over 20% 
of total body weight prior to ovulation (Tyler et al., 1990). Maturing females typically cannot 
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assimilate enough nutrients from the diet to support gonadal development and, therefore, must 
mobilize energy reserves to support the increased energy demand (Nassour and Legar, 1989; 
Shearer, 1994; Jonsson et al., 1997; Kiessling et al., 2001; Memis and Gun, 2004; Salem et al., 
2006; Salem et al., 2007; Gorgun and Akpinar, 2007; Aussanasuwannakul et al., 2011; Riberio et 
al., 2011; Aussanasuwannakul et al., 2012; and Manor et al., 2012).  Lipids are mobilized from 
visceral adipose tissue and muscle stores during maturation (Nassour and Legar, 1989; Shearer, 
1994; Jonsson et al., 1997; Aussanasuwannakul et al., 2011; Manor et al., 2012). However, 
effects of sexual maturation on body composition likely depend on size and composition of 
nutrient reserves, diet composition, and ration levels. Even though nutritional plane during 
maturation affects egg size, it does not affect the proximate composition or fatty acid content of 
eggs (Ridelman et al., 1984; Knox et al., 1988; Washburn et al., 1990; Cleveland et al., 2012; 
Manor et al., 2014). The lack of changes in gonadal development in response to changes in 
dietary nutrient availability indicates the importance of endogenous nutrient reserves during 
sexual maturation in female rainbow trout (Nassour and Legar, 1989).  
 
Although nutrient repartitioning is important to sexual maturation in female fish, little is 
understood about regulation of nutrient mobilization during this time period. Two pathways, 
known to regulate nutrient metabolism in mammals, are the mechanistic target of rapamycin 
(mTOR) and peroxisome proliferator activated receptors (PPAR) pathways (Laplante and 
Sabatini, 2011; Poulsen et al., 2012). Both pathways respond to nutrient availability and alter 
target gene expression of key enzymes involved in fatty acid metabolism. Nonetheless, both 
pathways are not specific to controlling lipid metabolism; they are also active in a variety of 
other processes such as inflammation, immune function, apoptosis, protein metabolism, and 
stress resistance (Laplante and Sabatini, 2011; Poulsen et al., 2012).  
 
The mTOR pathway is a central signaling cascade that plays a role in integrating energy-
sensing pathways. Regulation of mTOR provides a mechanism for cells to transition between 
anabolic and catabolic states in response to nutrient and energy availability (Laplante and 
Sabatini, 2011). The mTOR signaling pathway in fish is less characterized than that of mammals; 
however, through limited in vitro and in vivo studies, the consensus has been that the mTOR 
signaling pathway is highly conserved among species (Plagnes-Juan et al., 2008; Seiliez et al., 
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2008; Lansard et al., 2009; Lansard et al., 2010; Seiliez et al., 2011). There are two main paths 
mTOR can act through; the assembly of mTOR Complex 1 (TORC1) and mTOR Complex 2 
(TORC2). TORC1 elicits its effects on lipid metabolism by increasing the expression of genes 
involved in fatty acid synthesis (Laplante and Sabatini 2009; Caron, 2010). Whereas, TORC2 is 
less characterized, it is believed to play a role in regulating the transcription of genes involved in 
fatty acid β-oxidation (Jones et al., 2009).  However, most studies involving mTOR in salmonids 
are focused on effects of insulin (Plagnes-Juan et al., 2008; Lansard et al., 2010) or feeding 
regimen (Lansard et al., 2009; Seiliez et al., 2011) on energy, mostly protein, metabolism. There 
has been some assessment of the fatty acid synthesis pathway by investigating gene expression 
of fas, srebp1, and cpt1 (Lansard et al., 2009; Seiliez et al., 2011). However, one study focused 
on differences in lipid deposition between two divergently bred lines of rainbow trout (lean and 
fat) and the role mTOR signaling plays in developing those phenotypes (Skiba-Cassy et al., 
2009). 
 
The PPAR signaling pathway is known to respond to lipids and elicit transcriptional 
changes on genes involved in lipid metabolism in mammals. PPARs are members of the nuclear 
receptor superfamily of ligand-activated transcription factors (Poulsen et al., 2012). All three 
isoforms of PPAR must form a heterodimer with retinoid x receptor (rxr) in order to elicit their 
effects on gene transcription.  Gender and stage of life cycle influence expression levels of all the 
PPARs in brown trout; estrogen appears to play an important role in differential expression of 
PPARs (Batista-Pinto et al., 2009).   Activation of PPARγ specifically leads to increased TAG 
accumulation in muscle and liver (Pouslen et al., 2012). PPARγ is the most abundant of the 
PPARs, occurring in adipose tissue at levels 30-fold higher than levels found in other 
mammalian tissues (Varga et al., 2011). PPARγ affects transcription rates of a variety of 
lipogenic target genes such as fabp, cd36, lpl, leptin, acc, fas, and scd1 (Lee and Hossner, 2002). 
Additionally, PPARα and PPARβ are responsible for regulating fatty acid β-oxidation (Varga et 
al., 2011). 
 
This study is part of a series of publications examining effects of maturation and ration 
level on indices of protein degradation, fillet quality, body composition, and fatty acid content of 
energy stores in female diploid (fertile; 2N) and triploid (sterile; 3N) rainbow trout (Manor et al., 
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2014; Cleveland et al., 2012). As previously reported, ration levels employed in this study did 
not negatively impact maturation or fatty acid body composition. There was, however, an up-
regulation of gene expression within proteolytic pathways during sexual maturation that was also 
dependent on ration level. In addition, ration levels altered nutrient retention efficiencies and egg 
size. Conclusions among these studies were that the 0.50% ration level is an optimal feeding 
strategy for fish during the breeding cycle to increase efficiency and profitability.  The purpose 
of this current report is to assess differences in lipogenic gene expression in response to varying 
ration levels and sexual maturation by comparing maturing 2N females to sterile 3N females of 
the same age.  Understanding how genes within pathways related to lipid metabolism are 
regulated will indicate mechanisms responsible for nutrient repartitioning during sexual 
maturation.  Furthermore, identifying critical genes and pathways associated with phenotypic 
traits will enhance our knowledge of how management strategies or feeding practices can 
regulate these mechanisms for more efficient food-fish production. 
 
 
 
MATERIALS and METHODS 
 
Experimental Design   
Fish care and experimentation followed guidelines outlined by the US Department of 
Agriculture (USDA) and the National Center for Cool and Cold Water Aquaculture (NCCCWA; 
USDA—Agricultural Research Service; Kearneysville, WV, U.S.A.) Animal Care and Use 
Committee, which are in line with the National Research Council publication Guide for Care 
and Use of Laboratory Animals. Experimental design was reported in detail by Cleveland et al. 
(2012) and Manor et al. (2013). Briefly, 2N females were fed at 1) 0.25% tank biomass/day, 2) 
0.50% of tank biomass/day, and 3) apparent satiation (~0.75% of tank biomass/day) for 10 
weeks. The 3N fish were fed at 0.50% tank biomass/day. Two, 1000L tanks were assigned to 
each of the four treatments, with a total of 7 fish per family (3) per treatment.  Fish were fed 
Zeigler G, floating, 5.0mm (3/16”) pelleted feed (42% protein, 16% fat, 2% fiber; Zeigler 
Brothers, Inc.; Gardners, PA, U.S.A.) dispensed by automatic feeders (Arvotec; Huutokoski, 
Joroinen, Finland) that adjust feed released daily based on the predicted mass of the fish in the 
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tank. Feeders for those tanks fed to satiation dispensed feed at 0.50% of tank biomass/day, 
followed by hand-feeding at the end of day to apparent satiation.   
  
Sample Collection   
Fish were weighed and harvested in November at 20 M of age and in January at 22 M of 
age using an overdose of tricaine methanesulfonate (MS-222, Western Chemicals, Ferndale, CA, 
U.S.A.) at 300mg/L. Body weights and lengths were recorded along with standard gravimetric 
measurements as reported in Cleveland et al. (2012).  Subsamples of dorsal muscle, liver, and 
visceral adipose tissue were immediately frozen in liquid nitrogen and stored at -80
o
C for gene 
expression, proximate composition, and fatty acid analyses. Proximate and fatty acid 
compositions of liver, white muscle, gonad, and visceral adipose tissue are reported in Manor et 
al., 2014. Fish were processed the following day at West Virginia University’s Muscle Foods 
Laboratory (Morgantown, WV, U.S.A.). Boneless, skinless fillets were removed from each fish, 
weighed, and reported in Cleveland et al. (2012).  
 
Gene Expression Analysis  
Multiplex Analysis        
  The GenomeLab GeXP genetic analysis system (Beckman Coulter Inc.; Pasadena, CA, 
U.S.A.) was used to simultaneously analyze expression of thirty-nine genes in liver, white 
muscle, or visceral adipose tissue.  Within the multiplex, thirty-five genes were associated with 
fatty acid metabolic pathways and four served as potential reference genes.  Primers were 
designed using eXpress Designer software (Beckman Counter Inc.; Pasadena, CA, U.S.A.) and 
primer sequences were compared against other rainbow trout gene sequences using the BLAST 
function within the NCBI database to reduce unintended sequence amplification.  The size of 
each amplicon was confirmed with its expected length.  No undetermined peaks interfered with 
amplification of the intended multiplex.  Optimization of the multiplex, standard curve, reverse 
transcriptase (RT) and PCR reactions, and capillary electrophoresis were performed as 
recommended by the manufacturer (GeXP Chemistry protocol A29143AC; February, 2009) with 
reagents provided in the GeXP Start Kit (Beckman Coulter Inc.; Pasadena, CA, U.S.A.).  
GenBank accession numbers, database reference numbers, and references for sequences used to 
generate multiplex primers, the associated regulatory pathways, roles in lipid metabolism, and R
2
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values for the RNA standard curve (0.2 ng /μL – 100 ng/μL), are shown in Appendix 4, Table 6.  
Primer sequences that include universal tags are provided in Appendix 3, Table 5.  
 
Areas for each peak within the multiplex were exported to eXpress Profiler software 
(Beckman Coulter, Inc.; Pasadena, CA, U.S.A.) for analysis and normalization to the internal 
kanamycin control.  Concentrations were interpolated from the standard curves for each gene of 
interest.  Data were normalized to the highest expressing sample for input into GeNorm software 
to determine which reference genes were most stable.  The most stable reference genes were β-
actin, rplp2, and ef1a for all three tissues.  M-values for these three genes and for all three tissues 
were below 0.5; therefore, their geometric mean was used to generate a normalization factor for 
each sample.  Thus, the normalized expression of each gene transcript is reported as the quantity 
relative to the geometric mean of the selected reference genes.   
 
RNA Isolation 
To isolate RNA, 50 – 100 mg of tissue was homogenized in 1 mL TRIzol (Invitrogen; 
Carlsbad, CA, U.S.A.), per manufacturer’s suggested protocol, using a 5 mm steel bead and a 
multi-tube shaker. The RNA pellet was washed with 75% ethanol and resuspended in nuclease-
free water.  RNA quality and quantity was determined by measuring absorbance at 260 nm and 
280 nm.   
 
Multiplex PCR  
 The multiplex RT reactions were optimized for each tissue as recommended by the 
manufacturer. Liver RT included 1.25 μL of 100 ng DNase-treated RNA in a 10 μL RT reaction 
that included 2 μL 5X RT buffer, 1 μL gene-specific reverse primer mix, 0.5 μL RT, and 1.25 μL 
kanamycin RNA (internal control, 1:2 dilution).  White muscle RT reaction mixtures included 
2.5 μL of 100 ng DNase treated RNA in a 10 μL RT reaction that included 2 μL 5X RT buffer, 1 
μL gene-specific reverse primer mix, 0.5 μL RT, and 1.25 μL kanamycin RNA (internal control, 
stock).  Visceral adipose tissue RT included 2.5 μL of 100 ng DNase treated RNA in a 10 μL RT 
reaction that included 2 μL 5X RT buffer, 1 μL gene-specific reverse primer mix, 0.5 μL RT, and 
1.25 μL kanamycin RNA (internal control, stock).   The RT was incubated according to kit 
instructions (48
o
C for 1min, 42
o
C for 60min, 95
o
C for 5min, and 4
o
C hold). An aliquot (4.65 μL) 
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of the resultant cDNA was used in PCR reactions for all three tissues that included 2 μL of 25 
mM MgCl2, 2 μL of 5X PCR buffer, 1 μL forward primer mix, and 0.35 μL DNA Taq 
polymerase.  The PCR was incubated according to kit instructions (95
o
C for 10min, 95
o
C for 30 
sec, 55
o
C for 30sec, 70
o
C for 1min, repeat steps 2-4 for an additional 34 cycles (35 cycles total), 
and 4
o
C hold). 1 μL of PCR products was combined with 38.5 μl sample loading solution and 0.5 
μL size standard 400.  The PCR products were separated by capillary electrophoresis in the 
GeXP Genetic Analysis System using a modified Frag-3 protocol with a separation voltage of 
6.0 kV for 45 min. 
 
Statistical analysis  
Data were analyzed using analysis of variance to test for main effects of ration level, 
month, and family using PC-SAS (Version 9.1; Cary, NC, U.S.A.) general linear models 
procedure.  Effects were considered significant at P ≤ 0.05.  Pairwise comparisons between 
LSMeans were used to detect differences between treatments.  Differences were considered 
significant at P ≤ 0.05.  Data are presented as LSMeans  SEM (standard error of the mean). To 
normalize gene expression data, fold change values were log2 transformed prior to statistical 
analysis.  Gene data are presented as LSMeans  SEM of non-transformed data. Some genes 
have standard curves, however if the gene was not identified in at least 25% of samples, the gene 
was recorded as not detectable.  
 
 
 
RESULTS 
 
Table 1 contains the p-values and sample sizes for all variables and main effects tested 
for genes expressed in female trout liver, white muscle, and visceral adipose tissue. 
 
Gene Expression in Liver 
Four lipogenic genes were significantly affected by ploidy; gpat, acyl, fas, and scd1 had 
greater expression in 3N liver in November and January (Figure 1a). Triploid liver had double 
the expression of acyl and scd1, compared to the 2N counterparts. Triploid liver had a seven-fold 
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increase in fas expression in January. Only one of the isoforms encoding for the enzyme that 
controls the rate of mitochondrial β-oxidation was affected by ploidy; 2N liver had higher 
expression of cpt1a than 3N liver in November and January (Figure 1b). Two of the genes 
involved in peroxisomal β-oxidation of long chain fatty acids, aco and acdhvl, were increased in 
3N liver compared to 2N liver, regardless of month. A two-fold higher expression level of lpl 
was observed in 3N liver in November with a three-fold higher expression level in January 
(Figure 1c). A two-fold increase in expression of 3N liver me was observed at both time points. 
Both 2N and 3N females had greater expression of fabp3 in January when compared to 
November (Figure 1c). Triploid liver had greater expression of redd1 and rxr in November, but 
there were no differences in ploidy in January (Figure 1d). Triploid liver had greater expression 
of raptor at both time points. November 3N liver had the greatest expression of pparβ, while 
there was greater expression of pparγ in 3N liver at November and January (Figure 1d). 
Interestingly, ration did not affect liver gene expression (P>0.05; data not shown). 
 
Gene Expression in White Muscle 
 Diploid muscle had greater expression of gpat in both November and January, while 3N 
muscle had greater expression of scd1 (Figure 2a). Expression of magl was higher in November 
than in January at both time points. Diploid muscle had higher expression of cpt1a, cpt1b, cpt2, 
acdhvl, and acat2 compared to their 3N counterparts while the greatest expression of aco 
observed in January 2N (Figure 2b). Expression levels of fabp3 and cd36 were higher in 2N 
muscle at both sample periods (Figure 2c). The highest expression of lpl was observed in January 
3N muscle (Figure 2c). Diploid muscle had greater expression of erk and mo25 in November and 
January compared to their 3N counterparts (Figure 2d). January, 2N muscle had the highest 
expression of redd1. January also had higher expression of pparα, regardless of ploidy, 
compared to November (Figure 2d). Only two genes were affected by ration in white muscle, erk 
and acat2 (Figure 3a; p=0.0435 and p=0.0279, respectively). The β-oxidation gene, acat2, and 
signaling protein, erk, had the greatest expression at the highest ration level, satiation (Figure 
3a).   
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Gene Expression in Visceral Adipose Tissue    
 None of the genes involved in fatty acid synthesis were significantly affected by ploidy or 
month (Figure 4a). Four genes within β-oxidation had higher expression in 2N visceral adipose 
tissue than in the 3N counterparts for November and January (Figure 4b). The only isoform of 
the gene regulating the rate limiting step of mitochondrial β-oxidation to have significant month 
differences in visceral adipose tissue was cpt1c; its expression was higher in November 
compared to January, regardless of ploidy (Figure 4b). Triploid visceral adipose tissue had 
greater expression of fabp3 compared to their 2N counterparts at both time points (Figure 4c). 
Diploid visceral adipose tissue had the greatest expression of cd36 in November, while 3N fish 
in January had the greatest expression levels of me (Figure 4d). 
 
 
  
DISCUSSION 
 
 The current study identifies genes that differ between age-matched 3N and sexually 
maturing 2N female rainbow trout.  Time points were chosen based on previous studies using 
fish from the same population; we identified many significant differences between 2N and 3N 
females beginning at 20 M (November), and when 2N females begin to ovulate at 22 M 
(January) (Aussanasuwannakul et al., 2011; Aussanasuwannakul et al., 2012; Manor et al., 
2012). Comparisons of ploidies used fish that were consuming identical rations, therefore 
differences in gene expression between 2N and 3N fish can be attributed to maturation-related 
signals.  In contrast, differences in expression between 2N fish on different ration levels are 
mainly an effect of variation in nutrient supply.  Although, numerous genes responded to 
maturation (2N vs 3N), fewer genes responded to ration level; therefore, maturation-related 
signals are likely a predominant factor regulating expression of genes within fatty acid 
metabolism and lipid repartitioning in sexually maturing fish.  Furthermore, tissue-specific gene 
responses in maturing 2N females suggest that mechanisms regulating nutrient repartitioning are 
unique to each tissue. This pattern is plausible considering the specific role each tissue type has 
with respect to fatty acid metabolism.  
 
82 
 
 Collectively, data support an increased capacity for fatty acid synthesis in 3N liver 
compared to maturing 2N females with increased expression of all six lipogenic genes included 
in this multiplex. Conversely, 2N females exhibited higher expression levels of genes in β-
oxidation, including cpt1a, and aco in liver, cpt1a, cpt1b, cpt2, aco, acat2, acdhvl, and ehhadh  
muscle, and cpt1c, acdhm, acdvl, and ehhadh in visceral adipose tissue. These findings support 
the assertion that 2N females are oxidizing fatty acids in muscle and visceral adipose tissue to 
provide energy for gonadogenesis. Data further supports the assertion sterile 3N females are 
continuing to synthesize and store excess energy in the form of fatty acids and triglycerides 
because they are sterile.  These findings are supported by compositional data previously 
published (Manor et al., 2013). Manor et al. (2013) reported decreased saturated (SFA) and 
monounsaturated (MUFA) fatty acid content in 2N muscle and visceral adipose tissue compared 
to the 3N counterparts when analyzing these same fish.   Although gene expression data, along 
with phenotypic data, does support an up-regulation of fatty acid synthesis in 3N females and β-
oxidation in 2N females during this time period, it is important to remember these pathways are 
primarily regulated by post-transcriptional, protein phosphorylation. Therefore, changes in 
expression are only suggestive of pathway regulation. 
 
 Genes for fatty acid transporters were differently expressed across all three tissues. 
Triploid liver had over two-fold higher expression of lpl and me while 2N muscle had greater 
expression of fabp3 and cd36 and 3N visceral adipose tissue had higher expression of fabp3 in 
November and January. These data are indicative of 3N females having increased fatty acid up-
take in the liver and visceral adipose tissue with the 2N females having increased transport of 
fatty acid within muscle. This assertion is again supported by fatty acid compositions of muscle 
and visceral adipose tissue with 3N females increasing and 2N females decreasing lipid stores 
within both of these tissues during sexual maturation (Manor et al., 2013).  
 
 Expression profiles of signaling factors were also different across tissues, but appear to 
correspond well with target gene expression. Triploid liver had higher expression levels of raptor 
and pparγ. Raptor is involved in TORC1 assembly within the mTOR signaling pathway. Both 
raptor and PPARγ increase transcription of lipogenic genes, which was observed in this study in 
3N female liver. Conversely, 2N muscle had higher expression of three cofactors within the 
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mTOR signaling pathway that inhibit the assembly of TORC1, erk, redd1, and mo25. Inhibition 
of TORC1 prevents transcription of lipogenic genes. This assertion is supported by increased 
expression of β-oxidation genes within 2N muscle.  Additionally, 2N visceral adipose tissue had 
higher levels of erk and akt expression. Both genes code for inhibitors of TORC1 assembly, 
suggesting there may be an inhibition of lipogenic gene transcription which is supported by 
increased expression of β-oxidation genes. Changes in white muscle and visceral adipose tissue 
fatty acid metabolism during sexual maturation do not appear to be a result of altered PPAR gene 
expression because these genes did not differ between 2N and 3N females.  Again, it is important 
to remember both mTOR and PPAR signaling pathways are primarily regulated by protein 
phosphorylation, which was not measured in this study; therefore, gene expression is only 
indicative of a portion of pathway actions.  
 
β-oxidation genes within trout liver, muscle, and visceral adipose tissue responded 
similarly, with 2N females exhibiting an up-regulation of this pathway in these tissues, 
suggesting an increase in the use of lipids as an energy source.  There appears to be an inhibition 
of TORC1 assembly associated with an up-regulation of genes involved in the β-oxidation 
pathway. Two studies have used rapamycin as an mTOR inhibitor to elucidate mTOR’s role in β-
oxidation (Sipula et al., 2006; Brown et al., 2007).  Brown et al. (2007) used cultured primary rat 
hepatocytes and found that inhibition of mTOR by rapamycin increased β-oxidation of 
exogenous fatty acids 46% at 18 hours and 100% at 48 hours. Moreover, they showed that 
esterification of exogenous fatty acids and de novo lipid synthesis was reduced by 40% and 60%, 
respectively (Brown et al., 2007). We reported a reduction in muscle fat content, indicative of a 
reduction in fatty acid synthesis and/or an increase in β-oxidation in 2N females (Manor et al., 
2014). Rapamycin-inhibition of mTOR also decreased gene expression of acc and gpat (Brown 
et al., 2007); these genes were decreased in 2N liver when compared to 3N liver in our study as 
well. 
  
Sipula et al. (2006) showed that β-oxidation is increased in L6 myotubes and in S6K1-
deficient mice when mTOR is inhibited by rapamycin. These authors reported significant 
increases in the activities of cpt1 and cpt2 in culture with a subsequent increase in their mRNA 
levels in vivo (Sipula et al., 2006). We observed increases in cpt1 and cpt2 gene expressions; 
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however, we did not measure the activities of these enzymes. The mechanism by which mTOR 
elicits its effects on fatty acid β-oxidation remains unclear. Sipula et al. (2006) suggested that 
mTOR directly acts on key oxidative genes and proteins and causes a flux through the β-
oxidation pathway. However, Brown et al. (2007) suggested that decreased expression of acc 
during rapamycin-inhibition of mTOR caused a decrease in its product, malonyl-CoA. Malonyl-
CoA is the first intermediate in the fatty acid synthesis pathway and acts to inhibit CPT1. In the 
current study, we did not observe a decreased expression of acc in the muscle. Nevertheless, our 
data does support the idea that mTOR may play a role in regulating β-oxidation as well as fatty 
acid synthesis.  
 
  The marked up-regulation of genes involved in fatty acid synthesis in 3N females along 
with up-regulation of genes involved in β-oxidation in 2N females, with no effects of ration level 
on gene expression, suggests that sexual maturation is a dominant physiological process that 
alters fatty acid metabolism regardless of the level of nutrient restriction.  Therefore, fatty acid 
metabolism is primarily regulated by maturation-related signals, such as estrogen (E2) during 
this time period. Estrogen elicits its effects on lipid metabolism through the estrogen receptor α 
(ERα) (Wend et al., 2013). Estrogen administration decreases adipocyte size and number in 
cultured mouse adipocytes by inducing lipolysis (Wend et al., 2013). Additionally, IGF-1 is 
another important regulator of sexual maturation in trout and elicits effects on lipid metabolism 
(Taylor et al., 2008; Sanchez-Gurmaches et al., 2012). These authors reported that there was a 
differential expression of fabps and cd36 in response to insulin and IGF1. It is plausible 
maturation-associated signals, such as E2 and IGF1, could play an important role in regulating 
fatty acid metabolism and nutrient partitioning during sexual maturation in female trout by 
primarily up-regulating genes involved in β-oxidation in 2N females.  
 
 
CONCLUSION 
 
 Data from this study provide information about metabolism of lipid stores during 
moderate feed restriction at an important life stage. Additionally, comparisons between maturing 
2N and sterile 3N female rainbow trout are a unique model to study effects of maturation in fish.  
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In general, ration levels employed in this study did not affect expression of genes included in this 
multiplex. These findings suggest ration levels were not nutrient restrictive enough to alter fatty 
acid metabolism during this time period. Conversely, sexual maturation did have distinct effects 
on gene expression. Diploid females have increased expression levels of β-oxidation genes in 
muscle and visceral adipose tissue, while 3N females have increased expression of lipogenic and 
fatty acid up-take genes in liver. Increased β-oxidation in 2N females is associated with altered 
gene expression of mTOR cofactors that inhibit TORC1 in muscle as well as increased pparβ 
expression in visceral adipose tissue. Increased fatty acid synthesis in 3N females is associated 
with altered expression of mTOR cofactors that increase TORC1 and increased pparγ expression 
in the liver.  Additionally, the up-regulation of genes involved in β-oxidation pathways across 
ration levels in all three tissues suggests maturation-induced hormonal signals, such as estrogen 
and IGF1, are regulators of these effects. Data suggest moderate nutrient restriction does not alter 
lipid repartitioning during sexual maturation or negatively impact egg quality. These findings 
further support the assertion that moderate nutrient restriction is an optimal feeding strategy for 
fish retained for additional breeding cycles, as feeding to satiation does not reduce expression 
levels of β-oxidation genes in 2N females during sexual maturation.  
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TABLES and FIGURES 
 
 Liver White Muscle Visceral Adipose Tissue 
 Ploidy Month P x M n (43) Ploidy Month P x M n (44) Ploidy Month P x M n (40) 
Fatty Acid Synthesis 
 gpat <0.0001 0.0002 0.8292 42 0.0005 0.411 0.8886 44 0.0645 0.549 0.3105 40 
srebp1 0.0055 0.1609 0.1473 29 0.337 0.4315 0.7082 26 ND ND ND 0 
acyl <0.0001 0.007 0.3148 39 0.7753 0.8439 0.2768 44 0.3819 0.0662 0.5886 39 
acc 0.0546 0.1296 0.3018 39 0.4286 0.8301 0.7531 36 0.1588 0.9259 0.7785 36 
fas <0.0001 0.0019 0.3833 39 0.5228 0.8742 0.6465 38 0.9942 0.1372 0.9259 40 
scd1 0.0015 0.0176 0.5390 40 0.0013 0.235 0.7805 44 0.3571 0.0634 0.8217 35 
β-Oxidation  
magl 0.5653 0.0953 0.7080 36 0.7962 0.0203 0.2949 43 0.8946 0.9518 0.3029 39 
cpt1a <0.0001 0.7687 0.5158 38 0.0001 0.539 0.0773 36 0.3600 0.0311 0.4033 30 
cpt1b ND ND ND 16 0.0001 0.2008 0.9976 44 0.8457 0.5238 0.8364 35 
cpt1c 0.1357 0.5436 0.0748 43 0.7117 0.5127 0.1296 40 0.0134 0.4309 0.5829 39 
cpt1d ND ND ND 0 0.6438 0.1982 0.5183 44 0.4970 0.7752 0.9010 39 
cpt2 ND ND ND 0 <0.0001 0.5331 0.6790 36 0.8378 0.3614 0.1371 11 
acat2 ND ND ND 0 <0.0001 0.0125 0.2988 44 0.9001 0.1500 0.1270 40 
acdh ND ND ND 0 ND ND ND 0 0.1616 0.1134 0.2017 29 
acdhm ND ND ND 0 0.2383 0.5164 0.4608 44 0.0035 0.7076 0.7628 31 
acdhvl 0.0004 0.7817 0.0194 39 0.018 0.2607 0.0436 36 0.0008 0.2775 0.2768 34 
aco 0.0004 0.4694 0.3116 40 0.0285 0.1714 0.0585 43 0.0714 0.7634 0.1270 40 
ehhadh 0.696 0.0895 0.6406 40 <0.0001 0.392 0.1560 43 <0.0001 0.1621 0.1082 40 
Fatty Acid Transport 
fabp3 0.6455 0.0236 0.2725 38 0.0034 0.0684 0.3878 44 0.0109 0.2692 0.4621 39 
fabp4 0.8154 0.1437 0.3046 23 ND ND ND 0 0.0894 0.2117 0.3029 34 
lpl <0.0001 0.0938 0.5148 26 0.0033 <0.0001 0.5140 41 0.2003 0.0700 0.3774 38 
cd36 0.0615 0.1448 0.9396 41 <0.0001 0.104 0.5127 43 0.0228 0.5819 0.6799 35 
me 0.0062 0.9301 0.7814 41 0.4925 0.3906 0.7077 43 0.0518 0.8166 0.0383 40 
Signaling Factors 
erk 0.1055 0.1843 0.7566 26 0.0024 0.459 0.5987 38 0.0086 0.4337 0.0939 39 
akt2 ND ND ND 0 0.1205 0.1499 0.6524 43 0.0075 0.4452 0.1993 39 
redd1 0.0007 0.9077 0.0111 41 0.0127 0.0591 0.0508 43 0.5274 0.2651 0.8576 40 
mo25 0.2679 0.3604 0.4728 43 0.0006 0.3702 0.5499 43 0.4222 0.5097 0.0916 40 
mtor 0.8834 0.8641 0.5168 37 0.8369 0.6604 0.6603 39 0.6479 0.2682 0.4975 36 
raptor 0.0045 0.186 0.2191 26 0.9742 0.8264 0.7939 18 ND ND ND 8 
rictor 0.3901 0.7509 0.6161 43 0.6022 0.0643 0.8308 39 0.0040 0.8629 0.4913 40 
pras40 0.2646 0.6899 0.5871 43 0.1957 0.6252 0.1392 44 0.6561 0.4199 0.7033 38 
pparα ND ND ND 0 0.7364 0.0100 0.8875 19 0.383 0.2246 0.6770 27 
pparβ 0.428 0.1417 0.0376 32 0.1293 0.1224 0.9834 29 0.0123 0.6667 0.8021 40 
pparγ <0.0001 0.6318 0.4288 43 0.6591 0.7731 0.3553 35 0.8327 0.0466 0.1047 40 
rxr 0.0397 0.1218 0.1792 36 0.3504 0.7155 0.3882 43 0.0251 0.9339 0.7849 40 
 
TABLE 1: SIGNIFICANCE AND N-VALUES FOR ALL GENES TARGETED BY THE 
MULTIPLEX IN LIVER, WHITE MUSCLE, AND VISCERAL ADIPOSE 
TISSUE—RATION, PLOIDY, AND MONTH EFFECTS 
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FIGURE 1: LIVER GENE EXPRESSION—PLOIDY AND MONTH EFFECTS  
a.) Ploidy and month effects for liver in November and January of fatty acid synthesis genes; b.) 
ploidy and month effects in November and January of β-oxidation genes; c.) ploidy and month 
effects in November and January of fatty acid transport genes; d.) ploidy and month effects in 
November and January of signaling factor genes . Values are means ± SEM and represent the 
fold change in gene abundance, relative to the normalized mean of three reference genes (β-
actin, eF1a, and rplp2). Asterisks represent a significant difference between 2N and 3N fish 
(P≤0.05). Daggers represent a significant difference between November and January (P≤0.05). 
Double daggers represent a significant month-by-ploidy interaction (P≤0.05).  
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FIGURE 2: WHITE MUSCLE GENE EXPRESSION—PLOIDYAND MONTH EFFECTS 
a.) Ploidy and month effects for liver in November and January of fatty acid synthesis genes; b.) 
ploidy and month effects in November and January of β-oxidation genes; c.) ploidy and month 
effects in November and January of fatty acid transport genes; d.) ploidy and month effects in 
November and January of signaling factor genes . Values are means ± SEM and represent the 
fold change in gene abundance, relative to the normalized mean of three reference genes (β-
actin, eF1a, and rplp2). Asterisks represent a significant difference between 2N and 3N fish 
(P≤0.05). Daggers represent a significant difference between November and January (P≤0.05). 
Double daggers represent a significant month-by-ploidy interaction (P≤0.05).  
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FIGURE 3: RATION EFFECTS ON GENE EXPRESSION IN MUCLE AND VISCERAL 
ADIPOSE TISSUE 
A) Genes expressed in white muscle with significant ration effects and b) genes expressed in 
visceral adipose tissue with significant ration effects. Values are means ± SEM and represent the 
fold change in gene abundance, relative to the normalized mean of three reference genes (β-
actin, eF1a, and rplp2). Means without a common letter represent significant differences among 
mature 2N fish fed 0.25% of tank biomass/day, 0.50% of tank biomass/day, or satiation 
(P≤0.05).  
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FIGURE 4: VISCERAL ADIPOSE TISSUE GENE EXPRESSION—PLOIDYAND 
MONTH EFFECTS  
a.) Ploidy and month effects for liver in November and January of fatty acid synthesis genes; b.) 
ploidy and month effects in November and January of β-oxidation genes; c.) ploidy and month 
effects in November and January of fatty acid transport genes; d.) ploidy and month effects in 
November and January of signaling factor genes. Values are means ± SEM and represent the fold 
change in gene abundance, relative to the normalized mean of three reference genes (β-actin, 
eF1a, and rplp2). Asterisks represent a significant difference between 2N and 3N fish (P≤0.05). 
Daggers represent a significant difference between November and January (P≤0.05). Double 
daggers represent a significant month-by-ploidy interaction (P≤0.05). 
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ABSTRACT 
 
To study effects of sexual maturation on fatty acid metabolism in fish on a high 
nutritional plane, expression of thirty-five genes involved in fatty acid metabolism was 
determined in sexually maturing diploid (2N; fertile) and triploid (3N; sterile) female rainbow 
trout. Gene expression was assessed in liver, white muscle, and visceral adipose tissues for fish 
that were 16 to 24 M of age.  Previously, we reported minimal differences in most growth 
measurements, but there were changes in muscle proximate composition, visceral fat stores, and 
fatty acid contents at 21 M.  Here, we report that gene expression profiles of liver and white 
muscle corresponded to the previously measured phenotypes most closely. Differences in gene 
expression occurred at 20 M. Triploid females had increased expression of genes involved in 
fatty acid synthesis; including gpat, srebp1, acyl, acc, fas, and scd1 in liver and fas in muscle. 
Conversely, 2N muscle had increased expression of β-oxidation genes cpt1b, cpt2, ehhadh, and 
acat2 and TORC1 inhibitors redd1, erk, mo25, and pras40.  Diploid muscle also had increased 
expression of pparβ along with increased expression of the fatty acid transport gene cd36, and β-
oxidation genes cpt1a, cpt1c, aco, and acdhvl at 20 M. Additionally, 2N visceral adipose tissue 
had increased cpt1a expression at 22 M. Overall, data suggest 3N females are undergoing higher 
levels of fatty acid synthesis while 2N females have higher levels of β-oxidation during sexual 
maturation. Phenotypic data supports these findings with decreasing fatty acid stores in 2N 
females during this time period. Additionally, changes in gene expression are associated with 
altered expression within the mTOR and PPARβ signaling pathways.  
 
 
 
INTRODUCTION 
 
Although nutrient repartitioning is important to sexual maturation in female fish, little is 
understood about regulation of nutrient mobilization during this time period. Two pathways 
known to regulate nutrient metabolism in mammals are the mechanistic target of rapamycin 
(mTOR) and peroxisome proliferator activated receptors (PPAR) pathways (Laplante and 
Sabatini, 2011; Poulsen et al., 2012). Both pathways respond to nutrient availability and alter 
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target gene expression of key enzymes involved in fatty acid metabolism. Albeit, both pathways 
are not specific to controlling lipid metabolism; they are active in a variety of other processes 
such as inflammation, immune function, apoptosis, protein metabolism, and stress resistance 
(Laplante and Sabatini, 2011; Poulsen et al., 2012). Sexual maturation in salmonids, such as 
rainbow trout, is not only a period of immense restructuring of metabolism, it is also perceived as 
a stress (Sumpter et al., 1991). Increased energy demand during this time requires fat 
mobilization from muscle and visceral adipose tissue lipid stores (Nassour and Legar, 1989; 
Sumpter et al., 1991; Shearer, 1994; Jonsson et al., 1997; Kiessling et al., 2001; Memis and Gun, 
2004; Salem et al., 2006; Gorgun and Akpinar, 2007; Riberio et al., 2011). This restructuring of 
metabolism to support a shift from somatic to gonadal growth and the importance of lipid 
metabolism during this time period makes mTOR and PPAR signaling pathways primary 
candidates for regulating this process.  
 
The mTOR pathway is a central signaling cascade that plays a role in integrating energy-
sensing pathways. Regulation of mTOR provides a mechanism for cells to transition between 
anabolic and catabolic states in response to nutrient and energy availability (Laplante and 
Sabatini, 2011). There are two main paths mTOR can act through; the assembly of mTOR 
Complex 1 (TORC1) and mTOR Complex 2 (TORC2). TORC1 elicits its effects on lipid 
metabolism by increasing expression of genes involved in fatty acid synthesis (Laplante and 
Sabatini, 2009; Caron, 2010). Whereas, TORC2 is believed to play a role in regulating the 
transcription of genes involved in fatty acid β-oxidation (Sipula et al., 2006; Brown et al., 2007; 
Jones et al., 2009). There has been some assessment of the fatty acid metabolism by investigating 
gene expression of fas, srebp1, and cpt1 in salmonids (Lansard et al., 2009; Skiba-Cassy et al., 
2009; Seiliez et al., 2011). Data suggest there are metabolic differences in nutrient utilization 
between fish consuming altered protein (Seiliez et al., 2011) and fishmeal-replacement diets 
(Lansard et al., 2009). Divergently bred lines of rainbow trout (lean and fat) also have different 
nutrient utilization resulting in different phenotypes (Skiba-Cassy et al., 2009). The consensus 
among these studies is that the mTOR signaling pathway is involved in nutrient utilization in a 
variety of situations ranging from genetic selection to dietary alterations. These findings further 
support mTOR as a primary pathway of interest when investigating regulation of fatty acid 
metabolism during sexual maturation in fish.   
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Conversely, the PPAR signaling pathway is known to respond to lipids and elicit 
transcriptional changes on genes involved in lipid metabolism in mammals. PPARs are members 
of the nuclear receptor superfamily of ligand-activated transcription factors (Poulsen et al., 
2012). Gender and stage of life cycle influence expression levels of all PPARs (α, β, and γ) in 
brown trout (Batista-Pinto et al., 2009) with estrogen appearing to play an important role in their 
differential expression. PPARγ affects transcription rates of a variety of lipogenic target genes 
such as fabp, cd36, lpl, leptin, acc, fas, and scd1 (Lee and Hossner, 2002). Additionally, PPARα 
and PPARβ are responsible for regulating fatty acid β-oxidation (Varga et al., 2011). PPARs’ 
involvement in fatty acid metabolism makes them prime candidates as regulators of fatty acid 
metabolism during sexual maturation in fish. 
 
Previous work from this same research group has investigated effects of ration level and 
sexual maturation on expression of thirty-five genes involved in fatty acid metabolism using 
Multiplex-PCR (Manor et al., 2014a). Investigating only two time points during sexual 
maturation provided a brief glimpse into metabolic changes that occur in lipid stores when fish 
are moderately feed restricted. In general, ration levels did not meaningfully affect expression of 
genes included in the multiplex; however, sexual maturation did have distinct effects on gene 
expression between 20 and 22 M (Manor et al., 2014a). It is apparent mTOR and PPAR 
pathways are important signaling mechanisms during sexual maturation and that maturation-
related signals, such as estrogen, may be regulators of these processes.  The current study 
investigates changes in expression of thirty-five genes involved in fatty acid metabolism in 
diploid (2N; fertile) and triploid (3N; sterile) fish throughout sexual maturation from 16 to 24 M.  
This report is part of a larger, comprehensive investigation of growth parameters, fillet quality 
attributes, muscle collagen, muscle protein thermal stability, and fatty acid composition of liver, 
muscle, visceral adipose tissue, and ovaries of the same 2N and 3N female rainbow trout 
(Aussanasuwannakul et al., 2011; Aussanasuwannakul et al., 2012; Manor et al., 2012; Salem et 
al., 2013).  Understanding how genes within pathways related to fatty acid metabolism are 
regulated will indicate mechanisms responsible for nutrient repartitioning during sexual 
maturation.  Furthermore, identifying critical genes and pathways associated with phenotypic 
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traits will enhance our knowledge of how management strategies can regulate these mechanisms 
for more efficient food-fish production.    
 
 
 
MATERIALS and METHODS 
 
Experimental Design 
A two by two by six (2x2x6) factorial, randomized-complete block design was used. In 
this design, family (2) became the blocking variable. Independent variables included two sex 
conditions (fertile 2N females and sterile 3N females) and six sampling periods or harvest 
endpoints (16, 18, 20, 21, 22, and 24 M of age). These independent variables generated twenty-
four block-by-sex condition-by harvest endpoint combinations that were randomly assigned to 
fish. Treatments were replicated five times with fish as replicate. Tank layout necessitated that 
individual fish serve as the experimental unit. For each treatment combination, five fish were 
randomly selected for gravimetric and morphometric measurements, and chemical analyses.  
 
Animals  
Fish care and experimentation followed guidelines outlined by the US Department of 
Agriculture (USDA) and the National Center for Cool and Cold Water Aquaculture (NCCCWA; 
USDA—Agricultural Research Service; Kearneysville, WV, U.S.A.)  Animal Care and Use 
Committee, which are in line with the National Research Council publication Guide for Care 
and Use of Laboratory Animals. Two families, each containing 2N and 3N rainbow trout, were 
generated and maintained at the NCCCWA. Animals were fed a commercial feed, Zeigler 
GOLD Floating 5.0 mm pelleted feed (42% protein, 16% fat, and 2% fiber; 316520-36-44; 
Zeigler Brothers, Inc.; Gardners, PA, U.S.A.), throughout the course of the experiment. Part of 
the daily ration was delivered by a belt feeder. At the end of the day fish were fed by hand to 
apparent satiation. The amount of feed delivered by the belt feeder was altered depending on 
appetite. From 16 to 19 M fish were fed at 1% of body weight; between 19 and 21 M, fish were 
fed at 0.8%; and between 21 and 24 M, fish were fed at 0.3%.  Fish were initially maintained as 
part of stocks in five, 1.22 m diameter tanks.  In July, each of the five tanks were stocked with 
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thirty-five fish, totaling 175 fish for this study. The thirty-five fish assigned to each tank 
consisted of 2N and 3N fish from each of the two families. At each sampling period, fish were 
shifted to a different tank to reduce biases associated with tank. Similar tank densities were 
maintained during the study. To avoid temperature effects, water temperatures were maintained 
between 12.0 and 13.5
o
C. A simulated ambient photoperiod was maintained with artificial 
lighting. Passive integrated transponders (Avid Identification Systems Inc., Norco, CA, U.S.A.) 
were implanted in the musculature below the dorsal fin as tags for individual fish identification.   
 
Sampling  
All fish were weighed, and length (L) was measured (fork length) once a month between 
July (16 M post hatching) and March (24 M). In addition, five fish per treatment per block were 
randomly sampled at 16, 18, 20, 21, 22 and 24 M for a total of six sampling periods. This 
sampling rate resulted in 20 fish sampled at each time point. Fish were held off feed 24 hrs prior 
to sampling and were anesthetized using 150 mg/L tricaine methanesulfonate (tricane-S; Western 
Chemical, Inc., Ferndale, WA, U.S.A.). Liver, white muscle, and visceral adipose tissue samples 
were frozen in liquid nitrogen and stored at -80
o
C until further processing. Fish were manually 
filleted the following day at West Virginia University’s Muscle Foods Laboratory (Morgantown, 
WV, U.S.A.). Gravimetric and morphometric measurements and chemical analyses are reported 
in Aussanasuwannakul et al. (2011), Aussanasuwannakul et al. (2012), Manor et al. (2012), and 
Salem et al. (2013).  
 
Gene Expression Analysis  
Multiplex Analysis        
  The GenomeLab GeXP genetic analysis system (Beckman Coulter Inc.; Pasadena, CA, 
U.S.A.) was used to simultaneously analyze expression of thirty-nine genes in liver, white 
muscle, or visceral adipose tissue.  Within the multiplex, thirty-five genes were associated with 
fatty acid metabolic pathways and four served as potential reference genes.  Primers were 
designed using eXpress Designer software (Beckman Counter Inc.; Pasadena, CA, U.S.A.) and 
primer sequences were compared against other rainbow trout gene sequences using the BLAST 
function within the NCBI database to reduce unintended sequence amplification.  The size of 
each amplicon was confirmed with its expected length.  No undetermined peaks interfered with 
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amplification of the intended multiplex.  Optimization of the multiplex, standard curve, reverse 
transcriptase (RT) and PCR reactions, and capillary electrophoresis were performed as 
recommended by the manufacturer (GeXP Chemistry protocol A29143AC; February, 2009) with 
reagents provided in the GeXP Start Kit (Beckman Coulter Inc.; Pasadena, CA, U.S.A.).  
GenBank accession numbers, database reference numbers, and references for sequences used to 
generate multiplex primers, the associated regulatory pathways, roles in lipid metabolism, and R
2
 
values for the RNA standard curve (0.2 ng /μL – 100 ng/μL), are shown in Appendix 4, Table 6.  
Primer sequences that include universal tags are provided in the supplementary data file as, 
Appendix 3, Table 5.  
 
Areas for each peak within the multiplex were exported to eXpress Profiler software 
(Beckman Coulter, Inc., Pasadena, CA, U.S.A.) for analysis and normalization to the internal 
kanamycin control.  Concentrations were interpolated from the standard curves for each gene of 
interest.  GeNorm software was used to determine which reference genes were most stable.  The 
most stable reference genes were β-actin, rplp2, and ef1a for all three tissues.  M-values for these 
three genes and for all three tissues were below 0.5; therefore, their geometric mean was used to 
generate a normalization factor for each sample.  Thus, the normalized expression of each gene 
transcript is reported as the quantity relative to the geometric mean of the selected reference 
genes with arbituray units.  
 
RNA Isolation 
To isolate RNA, 50 – 100 mg of tissue was homogenized in 1 mL TRIzol (Invitrogen; 
Carlsbad, CA, U.S.A.), per manufacturer’s suggested protocol, using a 5 mm steel bead and a 
multi-tube shaker. The RNA pellet was washed with 75% ethanol and resuspended in nuclease-
free water.  RNA quality and quantity was determined by measuring absorbance at 260 nm and 
280 nm.   
 
Multiplex PCR 
The multiplex reverse transcription (RT) reactions were optimized for each tissue. 
Reverse transcription reactions included 2 μL 5X RT buffer, 1 μL gene-specific reverse primer 
mix, 0.5 μL RT, and 1.25 μL kanamycin RNA (internal control) in a 10 μL reaction. Reactions 
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included 1.25 μL, 2.5 μL, and2.5 μL of 100 ng DNase treated RNA for liver, white muscle, and 
visceral adipose tissue respectively.  The RT was incubated according to kit instructions.  An 
aliquot (4.65 μL) of the resultant cDNA was used in PCR reactions for all three tissues that 
included 2 μL 25 mM MgCl2, 2 μL 5X PCR buffer, 1 μL forward primer mix, and 0.35 μL DNA 
Taq polymerase.  The PCR was incubated according to kit instructions.  1 μL of PCR products 
was combined with 38.5 μl sample loading solution and 0.5 μL size standard 400.  The PCR 
products were separated by capillary electrophoresis in the GeXP Genetic Analysis System using 
a modified Frag-3 protocol with a separation voltage of 6.0 kV for 45 min. 
 
Statistical Analysis  
Data were analyzed by PROC MIXED procedure of SAS® system for Windows, version 
9.1 (SAS Institute Inc., 2004). Variance components were estimated by restricted maximum 
likelihood method (Ramon et al., 2006) for testing fixed effects which included age, ploidy, and 
their interaction. The blocking variable, family, was treated as a random effect. There was no 
significant effect of family as block. The DDFM=KR option was used to invoke an adjustment to 
standard errors, test statistics, and degree of freedom approximation. The PDIFF function of 
LSMEANS was used to perform pair-wise comparisons. Significant differences were defined at 
P < 0.05. Gene data are presented as LSMeans  SEM. Some genes have standard curves; 
however, if the gene was not identified in at least 25% of samples, the gene was recorded as not 
detectable.  
 
 
 
RESULTS 
 
P-values indicating main effects of age, ploidy, and age-by-ploidy interactions are 
reported in Table 1.  Means and significant differences are reported in Figures 1-3 for liver, 
muscle, and adipose tissue, respectively.   
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Liver Gene Expression 
 Regardless of ploidy, expression of raptor and srebp1 increased from 16-24 M, with the 
most rapid increase occurring from 22-24 M (figure 1a).  Significant effects of age in raptor and 
srebp1 expression were observed between 16 and 22 M, while differences in pras40 and ehhadh 
expression were noted at 24 M (figure 1a and 1b, respectively). Expression of cd36 showed a 
steady increase from 16 to 22 M (figure 1b). Main effects of ploidy were observed for genes 
shown in figure 1c (erk, raptor, rictor, pras40, srebp1, cd36, aco, acdhvl, and ehhadh); 3N 
females exhibited greater expression levels across all months when compared to their 2N 
counterparts. Age-by-ploidy interactions were observed for gpat, acyl, acc, fas, scd1, pparγ, 
fabp3, lpl, me, and cpt1a (figure 1d-1m). Expression of gpat was greater in 3N liver than in 2N 
liver only at 20 and 21 M.  Furthermore, gpat expression increased in 2N liver during the last 3 
months of sexual maturation (21-24 M).  Relative expression patterns of acyl, acc, fas, fabp3, 
and fas were similar (figure 1e-1i), with 3N liver displaying an expression “spike” at 20 M.  
Expression in 3N liver remained higher than 2N liver throughout the remainder of the study, with 
the exception of the 21 M period. At 21 M expression in 3N livers often returned to 2N levels 
(acyl, fabp3, scd1).  Relative expression of ppary (figure 1j) and me (figure 1l) displayed similar 
patterns; expression in 3N liver was greater at 20 M than in 2N liver, and remained higher for the 
remaining time periods.  In 2N liver, me expression steadily decreased over time (figure 1l). 
Expression of lpl steadily increased from 16 to 24 M in 2N liver, but was significantly greater 
than 3N liver only at 24 M (figure 1k).  Expression of cpt1a was significantly greater in 2N liver 
than in 3N liver throughout the entire sampling period (figure 1m).    
 
Muscle Gene Expression 
 There was a continued decrease in rictor and cpt1b from 16 to 24 M, while scd1 muscle 
expression had a “spike” in expression at 20 M (figure 2a). Diploid muscle had increased 
expression of erk, mo25, pras40, fabp4, cpt1b, cpt2, ehhadh, and acat2 compared to 3N muscle; 
whereas, 3N muscle had greater expression of fas than 2N muscle (figure 2b).  All seven genes 
with significant age-by-ploidy interactions have similar expression patterns (figure 2c-2i). 
Expression in 3N muscle was greater than (redd1 and acdhvl) or similar to (pparb, cd36, cpt1a, 
cpt1c, aco) expression levels in 2N muscle at 16 M, while expression at 18 M was not different 
between 2N and 3N females.  For all genes demonstrating an interaction, 2N muscle had a 
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“spike” in gene expression at 20 M, and then at 21 M, returned to and remained at levels 
observed in 3N muscle.  However, cd36 and cpt1a remained higher in 2N muscle compared to 
3N muscle at time points after 21 M.   
   
Visceral Adipose Tissue Gene Expression 
 Visceral adipose tissue expression of erk decreased between 16 and 18 M and increased 
between 22 and 24 M (figure 3a). Expression of acyl increased between 16 and 18 M then 
decreased between 18 and 24 M (figure 3a). There was over a 10-fold increase in pparγ 
expression between 16 and 18 M with a subsequent decrease through 24 M (figure 3a).  There 
was an increase in pparβ expression between 22 and 24 M (figure 3b). Expression of cd36 
increased between 16 and 20 M followed by a decrease in expression between 20 and 21 M 
(figure 3b). Expression of β-oxidation genes aco and ehhadh increased from 16 to 18 M with 
decreasing expression through 24 M (figure 3b). Triploid expression of erk and lpl was greater 
than expression in 2N visceral adipose tissue (figure 3c). Three genes had significant age-by-
ploidy interactions. Diploid visceral adipose tissue expression of mo25 increased from 21 to 24 
M, while 3Ns decreased between 21 and 22 M (figure 3d). Diploid mtor expression increased 
between 22 and 24 M, whereas 3N mtor decreased between 22 and 24 M (figure 3e). Likewise, 
cpt1a expression in 2N visceral adipose tissue increased between 22 and 24 M, while 3N visceral 
adipose tissue decreased from 16 to 22 M (figure 3f).  
 
 
 
DISCUSSION 
 
 The current study identifies genes that differ between age-matched 2N and 3N female 
rainbow trout undergoing sexual maturation. Fish were fed to satiation daily, putting them on a 
high plane of nutrition and allowing differences in gene expression to be caused by variation in 
maturation-induced signals, such as increasing estrogen levels in 2N females compared to their 
3N counterparts (Piferrer et al., 2009). Growth, composition, and fillet quality attributes from 
these same fish have been previously reported (Aussanasuwannakul et al., 2011; 
Aussanasuwannakul et al., 2012; Manor et. al., 2012; Salem et al., 2013). Additional studies have 
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investigated effects of ration on physiological mechanisms and fillet quality (Cleveland et al., 
2012; Manor et al., 2014a; Manor et al., 2014b). Collectively, these studies indicate body lipid 
stores differ between 2N and 3N females beginning at 21 M of age in a manner that supports 
mobilization of lipid and protein from various fat depots to support gonadogenesis in 2N 
females. In general, gene expression profiles in liver and white muscle from this current study 
corresponded to previously measured phenotypes most closely, with significant differences in 
gene expression beginning at 20 M, one month prior to significant phenotypic differences 
(Aussanasuwannakul et al., 2011; Aussanasuwannakul et al., 2012; Manor et. al., 2012; Salem et 
al., 2013). Triploid liver had increased expression of fatty acid synthesis-related genes while 2N 
muscle had increased expression of β-oxidation related genes.   
 
 In the current study, increased gpat, srebp1, acyl, acc, fas, and scd1 expression suggest 
greater fatty acid synthesis in 3N liver.  These data are in agreement with previous findings 
(Manor et al., 2014a). Furthermore, 3N liver exhibited increased expression of pparγ, a 
transcription factor responsible for increasing expression of lipogenic genes such as acyl, acc, 
fas, and scd1; this finding supports our previous reports as well. Increased expression of erk, akt, 
and raptor, activators of TORC1 signaling, suggests mTOR signaling may also play a role in 
regulating fatty acid synthesis in these fish. Interestingly, pparγ expression is increased through 
TORC1 signaling (Laplante and Sabatini, 2011). On the other hand, there was also increased 
expression of aco, acdhvl, and ehhadh, indicating increased β-oxidation within 3N liver.  These 
data contradict our previous findings where only fatty acid synthesis genes were up-regulated in 
3N liver (Manor et al., 2014a). The up-regulation of both fatty acid synthesis and β-oxidation 
genes in 3N liver compared to 2N liver suggests 3N females may have increased fatty acid 
turnover during this time period. Nevertheless, it is important to note that fish in the current 
study were on a much higher plane of nutrition, with greater intramuscular and visceral fat 
depots when compared to our previous work (Cleveland et al., 2012; Manor et al., 2013; Manor 
et al., 2014a).  These differences in energy reserves and rates of lipid mobilization may 
contribute to disparity in these two studies. Additionally, it is important to remember fatty acid 
metabolism is primarily regulated post-transcriptionally by protein phosphorylation; therefore, 
changes in expression are only suggestive of pathway regulation (Laplante and Sabatini, 2011).   
Perhaps increased liver, lipogenic gene expression at 20 M in 3N females may have contributed 
107 
 
to increased fillet yields, crude lipid, and saturated fatty acid (SFA) content of 3N fillets by 21 
M. 
 
 Conversely, liver data also revealed increased β-oxidation in 2N females through 
increased expression of cpt1a. There was a shift toward decreased β-oxidation between 21 and 
24 M and increased fatty acid uptake through increased lpl expression at 22 M. This time frame 
was compatible with maximum gonadosomatic indices (GSI), with most fish ovulating by 24 M 
(Aussanasuwannakul et al., 2011).  Interestingly, there was an indication of reduced fatty acid 
synthesis in 2N liver through decreased me expression from 16 to 22 M. Increased expression of 
liver β-oxidation genes supports the assertion that 2N females are oxidizing fatty acids to provide 
energy for gonadogenesis, while increased expression of lipogenic genes suggest sterile 3N 
females are continuing to synthesize and store excess energy in the form of fatty acids and 
triglycerides (Manor et al., 2012).  Although liver is not a lipid storage tissue, it is a central organ 
in lipid metabolism and is responsible for synthesis and β-oxidation of fatty acids. Liver is also 
responsible for packaging and distributing fatty acids to peripheral tissues during sexual 
maturation in rainbow trout (Kandemir and Polat, 2007).  
 
 In white muscle, ploidy primarily affected β-oxidation and mTOR genes. These 
observations suggest increased β-oxidation is associated with altered mTOR signaling and is 
responsible for distinct differences in 2N and 3N females. Diploid muscle gene expression 
suggests inhibition of TORC1 assembly is favored in muscle during sexual maturation as 
supported by increased expression of TORC1 inhibitors mo25, and pras40.  Elevated expression 
of TORC1 inhibitors in 2N muscle was also observed in our previous study (Manor et al., 2014).  
Interestingly, redd1, another inhibitor of TORC1, was increased at 20 M in 2N muscle, which 
corresponds to the time period of rapid gonadogenesis. Subsequent increased expression of β-
oxidation genes (pparβ, cd36, cpt1a, cpt1c, aco, and acdhvl) at 20 M further suggests an 
elevation of β-oxidation in 2N muscle.  This elevation is dependent on sexual maturation because 
expression levels of these genes did not change over time in 3N muscle.  Furthermore, these 
changes in gene expression in 2N muscle at 20 M correspond well with changes in growth and 
composition data that occurred in 2N females at 21 M; decreased crude lipid, SFA, and 
monounsaturated fatty acid (MUFA) contents in muscle were observed.  Collectively, these data 
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suggest that increased β-oxidation mobilizes fatty acids from 2N muscle to support 
gonadogenesis.  
 
Increased expression of pparβ at 20 M in 2N muscle suggests this pathway may also 
contribute to up-regulation of β-oxidation in 2N muscle, which is in agreement with previous 
findings (Batista-Pinto et al., 2009; Manor et al., 2014). Batista-Pinto et al. (2009) determined 
there were differences in PPAR expressions between male and female brown trout during 
spawning, and observed variations in pparβ and pparγ expressions in maturing female liver. 
Furthermore, Batista-Pinto et al. (2009) observed changes in pparα, a gene not detected by our 
multiplex-PCR.   In general, data suggest that while 2N females are mobilizing muscle lipids, 3N 
females are storing lipids in muscle, as demonstrated by increased expression of muscle fas and 
greater muscle crude lipid stores (Manor et al., 2013). Previous data indicate the aforementioned 
genes are not affected by ration in maturing 2N trout (Manor et al., 2014a); therefore, 
maturation-inducing signals, such as estrogen, may play an important role in facilitating these 
changes. Additionally, increased expression of cd36 in 2N white muscle for this study supports 
increased transport, as was previously suggested with increased expression of fabp3, cd36, and 
lpl (Manor et al., 2014a). Altered expression of these genes involved in fatty acid transport and 
uptake could be responsible for decreased SFA and MUFA contents of 2N muscle in both studies 
(Manor et al., 2014 and 2013).  
 
 Visceral adipose tissue exhibited a slightly different gene expression profile with fewer 
ploidy and age-by-ploidy interactions. There is evidence that increased β-oxidation in 2N 
females may be responsible for decreased visceral fat content in maturing 2N females. Increased 
β-oxidation is suggested by increased cpt1a expression; this enzyme catalyzes the rate limiting 
step in β-oxidation. Triploid females did have an increased expression of lpl, supporting the 
assertion that 3N females are taking up excess dietary fatty acids into their visceral adipose tissue 
for storage causing large visceral fat deposits in these fish (Manor et al., 2012).  
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CONCLUSION 
 
Sexual maturation is a dominant physiological process that causes a shift from somatic 
growth to gonadal growth. This study provides information about fatty acid metabolism in 
female rainbow trout during an important life stage. In general, genes related to fatty acid 
metabolism were most often differentially expressed in 2N and 3N liver and muscle beginning at 
20 M, which is when effects of sexual maturation on fillet quality and nutrient repartitioning 
became evident.  Triploid liver had increased expression of fatty acid synthesis-related genes, 
while 2N muscle had increased expression of β-oxidation related genes.  In addition, it appears 
PPAR signaling is involved in changes in fatty acid metabolism during sexual maturation, 
especially in liver and muscle. Additionally, gene expression within the mTOR signaling 
pathway is altered in maturing 2N fish and may also contribute to metabolic differences between 
2N and 3N female trout. Understanding the regulation of fatty acid metabolism in 2N and 3N 
fish is pertinent so the industry can use 2N and 3N females to their full production potential by 
maximizing energy use and profitability such as in determining optimal diet formulations, 
feeding strategies, and harvest endpoints when producing larger trout.  
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TABLES and FIGURES 
 
TABLE 1: SIGNIFICANCE AND SAMPLE SIZES FOR ALL GENES TARGETED BY 
THE MULTIPLEX IN LIVER, WHITE MUSCLE, AND VISCERAL 
ADIPOSE TISSUE OF 2N AND 3N FEMALE TROUT 
 
Liver (n=71) White Muscle (n=70) Visceral Adipose Tissue (n=60) 
Gene n  Age Ploidy A*P n Age Ploidy A*P n Age Ploidy A*P 
Fatty Acid Synthesis             
gpat 71 0.0104 0.0006 0.0168 68 0.6184 0.0590 0.4326 47 0.3290 0.7035 0.4447 
srebp1 61 0.0014 0.0067 0.2057 NA NA NA NA NA NA NA NA 
acyl 70 <0.0001 <0.0001 0.0010 69 0.1953 0.1148 0.5672 43 0.0480 0.1637 0.7512 
acc 70 <0.0001 <0.0001 <0.0001 67 0.1773 0.4353 0.0677 55 0.5985 0.7273 0.6430 
fas 61 0.0009 <0.0001 0.0197 67 0.1633 0.0070 0.6326 59 0.1624 0.1768 0.4424 
scd1 67 <0.0001 0.0036 0.0029 60 0.0512 0.7390 0.9137 NA NA NA NA 
β-Oxidation             
magl 70 0.7197 0.3661 0.1666 70 0.9659 0.7336 0.6719 55 0.2289 0.8480 0.3639 
cpt1a 67 0.0005 <0.0001 0.0367 70 0.2512 <0.0001 0.0145 38 0.0353 0.0064 0.0087 
cpt1b NA NA NA NA 69 0.0037 0.0004 0.6108 NA NA NA NA 
cpt1c 71 0.2022 0.0697 0.6202 70 0.0559 0.1771 0.0371 58 0.7920 0.7172 0.1698 
cpt1d NA NA NA NA 66 0.4380 0.8544 0.8977 55 0.8351 0.8209 0.3344 
cpt2 53 0.3080 0.2071 0.5283 69 0.4782 <0.0001 0.1050 NA NA NA NA 
aco 71 0.1179 <0.0001 0.2078 70 0.0075 0.0015 0.0217 60 0.0234 0.8927 0.8432 
acdhvl 68 0.5055 <0.0001 0.4752 69 0.0199 0.0019 <0.0001 56 0.5353 0.6241 0.0992 
ehhadh 71 0.0225 0.0055 0.0619 70 0.2626 0.0238 0.1475 60 0.0320 0.4549 0.8619 
acat2 53 0.4798 0.3946 0.6052 69 0.8517 0.0087 0.7597 51 0.1438 0.1424 0.1927 
Fatty Acid 
Transport             
fabp3 70 0.0014 <0.0001 0.0083 39 0.9195 0.1965 0.7752 32 0.5361 0.3197 0.1541 
fabp4 49 0.0912 0.0204 0.1135 48 0.5927 0.0005 0.6548 44 0.4623 0.1564 0.1665 
lpl 66 0.0128 0.0635 0.0460 44 0.6832 0.8674 0.0612 44 0.1327 0.0455 0.1776 
cd36 71 <0.0001 0.0336 0.0979 69 0.1717 <0.0001 0.0002 52 <0.0001 0.2464 0.3614 
me 71 0.0970 <0.0001 0.0123 70 0.2472 0.2562 0.1283 47 0.1298 0.5006 0.9487 
Signaling Factors             
erk 71 0.6891 0.0354 0.0816 69 0.3019 <0.0001 0.4809 53 <0.0001 0.0290 0.7603 
redd1 71 0.1037 0.7023 0.1092 70 0.0109 0.2821 0.0003 60 0.8703 0.6145 0.1207 
mo25 71 0.1067 0.1817 0.7233 70 0.1996 0.0287 0.3004 60 0.1901 0.5075 0.0494 
mtor 70 0.1096 0.1820 0.8023 69 0.2559 0.5038 0.3818 59 0.7747 0.4265 0.0503 
raptor 69 <0.0001 0.0141 0.5946 NA NA NA NA 30 0.1230 0.7006 0.4036 
rictor 71 0.2394 <0.0001 0.2167 70 0.0361 0.0991 0.1003 52 0.1086 0.5713 0.2075 
pras40 41 0.0111 0.0225 0.4226 70 0.1548 0.0248 0.2135 54 0.9577 0.3866 0.7850 
pparβ 61 0.4736 0.5314 0.2265 68 0.0265 0.0173 0.0153 60 0.0403 0.1607 0.2176 
pparγ 71 0.0003 <0.0001 0.0364 NA NA NA NA 33 0.0016 0.7962 0.7520 
rxr 69 0.7637 0.3196 0.1833 70 0.0584 0.1196 0.0586 58 0.1265 0.5622 0.1738 
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FIGURE 1: LIVER GENE EXPRESISON IN MATURING 2N AND 3N FEMALE 
TROUT  
A and B) Age effects in liver tissue. Letters indicate significant differences between endpoints 
within each gene. C) Ploidy effects in liver tissue. Letters indicate significant differences 
between ploidies within each gene. D-M) Age-by-Ploidy interactions in liver tissue. Only genes 
with significant effects are shown (P≤0.05). Values are means ± SEM and represent the 
normalized transcript abundance, relative to the normalized mean of three reference genes (β-
actin, ef1a, and rplp2). 
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FIGURE 2: MUSCLE GENE EXPRESISON IN MATURING 2N AND 3N FEMALE 
TROUT 
A) Age effects in muscle tissue. Letters indicate significant differences between endpoints within 
each gene. B) Ploidy effects in muscle tissue. Letters indicate significant differences between 
ploidies within each gene. C-L) Age-by-Ploidy interactions in muscle tissue. Only genes with 
significant effects are shown (P≤0.05). Values are means ± SEM and represent the normalized 
transcript abundance, relative to the normalized mean of three reference genes (β-actin, ef1a, and 
rplp2). 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
N
o
rm
al
iz
e
d
 T
ra
n
sc
ri
p
t 
A
b
u
n
d
an
ce
 (
A
rb
it
u
ar
y 
U
n
it
s)
 
113 
 
 
 
FIGURE 3: VISCERAL ADIPOSE TISSUE GENE EXPRESSION IN MATURING 2N 
AND 3N FEMALE TROUT 
A) Age effects in visceral adipose tissue. Letters indicate significant differences between 
endpoints within each gene. B) Ploidy effects in visceral adipose tissue. Letters indicate 
significant differences between ploidies within each gene. C-L) Age-by-Ploidy interactions in 
visceral adipose tissue. Only genes with significant effects are shown (P≤0.05). Values are 
means ± SEM and represent the normalized transcript abundance, relative to the normalized 
mean of three reference genes (β-actin, ef1a, and rplp2). 
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ABSTRACT 
 
Sexual maturation occurs at the expense of stored energy and nutrients, including lipids; 
however, little is known regarding gender effects on nutrient regulatory mechanisms in rainbow 
trout prior to maturity.  Thirty-two, 14 month old, male and female rainbow trout were sampled 
for growth, carcass yield, fillet composition, and gene expression of liver, white muscle, and 
visceral adipose tissue. Growth parameters, including gonadosomatic index, were not affected by 
gender. Females had higher percent separable muscle yield, but there were no gender effects on 
fillet proximate composition. Fillet shear force indicated females produce firmer fillets than 
males. Male livers had greater expression of three cofactors within the mTOR signaling pathway 
that act to inhibit TORC1 assembly; mo25, rictor, and pras40. Male liver also exhibited 
increased expression of β-oxidation genes cpt1b and ehhadh. These findings are indicative of 
increased mitochondrial β-oxidation in male liver. Compared to males, females exhibited 
increased expression of the mTOR cofactor raptor in white muscle and had higher expression 
levels of several genes within the fatty acid synthesis pathway; including gpat, srebp1, scd1, and 
cd36. Female muscle also had increased expression of β-oxidation genes cpt1d and cpt2. 
Increased expression of both fatty acid synthesis and β-oxidation genes suggests female muscle 
may have greater fatty acid turnover. Differences between genders were primarily associated 
with variation of gene expression within the mTOR signaling pathway. Overall, data suggests 
there is differential regulation of gene expression in male and female rainbow trout tissues prior 
to onset of sexual maturity that may lead to nutrient repartitioning during maturation. 
 
 
 
INTRODUCTION 
 
  Generally, rainbow trout are sexually differentiated by 18 days post-hatch for females 
and 28 days post-hatch for males (Billard, 1992). This process is controlled by sex genes and it is 
their actions that mediate the biochemical sex inducers, such as estrogen and testosterone, to 
induce gonadal differentiation (Yamamoto, 1969). Studies have shown that sex-biased 
differences in gene expression are present after sex determination and differentiation has taken 
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place in trout (Hale et al., 2011). Sex bias in gene expression has been documented in multiple 
species including fruit flies, mice, and zebrafish (McIntyre et al., 2006; Yang et al., 2006; Santos 
et al., 2007). These transcriptomic studies have found there are more genes up-regulated in males 
than in mature female zebrafish and drosophila (McIntyre et al., 2006; Yang et al., 2006; Santos 
et al., 2007). Patterns of sex-biased gene expression are variable between and within species and 
are dependent on tissue type and developmental stage examined (Hale et al., 2011). Most of the 
data available for fish is from gonadal tissue of sexually mature adults (Wen et al., 2005; Santos 
et al., 2007). There is some data on gender differences in gene expression of brown trout liver 
(Batista-Pinto et al., 2009) and zebrafish muscle (Wen et al., 2005). In general, there is little data 
on differences in gene expression of immature fish limiting our knowledge of regulatory 
mechanisms that may control sexual maturation (Hale et al., 2011). Additionally, few studies 
have included genes involved in fatty acid metabolism (Batista-Pinto et al., 2009; Hale et al., 
2011).  Typically, trout are harvested prior to the onset of sexual maturation to prevent negative 
impacts on lipid composition and fillet quality. Therefore, an examination of gene expression 
and muscle composition would be beneficial in understanding lipid metabolism at an early life 
stage, which is relevant to fillet quality. Moreover, this type of data will assist in describing 
genders differences in immature fish at the molecular level and identify potential pathways that 
play an important role in determining gender differences in growth, fillet quality, and fatty acid 
metabolism.  
 
 In salmonid production fillet lipid content is an important attribute affecting the 
nutritional value, mechanical texture, and sensory characteristics of the fillet (Quillet et al., 
2005). There appears to be an association between energy storage, increased body lipid content, 
and early maturity (Silverstein et al., 1997; Shearer and Swanson, 2000; Quillet et al., 2005). 
There is also dramatic nutrient repartitioning away from fatty acid synthesis for energy storage 
towards β-oxidation to supply energy for gonadogeneis during maturation (Manor et al., 2013). 
However, little is known regarding gender effects on nutrient regulatory mechanisms in rainbow 
trout prior to maturity.  There are two signaling pathways that are known to be involved in 
growth and development as well as in fatty acid metabolism; mechanistic target of rapamycin 
(mTOR) and peroxisome proliferator activated receptors (PPAR) signaling pathways. The 
mTOR pathway is a central signaling cascade that plays a role in integrating energy-sensing 
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pathways (Laplante and Sabatini, 2011). The mTOR signaling pathway in fish is less 
characterized than in mammals; nevertheless, the consensus has been that the mTOR signaling 
pathway is highly conserved among species through limited in vitro and in vivo studies (Plagnes-
Juan et al., 2008; Seiliez et al., 2008; Lansard et al., 2009; Lansard et al., 2010; Seiliez et al., 
2011). There are limited studies in salmonids examining the role of mTOR in fatty acid 
metabolism, gene expression (Skiba-Cassy et al., 2009). Conversely, the PPAR signaling 
pathway responds to lipids and elicits transcriptional changes on genes involved in fatty acid 
metabolism in mammals, but gene expression studies are limited in salmonids. Gender and stage 
of life cycle influence expression levels of all PPARs in brown trout liver; estrogen appears to 
play an important role in the differential expression of PPARs (Batista-Pinto et al., 2009).   
Activation of PPARγ specifically leads to increased triglyceride accumulation in muscle and 
liver (Pouslen et al., 2012). PPARγ affects transcription rates of a variety of lipogenic target 
genes such as fabp, cd36, lpl, leptin, acc, fas, and scd1 (Lee and Hossner, 2002). Conversely, 
PPARα and PPARβ are responsible for regulating fatty acid β-oxidation (Varga et al., 2011).  
 
 Our previous work has investigated differences in gene expression between diploid and 
triploid female trout and effects of ration level in maturing female trout (Manor et al., 2014a; 
Manor et al., 2014b). The objective of this study was to determine differences in growth, fillet 
quality, and the associated gene expression in immature male and female rainbow trout. Aspects 
of fillet quality investigated in this study include proximate composition, instrumental texture, 
color, and fatty acid content. In addition, relative expression levels of thirty-five multiplexed 
genes within the fatty acid synthesis and β-oxidation pathways were analyzed to determine if the 
physiological basis for differences in male and female growth and fillet quality are associated 
with differential regulation of genes within the mTOR and PPAR pathways. Gene expression 
profiles of liver, white muscle, and visceral adipose tissue were assessed. It is hypothesized that 
data from this study will show discrete differences in fillet quality and gene expression between 
immature male and female trout and identify possible gene-regulatory pathways involved in 
developing these differences.   
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MATERIALS and METHODS 
 
Animal Care 
 Fish care and experimentation followed the guidelines outlined by the US Department of 
Agriculture (USDA) and National Center for Cool and Cold Water Aquaculture (NCCCWA; 
U.S. Department of Agriculture, Agriculture Research Service, Kearneysville, WV, U.S.A.) 
Animal Care and Use Committee, which are in line with the National Research Council 
publication Guide for Care and Use of Laboratory Animals. Fish were hatched in March and 
reared at the NCCCWA. Passive integrated transponders (Avid Identification Systems Inc., 
Norco, CA, U.S.A.) were inserted in the left dorsal musculature at the fingerling stage. Fish were 
maintained indoors, under simulated ambient photoperiod, and supplied with partially 
recirculated treated spring and well water throughout the study.  Water temperatures ranged from 
12.4 to 14.0
oC. Fish were fed Zeigler G, floating, 5.0mm (3/16”) pelleted feed (42% protein, 
16% fat, 2% fiber; Zeigler Brothers, Inc.; Gardners, PA, U.S.A.) dispensed by automatic feeders 
(Arvotec, Huutokoski, Finland) that adjust feeding daily based on the predicted mass of the fish 
in the tank. Feeders dispensed feed in multiple feeding events between 7 am and 2 pm.  Fish 
from each tank were weighed monthly to maintain the accuracy of the feeder system.   
 
Sample Collection  
Fish were held off feed for five days prior to sampling and were harvested using an 
overdose of tricaine methanesulfonate (MS-222, Western Chemicals, Ferndale, CA, U.S.A.) at 
300 mg/L. Body weights were recorded. Gonads, liver, and gastrointestinal tract (GtSI; 
alimentary canal with associated visceral adipose tissue) were removed and weighed. 
Subsamples of dorsal muscle, liver, and visceral adipose tissue were immediately frozen in liquid 
nitrogen and stored at -80
o
C for gene expression. Frozen liver and visceral adipose tissue 
samples were also used for compositional analysis. Fish were processed the following day at 
West Virginia University Meats Laboratory (Morgantown, WV, U.S.A.). Boneless, skinless 
fillets were removed from each fish and weighed. Fillet quality measurements were taken from 
the right fillet and the left filet was frozen at -20
o
C until powdered in liquid nitrogen for 
compositional analysis. 
 
123 
 
 
Growth Parameters 
 Whole body weight (WBW) was used to calculate gonadosomatic index (GSI; gonad 
weight as a percent of WBW), hepatosomatic index (HSI; liver weight as a percent of WBW), 
and gastrosomatic index (GtSI; digestive tract and the associated visceral adipose tissue as a 
percent of WBW). Thermal growth coefficient (TGC) was calculated for each fish as [(
3√Wf – 
3√Wi)/(T × t)] × 1,000, where Wf and Wi are 13-month WBW and 10-month WBW, respectively, 
T is water temperature (°C), and t is time in days (Iwama & Tautz, 1981; Jobling, 2003).  A 
constant 13°C was assumed for all TGC calculations because all tanks were supplied with water 
from the same source and water temperature did not vary substantially during this growth period.    
Feed intake was measured in triplicate on individual fish over a two-week period at 12.8 
months of age (mean body weight = 860 grams) as a means to estimate feed efficiency.  Un-
pelleted meal from the commercial diet was sampled from the manufacturer, labeled with 
approximately 0.2% w/w of 0.4-0.6 mm diameter leaded-glass ballotini beads (Sigmund Linder 
GmbH, Warmensteinach, Germany), and pelleted and oil coated at the Bozeman Fish 
Technology Center (Bozeman, MT, U.S.A.) in a manner similar to that used to manufacture the 
unlabeled commercial diet.  On each of three days occurring one week apart, fish were fed the 
labeled feed using the same automated feeders and at the same feeding rate compared to the 
normal diet.  The labeled feed was fed for the first half of the day (i.e., 3.5 hours), after which 
feeding stopped and the fish were weighed and imaged using x-ray.  The x-ray opaque ballotini 
beads were counted from each radiograph and used to estimate feed intake.  Feed efficiency was 
estimated as gain in body weight ÷ weight of feed consumed, whereby gain in body weight 
represents total body weight gain during the two-week period and weight of feed consumed was 
calculated as the average of three repeated intake measurements and extrapolated over the two-
week period. 
 
Fillet Characteristics  
Fillet Yields:  Separable muscle is reported as a percent of WBW. Trim included the 
head, axial skeleton, belly flap, and skin and is reported as a percent of WBW. Fillet thickness 
was measured at the thickest portion of the right fillet with digital calipers. Belly-flap thickness 
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for each fish was measured using digital calipers at three standardized locations along the length 
of the ventral midline; just cranial to the pectoral fin, just caudal to the pelvic fin, and at the vent. 
Thickness was reported as the average of the three measurements. 
 
Fillet quality: Fresh fillet surface color was recorded with a chromameter (Minolta, 
Model CR-300; Minolta Camera Co., Osaka, Japan). This instrument was color calibrated using 
a standard white plate No. 21333180 (CIE Y 93.1; x 0.3161; y 0.3326), and L* (lightness), a* 
(redness), and b* (yellowness) values were recorded on the cranial and caudal ends of the right 
fillet.  
 
Instrumental Texture: Texture analysis was done on 8x4cm fillet sections that were taken 
from musculature centered on the lateral line, 2–3 cm caudal to the pectoral girdle on the right 
fillet. Sections were thermally processed in a microprocessor-controlled smoke oven (Model 
CVU-490; Enviro-Pak, Clackamas, OR, U.S.A.) at 82
o
C, and the cooking process was stopped 
when the internal temperature reached 65.5
o
C. This cooking temperature was selected according 
to the USDA recommended, minimum internal temperature for fish to achieve a safe temperature 
without overcooking (Nilsson and Ekstrand, 1995). Total cooking time was approximately 45 
minutes. After cooking, the product was allowed to cool to room temperature. Cook loss was 
calculated as [100-(cook weight/raw weight)x100]. Instrumental texture was measured using a 5-
blade, Allo-Kramer shear attachment mounted to the TA-HDi® Texture Analyzer (Texture 
Technologies Corporation; Scarsdale, NY, U.S.A.), which was equipped with a 50kg load cell 
and ran at a crosshead speed of 127 mm/min. Shear force was applied perpendicular to the 
muscle fiber orientation. Force deformation graphs were recorded; average peak force (peak 
force / gram of sample), and total energy of shear (grams/mm) was determined using the Texture 
Expert Exceed software (version 2.60; Stable Micro Systems Ltd., Surrey, UK).   
 
Proximate Analysis:  The left fillet was frozen in liquid nitrogen, powdered using a 
Waring commercial grade blender (Model 51BL31; Waring Commercial; Torrington, CT, 
U.S.A.), and stored at -80C until analysis. Liver and visceral adipose tissue samples were 
minced at the time of analysis. Moisture, crude lipid, crude protein, and ash analyses were 
completed using AOAC approved methods (AOAC, 2000).  Moisture content was determined by 
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weighing the sample before and after an 18 hr drying period at 110 C.  Crude lipid content was 
determined using Soxhlet extraction with petroleum ether. Crude protein was calculated by 
converting percent Kjeldahl nitrogen to crude protein using 6.25 as the conversion factor. 
(Kjeltec
TM
 2300; Foss North America; Eden Prairie, MN, U.S.A.).  Ash was determined by 
incinerating the samples at 550
o
C in a type A1500 furnace (F-A1525M-1; Thermolyne 
Corporation; Dubuque, IA, U.S.A.). 
 
pH: Five grams of powdered raw muscle were mixed with 25-mL distilled water, and pH 
was measured using a flat surface combination electrode (pH/ion analyzer 350; Corning Inc., 
NY, U.S.A.). Duplicate measurements were averaged and used as the observation for that 
sample.   
 
Fatty Acid Analysis: Total lipids were extracted from muscle tissue according to Bligh 
and Dyer (1959) using a chloroform-methanol mixture (2:1 v/v). A 0.5 gram sample of powdered 
muscle was used for fatty acid analysis. Fatty acids were methylated using the method described 
by Fritshe and Johnston (1990). Nonadecanoic acid (19:0) was used as an internal standard. Fatty 
acid methyl esters (FAMEs) were quantified using a Varian CP-3800 Gas Chromatograph 
(Varian Analytical Instruments; Walnut Creek, CA, U.S.A.) equipped with a flame ionization 
detector. A wall-coated, open-tubular (WCOT) fused silica capillary column (100-m length, 
0.25-mm inside diameter; Varian Inc., Walnut Creek, CA, U.S.A.) was used to separate FAMEs. 
The stationary phase was CP-Sil 88, and nitrogen was the carrier gas at a flow of 0.3mL/min. A 
10 to 1 split ratio was applied for all samples. An oven temperature of 140
o
C for 5 minutes, 
followed by a temperature ramp of 3
o
C/min to 235
o
C, was used; 235
o
C was held for 15 minutes. 
The total separation time per sample was 68.5 minutes. Injector (11-77 injector, Varian Inc., 
Walnut Creek, CA, U.S.A.) and detector (Flame Ionization Detector-FID, Varian Inc., Walnut 
Creek, CA, U.S.A.) temperatures were maintained at 270
o
C and 300
o
C, respectively. FAMEs 
were identified based on comparison to retention times of standard FAMEs (SupelcoTM 
quantitative standard FAME 37; Sigma-Aldrich, St. Louis, MO, U.S.A.). Peak area counts were 
computed by an integrator using the Star GC workstation version 6 software (Varian Inc., 
Walnut Creek, CA, U.S.A.).  
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Gene Expression Analysis 
Multiplex Analysis: The GenomeLab GeXP genetic analysis system (Beckman Coulter 
Inc.; Pasadena, CA, U.S.A.) was used to simultaneously analyze expression of thirty-nine genes 
in liver, white muscle, or visceral adipose tissue.  Within the multiplex, thirty-five genes were 
associated with fatty acid metabolic pathways and four served as potential reference genes.  
Primers were designed using eXpress Designer software (Beckman Counter Inc.; Pasadena, CA, 
U.S.A.), and primer sequences were compared against other rainbow trout gene sequences using 
the BLAST function within the NCBI database to reduce unintended sequence amplification.  
The size of each amplicon was confirmed with its expected length.  No undetermined peaks 
interfered with amplification of the intended multiplex.  Optimization of the multiplex, standard 
curve, reverse transcriptase (RT) and PCR reactions, and capillary electrophoresis were 
performed as recommended by the manufacturer (GeXP Chemistry protocol A29143AC; 
February, 2009) with reagents provided in the GeXP Start Kit (Beckman Coulter Inc.; Pasadena, 
CA, U.S.A.).  Primer sequences that include universal tags are provided Appendix 3, Table 5. 
GenBank accession numbers, database reference numbers, and references for sequences used to 
generate multiplex primers, the associated regulatory pathways, roles in lipid metabolism, and R
2
 
values for the RNA standard curve (0.2 ng /μL – 100 ng/μL), are shown in Appendix 4, Table 6.   
 
Areas for each peak within the multiplex were exported to eXpress Profiler software 
(Beckman Coulter, Inc.; Pasadena, CA, U.S.A.) for analysis and normalization to the internal 
kanamycin control.  Concentrations were interpolated from the standard curves for each gene of 
interest.  Data were normalized to the highest expressing sample for input into GeNorm software 
to determine which reference genes were most stable.  The most stable reference genes were 
βactin, rplp2, and ef1a for all three tissues.  M-values for these three genes and for all three 
tissues were below 0.5; therefore, their geometric mean was used to generate a normalization 
factor for each sample.  Thus, the normalized expression of each gene transcript is reported as 
the quantity relative to the geometric mean of the selected reference genes.   
 
RNA Isolation: To isolate RNA, 50 – 100 mg of tissue was homogenized in 1 mL TRIzol 
(Invitrogen; Carlsbad, CA, U.S.A.), per manufacturer’s suggested protocol, using a 5 mm steel 
bead and a multi-tube shaker. The RNA pellet was washed with 75% ethanol and resuspended in 
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nuclease-free water.  RNA quality and quantity was determined by measuring absorbance at 260 
nm and 280 nm.   
 
Multiplex PCR: The multiplex reverse transcription (RT) reactions were optimized for 
each tissue. Reverse transcription reactions included 2 μL 5X RT buffer, 1 μL gene-specific 
reverse primer mix, 0.5 μL RT, and 1.25 μL kanamycin RNA (internal control) in a 10 μL 
reaction. Reactions included 1.25 μL, 2.5 μL, and 2.5 μL of 100 ng DNase treated RNA for liver, 
white muscle, and visceral adipose tissue respectively.  The RT was incubated according to kit 
instructions.  An aliquot (4.65 μL) of the resultant cDNA was used in PCR reactions for all three 
tissues that included 2 μL 25 mM MgCl2, 2 μL 5X PCR buffer, 1 μL forward primer mix, and 
0.35 μL DNA Taq polymerase.  The PCR was incubated according to kit instructions.  1 μL of 
PCR products was combined with 38.5 μl sample loading solution and 0.5 μL size standard 400.  
The PCR products were separated by capillary electrophoresis in the GeXP Genetic Analysis 
System using a modified Frag-3 protocol with a separation voltage of 6.0 kV for 45 min. 
 
Statistical Analysis: There were 16 male and 16 female fish included in this study (2 fish 
x 2 genders x 8 families). All data were analyzed using analysis of variance to test for main 
effects of gender with PC-SAS (Version 9.1) general linear models procedure. Effects were 
considered significant at P≤0.05. Data are presented as LSMeans  SEM (standard error of the 
mean). To normalize gene expression data, fold change values were log2 transformed prior to 
statistical analysis.  Gene data are presented as LSMeans  SEM (standard error of the mean) of 
non-transformed data. All genes have standard curves; however, if the gene was not identified in 
at least 25% of the samples, the gene was recorded as not detectable.  
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RESULTS 
 
Growth Parameters 
 There were no significant differences between males and females in any of the growth 
parameters measured in this study including WBW, GSI, HSI, GtSI, TGC and feed efficiency 
(Table 1; P>0.05). However, there was a trend for females to be larger than males; 1022±48g and 
993±65g, respectively (P=0.0656). The GSI values indicate fish were immature with small 
gonads suggesting any subsequent differences in phenotypic characteristics likely result from 
inherent effects of gender and not onset of sexual maturation. 
 
Fillet Characteristics 
 Yields and Quality: Females did yield a higher percent separable muscle and thicker 
fillets than males; however, there were no significant differences between the sexes in any of the 
other yield measurements including trim loss, belly flap thickness, or cook loss (Table 2). There 
were no significant differences in fillet moisture, crude fat, crude protein, or ash content 
(P>0.05). Additionally, there were no differences in raw fillet pH, L*, or b values. Male fillets 
were redder in color as indicated by a higher a-value. Females did produce firmer cooked fillets 
than males as measured by peak force and energy required to shear. 
 
 Fatty Acid Composition: Differences in the fatty acid composition of the fillets were 
primarily in the polyunsaturated fatty acid (PUFA) content (Table 3). Female fillets had higher 
amounts of 18:2n6, 18:3n3, 18:3n6, 20:2, 20:3n6, 20:5n3, 22:2, and 22:6n3. Conversely, male 
fillets had higher amounts of 20:4n6.  Female fillets not only had higher amounts of PUFA, they 
specifically had higher amounts of omega 3 (ω3) and omega 6 (ω6) fatty acids when compared 
to their male counterparts. Fillet fatty acid composition reported as percent fatty acid is provided 
in Appendix 5, Table 7. 
 
Gene Expression 
Significance and n-values for all targeted genes expressed in the liver, muscle, and 
visceral adipose tissue are reported in Table 4. 
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 Liver Gene Expression: Male liver had increased expression of lipogenic genes gpat and 
scd1 (Figure 1a). The β-oxidation gene ehhadh was higher in male liver while cpt1a had higher 
expression in female liver (Figure 1b). Male liver had a two-fold increase in expression of fatty 
acid transport genes lpl and me (Figures 1c). Male liver also had higher expression of cpt1b, 
mo25, rictor, pras40, and pparγ (Figure 1d).   
 
 White Muscle Gene Expression: Lipogenic genes, gpat, srebp1, and scd1 (Figure 2a), and 
fatty acid transporter, cd36 (Figure 2c), had higher expression in female white muscle when 
compared to male muscle. Female white muscle also had an increased expression of β-oxidation 
genes, cpt1d and cpt2, when compared to the male counterparts (Figure 2b). Female muscle had 
higher expression of mo25, and raptor, within the mTOR signaling pathway, than male muscle 
(Figure 2d).  
 
 Visceral Adipose Tissue Gene Expression: There were no significant effects of gender on 
the gene expression profile of the visceral adipose tissue (Figure 3; P≥0.05). However, there was 
a trend for males to have higher cd36 expression than female visceral adipose tissue (Figure 3c; 
P≤0.10). 
 
 
 
DISCUSSION 
 
 The objectives of the current study were to describe gender differences in growth and 
fillet quality and to identify differentially regulated genes as an indication of physiological 
mechanisms leading to these phenotypic differences.  This study examined growth, fillet yield, 
composition, instrumental texture, fillet quality, and the associated fatty acid metabolism gene 
expression of liver, white muscle, and visceral adipose tissue. This experiment allowed for 
comparisons between immature male and female rainbow trout at roughly market size (1 kg at 14 
M) and reduced environmental effects because fish were raised in communal tanks. Although 
there were no differences in growth between genders, there were distinct differences in the 
quality and compositional attributes investigated in this study. Additionally, these findings were 
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associated with differential gene expression in liver and white muscle. These findings suggest 
that immature, male and female rainbow trout have differing fatty acid metabolisms prior to the 
onset of sexual maturity and these differences may contribute to differences in fillet yield and 
quality.   
 
 Previous studies investigating weights and growth rates in sexually immature fish also 
report similar growth performance in male and female fish (Satue and Lopez, 1996; Memis and 
Gun, 2004; Batista-Pinto et al., 2009; Hale et al., 2011; Harmon, et al., 2011).  Acharya (2011) 
found that immature female salmon have higher fillet yields than males; which supports our 
findings that female trout have higher percent separable muscle (1.5% greater) than their male 
counterparts.  However, Acharya (2011) reported higher fat content in male salmon and firmer 
fillets in female salmon, as measured by breaking force. Conversely, we report no significant 
gender differences in fillet fat content, although males did have numerically higher amount of 
fillet fat. We also found firmer fillets from females as measured by the peak force and energy 
required to shear. There were discrepancies in husbandry practices, with salmon being raised in 
seawater net pens off the coast of Norway while the trout were raised in freshwater, partially-
recirculated tanks under artificial, ambient photoperiod. Additionally, the salmon were over 2 
years old when processed and the trout were roughly 14 M old at sampling. These differences in 
the studies did not appear to affect the growth or composition of the fish.  
 
 Although there were no differences in fillet crude fat content in our studies, there were 
gender effects on fatty acid profiles of the fillets.  Female fillets had higher amounts of PUFAs, 
especially the ω3 and ω6 fatty acids. Salmonids, such as salmon and trout, differ in growth of 
maturing males and females, and these fish experience lipid mobilization and fillet quality 
deterioration during sexual maturation. However, these differences were not observed in the 
current study; primarily because fish were sampled prior to the onset of secondary sex 
characteristics (Nassour and Legar, 1989; Kiessling et al., 2001; Memis and Gun, 2004; and 
Manor et al., 2012).   
 
 No differences in growth and fillet proximate composition would suggest that underlying 
mechanisms regulating nutrient metabolism are similar for male and female fish, while 
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differences in fillet PUFA content suggests there may be differences in fatty acid metabolism. 
There are distinct expression profiles of genes involved in fatty acid metabolism in liver and 
white muscle of male and female rainbow trout. The presence of differentially regulated genes in 
these tissues reflects physiological mechanisms affected by gender in rainbow trout that may 
contribute to the observed differences in separable muscle and fatty acid profile.  Male livers 
have an increased expression of rictor and pras40. Rictor is a cofactor involved in the assembly 
of TORC2 while PRAS40 inhibits TORC1 assembly (Laplante and Sabatini, 2011). There has 
been some evidence in lower organisms that suggest TORC2 acts as a negative regulator of lipid 
deposition in rictor null worms (Jones et al., 2009). However, male trout liver still had an up-
regulation of gpat and scd1, which suggests increased levels of fatty acid synthesis. These 
contradictions are plausible as there is extensive post-transcriptional regulation of the mTOR 
signaling pathway (Lapanate and Sabatini, 2009; Caron et al., 2010; Laplante and Sabatini, 
2011). Additionally, male livers had an increased expression of pparγ, which also up-regulates 
scd1.  
 
 Likewise, female white muscle had increased expression of fatty acid synthesis genes, 
gpat, srebp1, and scd1, along with increased expression of the mTOR cofactor raptor. The 
increased expression of these lipogenic genes may contribute to the increased PUFA content of 
female fillets.  However, the physiological relevance of increased lipogenic genes in muscle is 
unclear as fish muscle demonstrates only very low levels of fatty acid synthesis (Rollin et al., 
2003). Nevertheless, data suggest that the increased PUFA content of female fillets may result 
from increased lipogenic gene expression within white muscle.  Gene expression data in the 
current study also suggest that females have increased capacity for β-oxidation, as indicated by 
increased expression of cpt1a in liver and cpt1d and cpt2 in white muscle. Increased β-oxidation 
is associated with increased expression of TORC1 inhibitors pras40 and mo25 in liver and white 
muscle, respectively. However, extensive post-translational regulation of both the mTOR and 
PPAR signaling pathways plays a significant role in the activation of these pathways, which is 
not reflected in our measure of transcript abundance.  Females having higher expression levels of 
genes involved in both fatty acid synthesis and β-oxidation suggest they may have higher fatty 
acid turnover than their male counterparts.  
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 The PPAR signaling pathway, specifically PPARγ signaling, appears to be an important 
regulatory pathway in liver lipogenic gene expression. Male trout liver has an increased 
expression of pparγ and its target genes involved in fatty acid transport, lpl and me. Phenotypic 
data does not support increased lipogeneis in male trout because there were no differences in 
fillet crude fat; however males did have a numerically higher amount of fillet crude fat. In 
addition, there is no evidence of altered PPAR signaling in male and female white muscle or 
visceral adipose tissue. PPARs are widely studied in mammals, but data on fish PPARs is 
limited. In brown trout, PPARα is highly expressed in white muscle, heart, and liver, pparβ 
predominates in testis, heart, liver, white muscle, and trunk kidney, and pparγ was only 
quantified in the trunk kidney and liver (Batista-Pinto et al., 2005). Our study agrees with Ruyter 
et al. (1997) who determined a more diverse expression of pparγ in salmonids, where it is found 
not only in adipose tissue, but is also highly expressed in liver.  
 
Expression of PPARs in brown trout is affected by gender and stage of development, 
with estrogen being a biological factor regulating expression of PPAR genes (Batista-Pinto et al., 
2009).  Estrogen elicits its effects on lipid metabolism through the estrogen receptor α (ERα) 
(Wend et al., 2013). Estrogen administration decreases adipocyte size and number in cultured 
mouse adipocytes by inducing lipolysis (Wend et al., 2013). Expression of pparα differed 
between genders only during early vitellogenesis (Batista-Pinto et al., 2009).  Fish in the current 
study were sexually immature and harvested prior to the onset of vitellogenesis; therefore, the 
similar levels of ppara are in agreement with Batista-Pinto et al. (2009).  Our data did differ 
from those of Batista-Pinto et al. (2009) in that we did not observe increased expression of pparβ 
in males pre-spawning compared to their female counterparts. Interestingly, our data did show 
decreased expression of pparγ in female liver. Differences in our findings compared to Batista-
Pinto et al. (2009) could be the result of comparing 14 M old, first spawning rainbow trout to 3-
yr old second spawning brown trout.  
 
Ibabe et al. (2005) further investigated the role of estrogen (17β-estradiol) in ppar 
expression in isolated zebrafish hepatocytes and found that estrogen did not alter the expression 
of pparα, but 10µM estrogen decreased pparγ expression. The lack of differences in male and 
female pparα expression and the lower expression level of pparγ in female trout support these 
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findings. However, there is evidence that estrogen up-regulates pparα expression in rat 
hepatocytes (Campbell et al., 2003) and down-regulates pparγ in human bone marrow stromal 
cells (Heim et al., 2004). These results suggest effects of estrogen vary considerably with specie, 
tissue, and concentration used in cell culture and warrants more in-depth study, especially in fish 
(Ibabe et al., 2005).  Hormones, such as estrogen, are significantly involved in regulating sexual 
maturation and, therefore, may also be involved in regulating gene expression within fatty acid 
metabolism and the mTOR and PPAR signaling pathways during this time period. This study 
indicates there are differences in the expression of genes involved in these pathways during 
immaturity when comparing male and female rainbow trout.  
  
 
 
CONCLUSION 
 
 Data from this study indicate that gender affects nutrient regulatory mechanisms in 
rainbow trout prior to maturity. Although there were no differences in growth or fillet proximate 
composition between genders, there were distinct differences in the quality attributes 
investigated in this study. Females produced firmer fillets and had greater separable muscle than 
male trout. Additionally, female fillets had higher amounts of PUFAs, especially ω3 and ω6 fatty 
acids.  Gene expression data suggest different capacities for fatty acid synthesis and β-oxidation 
in male and female trout, possibly leading to altered nutrient utilization.  Specifically, increased 
expression of fatty acid synthesis and β-oxidation genes may contribute to the increased PUFA 
content of female fillets. Overall, these findings suggest immature male and female rainbow trout 
have differing fatty acid metabolism gene expression profiles prior to the onset of sexual 
maturity, primarily associated with the altered gene expression in the mTOR and PPARγ 
signaling pathways in liver and white muscle. These differences in gene expression may 
contribute to variation in product yield and quality between genders.  Our findings suggest that 
gender-specific feeding strategies or diet formulations may maximize growth potential for single 
sex rearing; which is valuable as rainbow trout are often produced as all-female populations.  
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TABLES and FIGURES 
 
 Females Males  p-value 
WBW (g) 1022±48 993±65  0.0656 
GSI (%) 0.30±0.03 0.34±0.13  0.7969 
HSI (%) 0.97±0.02 1.04±0.04  0.1538 
GtSI (%) 8.2±0.3 7.7±0.3  0.1950 
TGC 2.1±0.1 2.0±0.2  0.2877 
Feed Efficiency 0.86±0.32 0.78±0.14  0.9065 
n 16 16   
 
TABLE 1: GROWTH PARAMETERS OF IMMATURE MALE AND FEMALE 
RAINBOW TROUT  
Values are LSmeans ± SEM. Means without a common letter represents significant differences 
among the four phenotypic groups (P≤0.05). Abbreviations: WBW-whole body weight; GSI-
gonadosomatic index; HSI-hepatosomatic index; GtSI-gastrointestinal tract; TGC-thermal 
growth coefficient. 
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 Females Males  p-value 
Yields     
Separable Muscle (%) 47.5±0.5
b 
46.3±0.7
a 
 0.0493 
Trim Loss (%) 29.9±0.4 30.1±0.9  0.6828 
Fillet Thickness (mm) 21.6±0.5 20.5±1.1  0.0508 
Belly Flap Thickness (mm) 10.3±0.4 9.8±0.6  0.3645 
Cook Loss (%) 13.8±0.9 12.3±1.0  0.3638 
pH 6.4±0.2 6.4±0.02  0.7741 
     
Proximate Composition     
Moisture (%) 70.6±0.4 70.6±0.5  0.9622 
Crude Fat (%) 8.6±0.4 8.9±0.5  0.2540 
Crude Protein (%) 20.6±0.1
 
20.2±0.2
 
 0.2023 
Ash (%) 1.4±0.03 1.4±0.02  0.2936 
     
Texture     
Peak Force (g force/g sample) 463±22
b 
385±26
a 
 0.0162 
Energy (kg/mm) 174.9±11.9
b 
149.9±13.7
a 
 0.0483 
     
Color     
L* 43.9±0.74 45.6±0.5  0.1723 
a 1.3±0.1
a 
1.9±0.2
b 
 0.0385 
b 4.5±0.4 5.1±0.4  0.4541 
     
n 16 16   
TABLE 2: FILLET CHARACTERISTICS OF IMMATURE MALE AND FEMALE 
RAINBOW TROUT  
Values are LSmeans ± SEM. Means without a common letter represents significant differences 
among the four phenotypic groups (P≤0.05). 
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mg/100g Female Male p-value 
12:0 0.4±0.1 0.3±0.1 0.0949 
13:0 0.1±0.01 0.08±0.01 0.2578 
14:0 20.3±1.6 15.9±1.6 0.0670 
14:1 0.6±0.1 0.5±0.1 0.0516 
15:0 1.5±0.1 1.2±0.1 0.0744 
16:0 128.2±10.6 106.4±9.8 0.1296 
16:1 48.1±3.7 37.7±3.7 0.0582 
17:0 1.2±0.1 1.0±0.1 0.2329 
17:1 0.6±0.1 0.5±0.1 0.8655 
18:0 25.4±2.1 23.2±2.1 0.4669 
18:1n9 145.9±10.4 122.7±10.4 0.1292 
18:2n6 91.0±6.3 63.1±6.3 0.0047 
18:3n3 8.6±0.6 5.6±0.6 0.0020 
18:3n6 1.5±0.1 1.0±0.1 0.0092 
20:0 0.5±0.1 0.5±0.1 0.9818 
20:1 10.5±0.8 9.3±0.8 0.2908 
20:2 9.8±0.7 6.7±0.7 0.0036 
20:3n3 0.5±0.04 0.4±0.04 0.0816 
20:3n6 3.6±0.3 2.6±0.3 0.0113 
20:4n6 0.3±0.3 1.6±0.2 0.0391 
20:5n3 17.3±1.2 11.5±1.2 0.0022 
21:0 0.2±0.02 0.1±0.02 0.3803 
22:0 0.2±0.04 0.2±0.03 0.7247 
22:1n9 1.2±0.1 1.2±0.1 0.9422 
22:2 4.2±0.3 2.7±0.3 0.0017 
22:6n3 56.0±4.2 39.3±4.2 0.0100 
24:1 0.9±0.1 1.0±0.1 0.4509 
    SFA 177.9±13.7 148.9±13.7 0.1489 
MUFA 207.9±14.9 172.9±14.9 0.1107 
PUFA 187.2±12.5 129.8±12.5 0.0035 
ω3 82.5±5.9 56.8±5.9 0.0051 
ω6 118.8±8.2 82.3±8.2 0.0044 
ω3: ω6 0.69±0.06 0.66±0.06 0.7248 
 
TABLE 3: FILLET FATTY ACID COMPOSITIONS OF IMMATURE MALE AND 
FEMALE RAINBOW TROUT  
Values are LSmeans ± SEM reported as mg of fatty acid per 100 g of sample. Means without a 
common letter represents significant differences between 14-month male and female rainbow 
trout (P≤0.05). 
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TABLE 4: SIGNIFICANCE AND N-VALUES OF ALL GENES TARGETED BY THE 
MULTIPLEX IN LIVER, WHITE MUSCLE, AND VISCERAL ADIPOSE TISSUE OF 
IMMATURE MALE AND FEMALE RAINBOW TROUT 
Gene  Liver n (32) Muscle n (32) Visceral AT n (31) 
Fatty Acid Synthesis       
gpat 0.0130 32 0.0178 32 0.8573 31 
srebp1 0.3813 30 0.0336 25 ND 0 
acyl 0.4420 27 0.3418 31 ND 0 
acc 0.4471 32 0.7842 32 0.9712 31 
fas 0.6157 32 0.9937 32 0.2819 31 
scd1 0.0461 31 0.0445 32 ND 0 
β-Oxidation       
magl 0.9315 29 0.7011 29 0.3639 31 
cpt1a 0.0034 32 0.6798 32 0.2632 30 
cpt1b 0.0382 23 0.2837 32 0.4080 31 
cpt1c 0.3035 32 0.1649 31 0.1558 31 
cpt1d 0.6117 21 0.0044 32 0.6489 31 
cpt2 0.2379 30 0.0244 32 ND 0 
aco 0.5880 32 0.4735 32 0.4063 31 
acdhvl 0.4926 32 0.5261 31 0.5451 31 
ehhadh 0.0506 32 0.5675 32 0.6605 31 
acat2 0.1068 30 0.6462 31 0.6465 31 
Fatty Acid Transport       
fabp3 0.6311 31 0.3650 32 ND 0 
fabp4 0.1276 28 0.5979 32 0.9926 31 
lpl 0.0019 31 ND 6 0.9197 30 
cd36 0.6637 32 0.0455 31 0.0563 30 
me 0.0171 32 0.8103 32 ND 0 
Transcription Factors       
erk 0.8671 26 0.3191 32 ND 0 
akt2 ND 0 0.6485 24 0.3455 31 
redd1 0.8608 32 ND 8 0.7592 31 
mo25 0.0503 32 0.0504 32 0.2649 31 
mtor 0.3381 32 0.8196 32 0.1491 31 
raptor 0.1334 31 0.0471 32 ND 0 
rictor 0.0220 32 0.7289 32 0.6703 31 
pras40 0.0181 32 0.2954 23 0.9718 31 
pparα ND 0 0.1901 31 ND 0 
pparβ 0.9175 32 ND 1 0.8350 31 
pparγ 0.0139 32 0.9897 32 0.7555 30 
rxr 0.1964 30 0.2469 32 0.3793 31 
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FIGURE 1: LIVER GENE RXPRESSION IN IMMATURE MALE AND FEMALE 
RAINBOW TROUT 
a) Gender effects on genes within the fatty acid synthesis pathway expressed in the liver; b) 
Gender effects on genes within the β-oxidation pathway expressed in the liver; c) Gender effects 
on genes within the fatty acid transport expressed in the liver; d) Gender effects on genes of 
transcription factors with mTOR and PPAR signaling pathways. Values are LSmeans ± SEM and 
represent the fold change in gene abundance, relative to the normalized mean of three reference 
genes (β-actin, eF1a, and rplp2). Significant differences between genders are indicated by 
asterisks (P≤0.05). 
 
  
 
 
* 
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FIGURE 2:  WHITE MUSCLE GENE EXPRESSION IN IMMATURE MALE AND 
FEMALE RAINBOW TROUT  
a) Gender effects on genes within the fatty acid synthesis pathway expressed in the liver; b) 
Gender effects on genes within the β-oxidation pathway expressed in the liver; c) Gender effects 
on genes within the fatty acid transport expressed in the liver; d) Gender effects on genes of 
transcription factors with mTOR and PPAR signaling pathways. Values are LSmeans ± SEM and 
represent the fold change in gene abundance, relative to the normalized mean of three reference 
genes (β-actin, eF1a, and rplp2). Significant differences between genders are indicated by 
asterisks (P≤0.05). 
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FIGURE 3: VISCERAL ADIPOSE TISSUE GENE EXPRESSION IN IMMATURE 
MALE AND FEMALE RAINBOW TROUT 
a) Gender effects on genes within the fatty acid synthesis pathway expressed in the liver; b) 
Gender effects on genes within the β-oxidation pathway expressed in the liver; c) Gender effects 
on genes within the fatty acid transport expressed in the liver; d) Gender effects on genes of 
transcription factors with mTOR and PPAR signaling pathways. Values are LSmeans ± SEM and 
represent the fold change in gene abundance, relative to the normalized mean of three reference 
genes (β -actin, eF1a, and rplp2). Significant differences between genders are indicated by 
asterisks (P≤0.05). 
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ABSTRACT 
 
To determine the associations of fillet yield and fat content on fillet quality attributes and 
gene expression, 14-month old female rainbow trout were chosen, after processing, based on 
fillet yield and crude fat content. Families were divided into four phenotypic categories: low 
yield/low fat (LY/LF; n=22), low yield/high fat (LY/HF; n=22), high yield/low fat (HY/LF; 
n=24), and high yield/high fat (HY/HF; n=24). LY/LF fish had the lightest whole body weight, 
and HY/HF fish were heaviest. The only difference in fillet fatty acid composition was that HF 
groups contained higher amounts of monounsaturated fatty acids than LF groups. LF groups had 
higher hepatic expression of scd1 compared to HF groups. LY/LF muscle had increased cpt1d 
expression that may contribute to a lower fat content since this is the rate-limiting gene for β-
oxidation. In visceral adipose tissue, akt2 was expressed more in HF groups compared to LF 
groups. The correlations of β-oxidation genes, specifically cpt1 isoforms, in white muscle with 
fillet fat content and shear force values suggests increased β-oxidation is a mechanism negatively 
affecting fillet fat content and quality by decreasing the amount of lipid within the muscle and 
altering the firmness of the fillet. Overall, data suggest that differences in growth and fillet 
quality phenotypes may result from variation in the capacity for β-oxidation; fat content may be 
associated with the mTOR signaling pathway and yield with the PPAR signaling pathway.  
 
 
 
INTRODUCTION 
 
 The aquaculture industry has improved the cultivation of salmonids through various 
approaches, that include establishing breeding programs, optimizing feeds, improving disease 
treatments, and reducing production times; however, low slaughter yields and less visceral fat 
content are areas of potential improvement (Rasmussen and Ostenfeld, 2000). Improving these 
areas of production will aid in enhancing the overall quality of fish products. Fillet quality is 
impacted by a diverse set of physical, microbiological, and nutritional attributes that vary among 
market sectors, regions, cultures, and individuals (Setala et al., 2000). Nutritional value, 
flawlessness, and firmness of fillets are high-ranking quality attributes to consumers (Setala et 
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al., 2000; Rasmussen, 2001). The quality of the raw fillet, including the cultivation environment, 
size, fat content, and the overall product consistency, has the greatest value to producers (Setala 
et al., 2000). Fauconneau et al. (1995) suggest that maximum protein and lipid levels of fish 
fillets should be reached to achieve higher quality products. However, it is not simply the lipid 
content of the fillet; it is the lipid composition that is of primary importance when considering 
the nutritional value of fillets. Salmonids, such as salmon and trout, are known for producing 
fillets with high amounts of polyunsaturated fatty acids (PUFA), especially the omega-3 fatty 
acids (ω3). These fatty acids are important to human nutrition because of their implications in 
cardiovascular and neural health (Spector, 1999).  Therefore, increasing the amount of fat, 
specifically PUFA, in the muscle, while reducing the amount of fat discarded as visceral waste, 
will increase fillet yield and generate a higher quality product for producers and consumers.  
 
Although lipid content of fillets is regularly manipulated by diet, little is understood 
about the regulation of lipid deposition within the various adipose tissue depots. Two pathways 
known to regulate fatty acid metabolism are the mechanistic target of rapamycin (mTOR) and 
peroxisome proliferator activated receptors (PPAR) pathways (Laplante and Sabatini, 2011; 
Poulsen et al., 2012). Understanding how genes within these two pathways are regulated and 
their associations with phenotypic traits will improve our ability to develop better management 
and breeding practices for more efficient food-fish production.  
 
The mTOR pathway is a central signaling cascade that plays a role in integrating energy-
sensing pathways. The mTOR signaling pathway in fish is less characterized than that of 
mammals; however, the consensus is that the mTOR signaling pathway is highly conserved 
among species based on limited in vitro and in vivo studies (Plagnes-Juan et al., 2008; Seiliez et 
al., 2008; Lansard et al., 2009; Lansard et al., 2010; Seiliez et al., 2011).  Most studies 
investigating mTOR in salmonids have focused on effects of insulin (Plagnes-Juan et al., 2008; 
Lansard et al., 2010) or feeding regimen (Lansard et al., 2009; Seiliez et al., 2010) on energy, 
mostly protein metabolism. There was some assessment of the fatty acid synthesis pathway by 
investigating expression of fas, srebp1, and cpt1 genes using trout divergently selected for high 
and low muscle fat for three generations to determine if there was an altered nutrient utilization 
through changes in the mTOR signaling pathway (Skiba-Cassy et al., 2009). Skiba-Cassy et al. 
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(2009) concluded that genetic selection for increased muscle fat content results in over activation 
of the mTOR signaling pathway and increased expression of lipogenic genes in rainbow trout. 
 
The PPAR signaling pathway is known to respond to lipids and elicit transcriptional 
changes of genes involved in fatty acid metabolism in mammals. PPARs are widely studied in 
mammals, but little is known about PPARs in salmonids. Most studies involving PPARs in 
salmonids characterize gene expression in various tissues (Ruyter et al., 1997; Andersen et al., 
2000; Batista-Pinto et al., 2005). Gender and developmental stage are known to influence the 
expression of all PPARs in brown trout liver (Batista-Pinto et al., 2009). Nevertheless, few 
studies have investigated the relationship between gene expression within fatty acid metabolism 
and specific phenotypes of salmonids (Kolditz et al., 2008; Skiba-Cassy et al., 2009; Kolditz et 
al., 2010). This study uniquely investigated specific associations between gene expression of 
major lipid depots (liver, muscle, and visceral adipose tissue) and fillet quality attributes (yield 
and composition) with a focus on fatty acid synthesis and β-oxidation pathways. 
 
 The objective of this study was to determine the association of variations in fillet yield 
and fat content with fillet quality parameters and gene expression in rainbow trout. Full-sib 
families originating from the National Center for Cool and Cold Water Aquaculture (NCCCWA; 
U.S. Department of Agriculture, Agricultural Research Service. Keraneysville, WV, U.S.A.) 
selective breeding program were divided into four phenotypic categories according to family 
mean fillet yield and fat content: low yield/low fat (LY/LF), low yield/high fat (LY/HF), high 
yield/low fat (HY/LF), and high yield/high fat (HY/HF). Aspects of fillet quality investigated in 
this study included proximate composition, instrumental texture, color, and fatty acid content. In 
addition, the relative expression levels of 35 genes were analyzed to determine if the 
physiological basis for the phenotypes can be attributed to differential regulation of gene 
expression within fatty acid metabolism.  Furthermore, this study characterized quality of 
rainbow trout from an intensive breeding program focused on improving growth rate. It is 
hypothesized that muscle yield and fat content will be associated with altered fillet quality 
attributes and expression of  genes involved in regulating fatty acid metabolism.  
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MATERIALS and METHODS 
 
Experimental Design 
Ninety-eight rainbow trout families from the NCCCWA population selected for three 
generations for greater whole body weight (WBW) and thermal growth coefficient (TGC) at 10 
months of age were evaluated for fillet yield and fillet fat content.  All fish were hatched within a 
three-week period in late March/early April of 2010 and reared at the NCCCWA according to 
standard operating procedures.  Passive integrated transponders (PIT-tags; Avid Identification 
Systems Inc., Norco, CA, U.S.A.) were inserted in the left dorsal musculature at approximately 
5.5 months of age (~75 g WBW) in 17 fish per family for individual identification.  At 
approximately 14 months of age, five fish were systematically sampled from each family to 
capture within-family variation for WBW (e.g., the 3
rd
, 6
th
, 9
th
, 12
th
, and 15
th
 largest fish per 
family).  Fish within a family were randomly assigned to one of five harvest groups, and one 
group per week was harvested over a five-week period.  Gravimetric measurements, fillet yield, 
and proximate composition analysis were completed on all fish (490 fish).  For the current study, 
a subset of families were selected based on separable muscle [high yield—HY (52-49%) and low 
yield—LY (44-47%)] and fillet crude fat content [high fat—HF (9-11%) and low fat—LF (6-
7%)]. Five families per phenotype combination were selected (LY/LF, LY/HF, HY/LF, and 
HY/HF) for a total of twenty families. Family selection was dependent on the family having at 
least five female fish; therefore there was a total of 20 fish within each phenotypic group.  Fillet 
fatty acid profiles and gene expression were subsequently analyzed on these twenty families 
only.   
 
Animal Husbandry  
Methods for animal husbandry followed the guidelines outlined by the US Department of 
Agriculture (USDA) and NCCCWA Animal Care and Use Committee, which are in line with the 
National Research Council publication Guide for Care and Use of Laboratory Animals. Fish 
were reared in flow-through spring water for the first three months and then partially-recirculated 
spring water thereafter.  Water temperatures ranged from 12.4 to 14.0
o
C. Between hatching and 
tagging, fish were reared separately by family in 200-L tanks, and then co-mingled in 1,000-L 
tanks after tagging for growth performance evaluation until approximately 13 months of age.  At 
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approximately 8 and 10 months of age, fish were weighed and split into additional 1,000-L tanks 
to maintain biomass densities ≤80 kg/m3.  Fish were fed a commercial fishmeal-based diet 
consisting of 16% crude fat and 42% crude protein (Ziegler Bros. Inc., Gardners, PA, U.S.A.) 
using automated feeders (Arvotec, Huutokoski, Finland) with a feeding schedule similar to that 
given in Hinshaw (1999).  At the end of the growth performance evaluation period, fish were 
weighed and separated by harvest group into five 1,000-L tanks (98 fish per tank), with one fish 
per family per tank. Feed was withheld five days prior to harvest. Fish were harvested using an 
overdose of tricaine methanesulfonate (MS-222, Western Chemicals, Ferndale, CA, U.S.A.), and 
WBW and weights of gonads, liver, and gastrointestinal tract were recorded. Weights were used 
to calculate the gonadosomatic index (GSI), hepatosomatic index (HSI), and gastrointestinal tract 
somatic index (GtSI), respectively; tissue weights were expressed as a percent of WBW. 
Subsamples of epaxial muscle, liver, and visceral adipose tissue were taken, immediately frozen 
in liquid nitrogen, and stored at -80
o
C for gene expression analysis. Carcasses were packed on 
ice and processed the following day at the West Virginia University Muscle Foods Laboratory 
(Morgantown, WV, U.S.A.). Boneless, skinless fillets were removed from each fish, weighed, 
and analyzed for color.  The remainder of the fillet, after sectioning for texture analysis as 
described below, was vacuumed-packaged and stored at -20
o
C until powdering for compositional 
analyses. 
 
Thermal Growth Coefficient and Feed Efficiency 
Thermal growth coefficient (TGC) was calculated for each fish as [(
3√Wf – 
3√Wi)/(T × t)] 
× 1,000, where Wf and Wi are 13-month WBW and 10-month WBW, respectively, T is water 
temperature (°C), and t is time in days (Iwama & Tautz, 1981;  Jobling, 2003).  A constant 13°C 
was assumed for all TGC calculations because all tanks were supplied with water from the same 
source and water temperature did not vary substantially during this growth period.   
  
Feed intake was measured in triplicate on individual fish over a two-week period at 12.8 
months of age (mean body weight = 860 grams) as a means to estimate feed efficiency.  Un-
pelleted meal from the commercial diet was sampled from the manufacturer, labeled with 
approximately 0.2% w/w of 0.4-0.6 mm diameter leaded-glass ballotini beads (Sigmund Linder 
GmbH, Warmensteinach, Germany), and pelleted and oil coated at the Bozeman Fish 
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Technology Center (Bozeman, MT, U.S.A.) in a manner similar to that used to manufacture the 
unlabeled commercial diet.  On each of three days, occurring one week apart, fish were fed the 
labeled feed using the same automated feeders at the same feeding rate as the normal diet.  The 
labeled feed was fed for the first half of the day (i.e., 3.5 hours), after which feeding stopped and 
the fish were weighed and imaged using x-ray.  The x-ray opaque ballotini beads were counted 
from each radiograph and used to estimate feed intake.  Feed efficiency was estimated as gain in 
body weight ÷ weight of feed consumed, whereby gain in body weight represents total body 
weight gain during the two-week period and weight of feed consumed was calculated as the 
average of three repeated intake measurements and extrapolated over the two-week period. 
 
Fillet Characteristics 
Fillet Yields: Separable muscle is reported as a percent of WBW. Trim included the head, 
vertebral column, ribs, belly flap, and skin and is reported as a percent of WBW. Fillet thickness 
for each fish was measured using calipers at the thickest part of the fillet. 
 
Quality Attributes: Fresh fillet surface color was recorded with a chromameter (Minolta, 
Model CR-300; Minolta Camera Co., Osaka, Japan). This instrument was color calibrated using 
a standard white plate No. 21333180 (CIE Y 93.1; x 0.3161; y 0.3326), and L* (lightness), a* 
(redness), and b* (yellowness) values were recorded at the cranial, middle, and caudal regions of 
the fillet.  
 
Texture analysis was performed on 8x4-cm fillet sections that were taken, centered on the 
lateral line, 2–3 cm caudal to the pectoral girdle. Sections were stored at 4oC overnight on PVC-
overwrapped trays. Sections were then thermally processed in a microprocessor-controlled 
smoke oven (Model CVU-490; Enviro-Pak, Clackamas, OR, U.S.A.) set at 82
o
C, and the 
cooking process was stopped when the internal temperature reached 65.5
o
C. This cooking 
temperature was selected according to the USDA recommended minimum internal temperature 
for fish to achieve a safe temperature without overcooking (Nilsson and Ekstrand, 1995). Total 
cooking time was approximately 45 min. After cooking, product was allowed to cool to room 
temperature. Weights of the raw and cooked sections were recorded to calculate percent cook 
loss. Instrumental texture was measured using a 5-blade, Allo-Kramer shear attachment mounted 
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to a TA-HDi® Texture Analyzer (Texture Technologies Corporation; Scarsdale, NY, U.S.A.). 
The texture analyzer was equipped with a 50-kg load cell and tests were performed at a 
crosshead speed of 127mm/min. Shear force was applied perpendicular to the long axis of the 
fillet. Force deformation curves were recorded, and maximum shear force (gram per gram of 
sample) and total energy of shear (grams/mm) were determined using the Texture Expert Exceed 
software (version 2.60; Stable Micro Systems Ltd., Surrey, UK).   
 
Proximate Analyses: Boneless-skinless fillets were stored at -20
o
C under vacuum for no 
more than one month before being snap-frozen in liquid nitrogen and powdered using a Waring 
commercial grade blender (Model 51BL31; Waring Commercial; Torrington, CT, U.S.A.). 
Powdered sample was and stored at -80C until analysis. Moisture, crude lipid, crude protein, 
and ash content were determined using AOAC approved methods (AOAC, 2000).  Moisture 
analysis was performed by weighing the sample before and after an 18 hr drying period at 
110C.  Crude lipid content was determined indirectly using petroleum ether in a Soxhlet 
extractor. Crude protein was calculated by converting percent nitrogen (Kjeltec
TM
 2300; Foss 
North America; Eden Prairie, MN, U.S.A.) to crude protein using 6.25 as the conversion factor.  
Ash was determined by incinerating samples at 550
o
C in a type A1500 furnace (F-A1525M-1; 
Thermolyne Corporation; Dubuque, IA, U.S.A.).  
 
Fatty Acid Analysis: Total lipids were extracted from 0.5-g samples of powdered muscle 
tissue, according to Bligh and Dyer (1959), using a chloroform-methanol mixture (4:1 v/v). Fatty 
acids were methylated using the method described by Fritshe and Johnston (1990). 
Nonadecanoic acid (19:0) was used as an internal standard. Fatty acid methyl esters (FAMEs) 
were quantified using a Varian CP-3800 Gas Chromatograph (Varian Analytical Instruments; 
Walnut Creek, CA, U.S.A.) equipped with a flame ionization detector. A wall-coated, open-
tubular fused silica capillary column (100m length, 0.25mm inside diameter; Varian Inc., Walnut 
Creek, CA, U.S.A.) was used to separate FAMEs. The stationary phase was CP-Sil 88, and 
nitrogen was the carrier gas at a flow of 0.3mL/min. A 10:1 split ratio was applied for all 
samples. An oven temperature of 140
o
C for 5 min, followed by a temperature ramp of 3
o
C/min to 
235
o
C, was used; dwell time at 235
o
C was 15 min. The total separation time per sample was 68.5 
min. Injector (11-77 injector, Varian Inc., Walnut Creek, CA, U.S.A.) and detector (Flame 
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Ionization Detector-FID, Varian Inc., Walnut Creek, CA, U.S.A.) temperatures were maintained 
at 270
o
C and 300
o
C, respectively. FAMEs were identified based on comparison to retention 
times of standard FAMEs (SupelcoTM quantitative standard FAME 37; Sigma-Aldrich, St. 
Louis, MO, U.S.A.). Peak area counts were computed by an integrator using the Star GC 
workstation version 6 software (Varian Inc., Walnut Creek, CA, U.S.A.). Fatty acids were 
reported as mg/g of sample. 
       
Gene Expression Analysis 
Multiplex Analysis: The GenomeLab GeXP genetic analysis system (Beckman Coulter 
Inc.) was used to simultaneously analyze expression of thirty-nine genes in liver, white muscle, 
and visceral adipose tissue.  Within the multiplex, thirty-five genes were associated with fatty 
acid metabolism and four served as potential reference genes.  Primers were designed using 
eXpress Designer software (Beckman Counter Inc., Pasadena, CA, U.S.A.), and primer 
sequences were compared against other rainbow trout gene sequences using the BLAST function 
within the NCBI database to reduce unintended sequence amplification.  The size of each 
amplicon was confirmed based on its expected length.  No undetermined peaks interfered with 
amplification of the intended multiplex.  Optimization of the multiplex, standard curves, reverse 
transcriptase (RT) and PCR reactions, and capillary electrophoresis were performed as 
recommended by the manufacturer (GeXP Chemistry protocol A29143AC; February, 2009) with 
reagents provided in the GeXP Start Kit (Beckman Coulter Inc., Pasadena, CA, U.S.A.).  
GenBank accession numbers, database reference numbers, and references for the sequences used 
to generate multiplex primers are shown in Appendix 4, Table 6. A summary of the associated 
regulatory pathway, role in lipid metabolism, and R
2
 values for the RNA standard curve (0.2 ng 
/μL – 100 ng/μL) for each gene is also reported in Appendix 4, Table 6.  Primer sequences that 
include universal tags are provided in Appendix 3, Table 5.  
 
Areas for each peak within the multiplex were exported to eXpress Profiler software 
(Beckman Coulter, Inc., Pasadena, CA, U.S.A.) for analysis and normalization to the internal 
kanamycin control.  Concentrations were interpolated from the standard curves for each gene of 
interest.  GeNorm software was used to determine which reference genes were most stable.  The 
most stable reference genes were β-actin, rplp2, and ef1a for all three tissues.  M-values for these 
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three genes and for all three tissues were below 0.5; therefore, their geometric mean was used to 
generate a normalization factor for each sample.  Thus, the normalized expression of each gene 
transcript is reported as the quantity relative to the geometric mean of the selected reference 
genes with arbituray units.  
 
RNA Isolation: To isolate RNA, 50 – 100 mg of tissue was homogenized in 1 mL TRIzol 
(Invitrogen, Carlsbad, CA, U.S.A.) per manufacturer’s suggested protocol using a 5 mm steel 
bead and a multi-tube shaker.  RNA was isolated per manufacturer’s protocol. The RNA pellet 
was washed twice with 75% ethanol, and re-suspended in nuclease-free water.  RNA quality and 
quantity was determined by measuring absorbance at 260 nm and 280 nm.   
 
Multiplex PCR: The multiplex reverse transcription (RT) reactions were optimized for 
each tissue. Reverse transcription reactions included 2 μL 5X RT buffer, 1 μL gene-specific 
reverse primer mix, 0.5 μL RT, and 1.25 μL kanamycin RNA (internal control) in a 10 μL 
reaction. Reactions included 1.25 μL, 2.5 μL, and2.5 μL of 100 ng DNase treated RNA for liver, 
white muscle, and visceral adipose tissue respectively.  The RT was incubated according to kit 
instructions.  An aliquot (4.65 μL) of the resultant cDNA was used in PCR reactions for all three 
tissues that included 2 μL 25 mM MgCl2, 2 μL 5X PCR buffer, 1 μL forward primer mix, and 
0.35 μL DNA Taq polymerase.  The PCR was incubated according to kit instructions.  1 μL of 
PCR products was combined with 38.5 μl sample loading solution and 0.5 μL size standard 400.  
The PCR products were separated by capillary electrophoresis in the GeXP Genetic Analysis 
System using a modified Frag-3 protocol with a separation voltage of 6.0 kV for 45 min. 
 
Statistical Analysis 
 Data were analyzed using analysis of variance to test for main effects of phenotype and 
family with PC-SAS (Version 9.1, 2004) general linear models procedure.  A 4x5x5 (phenotype 
x family x tank) design was used to test main effects; a total of 92 fish were included in the 
experiment because of the female constraint. Effects were considered significant at P ≤ 0.05.  
There were no significant effects of tank. Data are presented as LSMeans  SEM (standard error 
of the mean). Correlations using individual fish data were analyzed with the PROC CORR 
procedure of PC-SAS (Version 9.1, 2004). A Bonferroni correction was used to reduce the 
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occurrence of Type I errors due to multiple comparisons; the corrected significance value was 
P≤0.0018. 
 
 
 
RESULTS 
 
Growth Responses 
All growth responses are reported in Table 1. The LY/LF group had the lowest WBW 
(772±45g) and the HY/HF group had the largest WBW (1152±43g). Phenotype affected GSI 
(P≤0.05); however, as expected, gonads were small and underdeveloped as GSI averages ranged 
from 0.25±0.02% to 0.33±0.02%.  Therefore, fish were in the very early stages of sexual 
maturation and were harvested prior to the point at which maturation-related processes affect 
growth performance and fillet attributes. HSI was highest for the LY/HF phenotypic group 
(1.20±0.03%) and lowest for the HY/LF phenotypic group (0.98±0.03%). GtSI was lowest for 
the HY/LF phenotypic group (7.04±0.31%) and highest for the LY/HF phenotypic group 
(9.33±0.32%). TGC was also affected by phenotype with the HY/HF phenotypic group having 
the highest TGC (2.3±0.05) and the LY/LF phenotypic group exhibiting the lowest TGC 
(1.9±0.06). Feed efficiency was not affected by phenotype (P>0.05; Table 1).  
 
Fillet Characteristics 
All fillet quality attributes are reported in Table 2. Fillet yield, as measured by percent 
separable muscle, was one criterion used for categorizing fish for this study; therefore a 
significant effect of phenotype was expected. Yields were 46.0±0.04% and 47.1±0.04% for the 
LY groups and 49.8±0.04% and 50.3±0.04% for the HY groups. Low yield groups had higher 
trim losses than HY groups. In addition, LY groups had thinner fillets when compared to HY 
groups. The HY/HF phenotypic group had the lowest cook loss (12.6±0.3%) and the LY/LF 
phenotypic group had the highest cook loss (14.2±0.3%). The other parameter used to categorize 
fish was crude fat of the fillet, which, as expected, was affected by phenotype. Crude fat was 
7.1±0.3% and 6.8±0.3% for the LF groups and 9.6±0.3% and 9.9±0.3% for the HF groups. Fillet 
moisture was inversely related to crude fat, as anticipated. There were no significant differences 
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in fillet protein content (P>0.05). LY phenotypic groups had higher percent ash than HY groups. 
The LY/LF phenotypic group had the lowest peak force and energy of shear while the HY/HF 
phenotypic group had the firmest fillets. LF raw fillets had lower L*-values and b-values than 
HF fillets. There were no significant effects of group on a-values for raw fillets.   
 
Fillet Fatty Acids      
The saturated fatty acids 12:0 and 20:0 were significantly higher in the HY/HF group 
while 14:0, 16:0, and 18:0 trended higher in the HF groups (P≤0.10) (Table 3). The 
monounsaturated fatty acids (MUFA), 14:1, 16:1, and 18:1, were also higher in HY/HF group, 
with 18:1 being 30% higher in the HY/HF group (6.63 ± 0.56mg/g) than in the HY/LF group 
(4.60 ± 0.56mg/g). Total MUFA was affected by phenotype with the HY/HF group having 
2.9mg/g more MUFA than HY/LF group. Total SFA trended higher in the HF groups as well, 
(P≤0.10). There were no significant effects of phenotype on any of the PUFAs. Additionally, 
there were no significant effects of family on any of the fatty acids measured in this study. 
Percent fatty acid data are reported in Appendix 6, Table 8. 
 
Gene Expression  
 Significance and n-values for all genes expressed in the liver, muscle, and visceral 
adipose tissue are reported in Table 4. 
  
Liver: The only gene in the liver to be affected by phenotype was scd1; LF groups had 
higher expression of scd1 compared to the HF groups (figure 1a). Additionally, there were 
significant positive correlations between muscle crude fat content and fabp3 (p=0.0018; 
r
2
=0.4277), lpl (p=0.0015; r
2
=0.4912), and scd1 (p=0.0015; r
2
=0.4988).  
 
White Muscle: Phenotype did not affect genes expressed in white muscle (P > 0.05); 
however, cpt1d and magl did show trends at P≤0.10 (figure 2). LY/LF fish had the highest 
expression of cp1d and the lowest expression of magl. LY/LF expression of magl was 85% lower 
than the LY/HF group (69.07 ± 102.55 and 467.01 ± 105.09 normalized transcript abundance 
(ng/µL), respectively). Additionally, force required to shear is positively correlated with the β-
oxidation gene cpt1a (p=0.0012; r
2
=0.5182).  
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 Visceral Adipose Tissue: HF groups had greater expression of akt2 compared to the LF 
groups (figure 3d). Whereas rictor and gpat had similar expression patterns, with the LY/HF and 
HY/LF groups having more transcripts than the LY/LF and HY/HF groups. The only gene in the 
visceral adipose tissue to show a trend (P≤0.10) was scd1. The LY/HF group had almost double 
the expression of the LY/LF group; 276.01 ± 37.23 and 151.09 ± 33.30 normalized transcript 
abundance (ng/µL), respectively (figure 1a).  Additionally, GtSI was negatively correlated with 
β-oxidation genes, cpt1c (p=0.0018; r2=-0.3967), redd1 (p=<0.0001; r2=-0.5235), and pparb 
(p=0.0016; r
2
=-0.4886). Trim losses were positively correlated with redd1 (p=0.0017; r
2
=0.4373) 
expression in visceral adipose tissue.  
 
 
 
DISCUSSION 
 
 The objective of the current study was to evaluate potential molecular mechanisms 
leading to increased muscle yield and muscle fat accumulation in female rainbow trout at 
approximately market size (1 kg at 14 M). This study examined growth, fillet yield, composition, 
mechanical texture, quality, and the associated gene expression of liver, white muscle, and 
visceral adipose tissue. This approach allowed for comparisons between fish with high and low 
muscle yield and fat content that had been selected for increased growth for three generations. 
Environmental effects were reduced by rearing fish in communal tanks. Furthermore, fish were 
immature females, avoiding any effects of sex or sexual maturation.   Although muscle yield and 
fat content differed only by approximately 3% for each variable, distinct associations were 
observed between fillet quality and gene expression data, suggesting that subtle genetic effects 
on physiological processes can impact phenotype and economics of production.   
 
 There is evidence that fast-growing strains of rainbow trout have increased adipose tissue 
accretion (Fauconneau et al., 1995). However, this research indicates that rainbow trout selected 
for growth vary in total lipid content and adipose tissue deposition. GtSI can serve as an index of 
the amount of visceral fat stores, and visceral adipose tissue associated with the digestive tract is 
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a major contributor to the weight of the viscera in rainbow trout (Regost et al., 2001).  GtSI was 
variable among the phenotypic groups with the HY/LF group having the lowest GtSI and LY/HF 
group having the largest amount of visceral adipose tissue. This translated into the HY/LF group 
having low trim losses and the LY/LF group having the highest trim losses along with the 
greatest cook losses. Cook losses are associated with cooking rate and moisture and lipid lost 
during cooking, in turn affecting palatability. Interestingly, the fastest growing fish, HY/HF, as 
measured by the WBW and TGC, did not have the largest visceral adipose tissue stores. This 
finding is beneficial to the aquaculture industry since the aim of production is to reduce the 
percentage of offal (Rassmussen, 2001); this reduction was observed in this phenotypic group 
without compromising growth, decreasing fillet fat content, or fillet yield. These are unique 
findings since slaughter yield decreased with fish size in larger salmonids (Einen and Skrede, 
1998), and fast-growing strains of rainbow trout exhibited lower carcass yields (Morkramer et 
al., 1985).   
 
Several fillet quality attributes varied by phenotypic groups.  LY/LF fish produced the 
softest cooked fillets, as measured by peak force and energy required to shear, and the darkest, 
most yellow raw fillets.  However, crude protein content did not differ among the phenotypic 
groups supporting Shearer’s (1994) conclusion that protein content is influenced by diet or 
genetics less than fillet lipid content. Since the diet used in this study did not differ among 
groups, few differences were observed in the fatty acid composition of the fillet. This 
consistency was expected because the primary contributor to muscle fatty acid composition is 
diet (Turchini and Francis, 2008). Primary differences were within the medium-chain MUFAs; 
HY/HF fillets had the highest amounts of 14:1, 16:1, and 18:1 fatty acids. In general, HY/LF fish 
had the most desirable fillet characteristics including bright, firm attributes that are preferred by 
consumers (Rasmussen, 2001), and high yields that are preferred by producers (Setala et al., 
2000). Additionally, HY/LF fish had the highest ω3:ω6 ratio while maintaining optimal growth, 
supporting the Bugeon et al. (2010) assertion that increasing fillet yield does not negatively 
impact fillet quality. Our suggestion that HY/LF fish produce the highest quality fillets may 
contradict Fauconneau et al. (1995), who suggest that maximum protein and lipid levels should 
be reached to achieve higher quality products. 
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 Nutritional manipulation of intramuscular fat, independent of other body fat stores, is 
difficult; therefore, biological markers for increased intramuscular fat would be beneficial, 
allowing for prediction of muscle adiposity at an early age. However, identification of 
biomarkers relies on existing scientific knowledge regarding regulation of intramuscular fat 
content by physiological and nutritional factors (Hocquette et al., 2010).  Albeit, little is known 
about metabolic integration that regulates nutrient partitioning in fish. Two pathways that 
regulate nutrient metabolism in mammals are the mTOR and PPAR pathways (Laplante and 
Sabatini, 2011; Poulsen et al., 2012). Both pathways respond to nutrient availability and alter 
target gene expression of key enzymes involved in fatty acid metabolism. However, both 
pathways do not uniquely control lipid metabolism (Laplante and Sabatini, 2011; Poulsen et al., 
2012). Several genes within both pathways have the potential to serve as markers for increased 
intramuscular fat; several of those potential genes are included in the multiplex used in this study 
(Hocoquette et al., 2010). 
 
Skiba-Cassy et al. (2009) investigated the role mTOR plays in controlling lipid synthesis. 
These authors wanted to determine if divergent selection for high and low muscle fat altered 
nutrient utilization through changes in mTOR signaling in rainbow trout. Body weight and feed 
intake were not different between the two groups; this finding suggests there are metabolic 
differences in nutrient utilization between the lines resulting in the different phenotypes (Skiba-
Cassy et al., 2009). Our study did not reveal differences in feed intake or feed efficiency.  
Moreover, Skiba-Cassy et al. (2009) determined that mtor transcripts were more abundant in the 
liver of the fat-line fish. However, our data did not reveal differences in mtor expression in any 
of the tissues measured; but, most of the genes investigated in this study are subject to 
posttranscriptional regulation.  
 
In addition, Skiba-Cassy et al. (2009) reported low cpt1 expression in the fat-line fish 
compared to the lean-line fish, suggesting a decreased ability for β-oxidation, which may 
contribute to accumulation of lipid stores. Our results support the concept that β-oxidation affects 
composition and yield because there was a trend for increased expression of cpt1d in white 
muscle of LY/LF fish (P≤0.10). Combining these findings and those of Corraze et al. (1999), 
who determined that de novo synthesized lipids are preferentially incorporated in muscle rather 
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than adipose tissue, Skiba-Cassy et al. (2009) concluded genetic selection for increased muscle 
fat content results in over activation of the mTOR signaling pathway and increased expression of 
lipogenic genes. Although our study used fish selected on growth rather than muscle fat content, 
our fish do have variation in muscle fat content and our data do support the assertion that genetic 
effects on lipogenic gene expression contribute to variations in lipid deposition in muscle. 
 
The PPAR signaling pathway is known to respond to lipids and elicit transcriptional 
changes on genes involved in lipid metabolism in mammals.  Specifically, activation of PPARγ 
leads to increased triglyceride accumulation in muscle and liver (Pouslen et al., 2012). It is the 
most abundant of the PPARs, occurring in adipose tissue at levels 30-fold higher than levels 
found in other tissues (Varga et al., 2011). PPARγ affects transcription rates of a variety of 
lipogenic target genes such as fabp, cd36, lpl, leptin, acc, fas, and scd1 (Lee and Hossner, 2002). 
Additionally, PPARα and PPARβ are responsible for regulating fatty acid β-oxidation (Varga et 
al., 2011). Of these genes, pparγ, srebp1, fas, scd1, fabp4, and cd36 have shown the most 
association with increased intramuscular fat while pparα shows the most association with 
decreased intramuscular fat in mammals as well as aquatic animals (Childs et al., 2002; Kolditz 
et al., 2008; Wang et al., 2009; Hocquette et al., 2010). Although PPAR transcription factors and 
their associated genes have potential to predict intramuscular fat, there were no effects of 
phenotype on any of the PPAR genes in tissues included in this study. This finding suggests that 
post-translational modifications of PPAR-related genes, or additional regulatory mechanisms, 
beyond those measured in this study, contribute to the observed phenotypes.  
 
Although there were no specific associations of gene expression with the phenotypic 
groups investigated in this study, there were several notable correlations between variables 
measured and gene expression. GtSI was negatively correlated with redd1 while trim losses were 
positively correlated with redd1 in the visceral adipose tissue. REDD1 inhibits the TORC1 
complex and thereby inhibits expression of lipogenic genes (Laplante and Sabatini 2009; Caron, 
2010). However, increased GtSI appears to be more closely related to decreased β-oxidation 
gene expression in the visceral adipose tissue, especially with pparβ and cpt1c. These findings 
suggest that a reduced capacity for β-oxidation in this tissue contributes to accumulation of 
visceral lipid stores more so than increased lipogenesis.  Fillet crude fat content is positively 
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correlated with lipogenic genes, fabp3, lpl, and scd1, in the liver. These data suggest that 
increased expression of lipogenic genes in the liver may account for increased muscle fat content 
in HF fish while increased visceral adipose tissue stores, as indicated by high GtSI, are 
associated with decreased β-oxidation gene expression in LF fish. With respect to indices of fillet 
quality, the only correlation was between cpt1a expression in the muscle and shear force, 
suggesting that increased β-oxidation gene expression in the muscle leads to a lower muscle fat 
content and, in turn, a firmer fillet. 
 
In general, it appears that genes within the β-oxidation pathway of muscle and visceral 
adipose tissue, especially the cpt1 isoforms, may serve as potential indicators of fillet yield and 
fatness. The lack of muscle yield and fat associations with genes within the fatty acid synthesis 
pathway may be a result of fish having negligible lipid synthesis within the muscle (Rollin et al., 
2003). The absence of a correlation between fillet crude fat content and pparγ agrees with Childs 
et al. (2002) work with cattle that also did not show an association with intramuscular fat and 
pparγ. In addition, we did not observe a correlation with muscle fat and cd36 like Kolditz et al. 
(2010) did in rainbow trout. Moreover, we did not observe correlations with muscle fat and 
fabp4 or me as has been reported in pigs and cattle (Mourot and Kouba, 1999; Bonnet et al., 
2007). Potential markers for increased intramuscular fat, including lpl, fabp3, and scd1 
expression in the liver, were associated with increased intramuscular fat; however, other 
potential markers including pparγ, srebp1, and subsequent lipogenic genes, were not associated 
with fillet fat content in this study as has been reported in mammals (Hausman et al., 2009). The 
lack of correlations with specific traits, especially with fillet fat content, could be caused by 
narrow differences in fat content and other traits in this study.  
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CONCLUSION 
 
Data from this study provide information about the metabolism of lipid stores and its 
association with two important traits in fish production, fillet yield and fillet fat content. LY/LF 
fish produced the softest cooked fillets, and the darkest, most yellow raw fillets. Whereas HY/LF 
fish have the most desirable fillet characteristics including bright, firm fillets with high separable 
muscle yields. Additionally, HY/LF fish had the highest ω3:ω6 ratio while maintaining optimal 
growth, suggesting that increasing fillet yield does not negatively impact other aspects of fillet 
quality besides ω3:ω6 ratio. There were limited effects of phenotype on gene expression with the 
visceral adipose tissue having the most association with phenotype. The correlations of β-
oxidation genes, specifically cpt1 isoforms in white muscle, with fillet fat content and shear force 
suggests increased β-oxidation is a mechanism negatively affecting fillet fat content and fillet 
quality by decreasing the amount of lipid within the muscle and altering the firmness of the fillet. 
Overall, data suggest that differences in growth and fillet quality may result from variation in the 
capacity for β-oxidation. Therefore, based on results of this work it may be possible to identify 
specific genes, within fatty acid metabolism, as potential markers for traits of interest in the 
aquaculture industry.  
 
   
ACKNOWLEDGEMENTS 
 
This study was funded by USDA/CSREES#2007-35205-17914 National Research 
Initiative Competitive Grants Program and supported by USDA/ARS CRIS Project 1930-31000-
010-000D and USDA-ARS Cooperative Agreement No. 58-1930-5-537. We would like to thank 
NCCCWA staff members Dave Payne for his technical assistance during sample collection, and 
Jim Everson, Josh Kretzer, Jenea McGowan, and Kyle Jenkins for their assistance with animal 
care. We would also like to thank West Virginia University staff Dr. Hao Ma, Susan Slider, 
Johnni-Ann Sims, Aunchalee Aussanasuwannakul, and Annas Sabbagh for their technical 
support of this study.  Mention of trade names is solely for the purpose of providing accurate 
information and should not imply product endorsement by the United States Department of 
Agriculture (USDA). USDA is an equal opportunity provider and employer. 
164 
 
TABLES and FIGURES 
 
 Phenotypic Group  P-values 
 LY/LF LY/HF HY/LF HY/HF  Phenotype Family 
WBW (g) 772±45
a
 1000±45
b
 983±43
b
 1152±43
c
  <0.0001 <0.0001 
GSI (%) 0.24±0.02
a
 0.30±0.02
ab
 0.30±0.02
b
 0.33±0.02
b
  0.0448 0.0011 
HSI (%) 1.06±0.03
ab
 1.20±0.03
c
 0.98±0.03
a
 1.12±0.03
bc
  <0.0001 0.0785 
GtSI (%) 7.88±0.32
ab
 9.33±0.32
c
 7.04±0.31
a
 7.95±0.31
b
  <0.0001 <0.0001 
TGC 1.9±0.06
a
 2.1±0.06b
b
 2.1±0.05
b
 2.3±0.05
c
  <0.0001 <0.0001 
Feed 
Efficiency 
0.81±0.16 0.49±0.16 0.69±0.016 0.90±0.15  0.2621 0.3432 
n 22 22 24 24    
TABLE 1: GROWTH RESPONSES OF PHENOTYPIC GROUPS 
Values are LSmeans ± SEM. Means without a common letter represents significant differences 
among the four phenotypic groups (P≤0.05). Abbreviations: LY/LF-low yield/low fat; LY/HF-
low yield/high fat; HY/LF-high yield/low fat; HY/HF-high yield/high fat; WBW-whole body 
weight; GSI-gonadosomatic index; HIS-hepatosomatic index; GtSI-gastrointestinal tract; TGC-
thermal growth coefficient. 
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 Phenotypic Group P-values  
 LY/LF LY/HF HY/LF HY/HF  Phenotype Family 
Yields        
Separable Muscle (%) 46.0±0.4
a
 47.1±0.4
a
 49.8±0.4
b
 50.3±0.4
b
  <0.0001 <0.0001 
Trim Loss (%) 31.4±0.4
b
 29.6±0.4
a
 29.9±0.4
a
 29.0±0.4
a 
 <0.0001 <0.0001 
Fillet Thickness (mm) 19.1±0.5
a
 21.0±0.5
b
 20.9±0.5
b
 22.5±0.5
c
  0.0002 <0.0001 
Cook Loss (%) 14.2±0.3
c
 13.6±0.3
bc
 13.2±0.3
ab
 12.6±0.3
a
  0.0018 0.0004 
        
Proximate Composition        
Moisture (%) 72.4±0.3
b
 70.1±0.3
a
 71.8±0.3
b
 69.7±0.3
a
  <0.0001 <0.0001 
Crude Fat (%) 7.1±0.3
a
 9.6±0.3
b
 6.8±0.3
a
 9.9±0.3
b
  <0.0001 <0.0001 
Crude Protein (%) 20.4±0.1 20.4±0.1 20.6±0.1 20.7±0.1  0.4949 0.6119 
Ash (%) 1.4±0.02
a
 1.5±0.02
b
 1.4±0.02
a
 1.5±0.02
b
  0.0058 0.0155 
        
Texture        
Peak Force  
       (g force/g sample) 
413±17
a
 475±17
b
 454±16
b
 455±16
b
 
 
0.0793 0.1237 
Energy (kg/mm) 130.8±8.6
a
 170.3±8.6
b
 166.5±8.3
b
 182.2±8.3
b
 0.0004              <0.0001 
        
Color        
L* 42.8±0.4
a
 43.9±0.4
b
 42.4±0.4
a
 43.6±0.4
b
  0.0448 0.0798 
a 1.1±0.1 1.1±0.1 1.3±0.1 1.3±0.1  0.3684 0.1096 
b 3.4±0.2
a
 4.0±0.2
b
 3.3±0.2
a
 4.1±0.2
b
  0.0091 0.0388 
        
n 22 22 24 24    
TABLE 2: FILLET CHARACTERISTICS OF PHENOTYPIC GROUPS 
Values are LSmeans ± SEM. Means without a common letter represents significant differences 
among the four phenotypic groups (P≤0.05). Abbreviations: LY/LF-low yield/low fat; LY/HF-
low yield/high fat; HY/LF-high yield/low fat; HY/HF-high yield/high fat.  
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 Phenotypic Group  P-values 
Fatty 
Acid 
mg / g tissue 
LY/LF LY/HF HY/LF HY/HF  Phenotype Family 
12:0 0.012±0.002
a 
0.012±0.002
a
 0.010±0.002
a
 0.019±0.002
b
  0.0034 0.2372 
14:0 0.58±0.07 0.65±0.07 0.57±0.07 0.81±0.07  0.0651 0.4276 
14:1 0.016±0.003
a
 0.019±0.003
ab
 0.016±0.002
a
 0.025±0.002
b
  0.0484 0.2158 
15:0 0.049±0.005 0.050±0.005 0.050±0.005 0.062±0.005  0.2472 0.4291 
16:0 3.94±0.48 4.58±0.48 3.90±0.46 5.47±0.46  0.0663 0.4508 
16:1 1.38±0.17
a
 1.69±0.17
ab
 1.32±0.17
a
 2.00±0.17
b
  0.0178 0.2991 
17:0 0.042±0.005 0.044±0.005 0.044±0.005 0.055±0.005  0.2523 0.4921 
18:0 0.85±0.11 0.97±0.11 0.83±0.10 1.18±0.10  0.0609 0.4548 
18:1n-9 4.71±0.59
a
 5.60±0.59
ab
 4.60±0.56
a
 6.63±0.56
b
  0.0479 0.5080 
18:2n-6 2.94±0.32 2.89±0.32 2.84±0.31 3.62±0.31  0.2427 0.4689 
18:3n-6 0.048±0.006 0.053±0.006 0.045±0.006 0.058±0.006  0.4027 0.7088 
18:3n-3 0.29±0.03 0.28±0.03 0.28±0.03 0.37±0.03  0.1346 0.2653 
20:0 0.20±0.003
a
 0.024±0.003
ab
 0.021±0.002
a
 0.029±0.002
b
  0.0350 0.2195 
20:1 0.43±0.05 0.47±0.05 0.42±0.5 0.58±0.05  0.0964 0.2984 
20:2 0.23±0.03 0.24±0.03 0.22±0.03 0.27±0.03  0.7358 0.5758 
20:3n-6 0.14±0.02 0.15±0.02 0.13±0.02 0.16±0.02  0.6573 0.2583 
20:3n-3 0.033±0.004 0.028±0.004 0.029±0.004 0.037±0.004  0.3002 0.3318 
20:4n-6 0.18±0.02 0.19±0.02 0.19±0.02 0.23±0.02  0.3378 0.5457 
20:5n-3 0.54±0.06 0.57±0.06 0.56±0.06 0.68±0.06  0.2670 0.4263 
22:1n-9 0.048±0.006 0.051±0.006 0.047±0.006 0.061±0.006  0.4041 0.3941 
22:6n-3 1.88±0.19 1.94±0.19 1.97±0.18 2.15±0.18  0.7726 0.4064 
24:1 0.050±0.005 0.048±0.005 0.044±0.005 0.059±0.005  0.1653 0.3599 
        
SFA 5.50±0.67 6.33±0.67 5.43±0.64 7.63±0.64  0.0655 0.4509 
MUFA 6.63±0.82
a
 7.88±0.82
ab
 6.44±0.79
a
 9.35±0.79
b
  0.0410 0.4542 
PUFA 6.28±0.66 6.34±0.66 6.27±0.63 7.57±0.63  0.3955 0.4527 
ω3 2.74±0.28 2.81±0.28 2.84±0.27 3.23±0.27  0.5787 0.4144 
ω6 3.54±0.39 3.53±0.39 3.43±0.37 4.34±0.37  0.2853 0.4910 
ω3: ω6 0.82±0.03b 0.80±0.03ab 0.85±0.03b 0.74±0.03a  0.0301 0.0877 
n 22 22 24 24    
TABLE 3: FILLET FATTY ACID COMPOSITION OF PHENOTYPIC GROUPS                                     
Values are LSmeans ± SEM. Means without a common letter represents significant differences among the 
four phenotypic groups (P≤0.05). Abbreviations: LY/LF-low yield/low fat; LY/HF-low yield/high fat; 
HY/LF-high yield/low fat; HY/HF-high yield/high fat.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
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Liver White Muscle Visceral Adipose Tissue 
Gene  Phenotype Family n (89) Phenotype Family n (84) Phenotype Family n (82) 
Fatty Acid Synthesis          
gpat 0.7474  0.4993 84 0.8439 0.9150 84 0.0031 0.5562 79 
srebp1 0.2046  0.8491 53 0.7362 0.6046 15 ND ND 0 
acyl 0.1001  0.2663 72 0.6313 0.8049 66 0.7623 0.1755 52 
acc 0.6085  0.8342 82 0.4191 0.8500 81 0.7539 0.6657 72 
fas 0.4338  0.9372 87 0.2370 0.5599 84 0.9158 0.1119 78 
scd1 0.0239  0.5736 79 0.8066 0.8311 52 0.0994 0.3318 39 
β-Oxidation          
magl 0.2564  0.2665 82 0.0656 0.2173 84 0.4953 0.0377 79 
cpt1a 0.4710  0.2734 89 0.2246 0.3653 84 0.2089 0.1485 59 
cpt1b 0.7945  0.4475 50 0.8391 0.4955 84 0.3954 0.1388 74 
cpt1c 0.5700  0.9939 89 0.2814 0.7187 84 0.3649 0.2036 82 
cpt1d 0.8200  0.6973 30 0.0878 0.0372 72 0.7639 0.5674 82 
cpt2 0.9183  0.9557 84 0.7585 0.3786 83 0.8383 0.4608 14 
aco 0.2189  0.7182 86 0.3186 0.4389 84 0.9252 0.6317 81 
acdh 0.1655  0.5036 83 0.2372 0.2436 80 0.9351 0.2814 67 
ehhadh 0.2367  0.7476 87 0.2491 0.0003 84 0.4287 0.1822 82 
acat2 0.6491  0.5901 71 0.6688 0.3031 84 0.1690 0.5286 81 
Fatty Acid 
Transport          
fabp3 0.3040  0.8865 87 0.7340 0.7480 75 0.1994 0.5384 79 
fabp4 0.1516  0.6020 76 0.4375 0.4474 74 0.7385 0.5401 75 
lpl 0.4155  0.4099 88 0.6189 0.8641 67 0.9224 0.5166 82 
cd36 0.9803  0.4588 89 0.2726 0.0898 84 0.5102 0.5011 81 
me 0.4732  0.3539 89 0.4994 0.3266 84 0.8171 0.6178 56 
Signaling Factors          
erk 0.1554  0.7829 70 0.2034 0.3513 82 0.6256 0.0857 81 
akt2 ND  ND 0 0.9395 0.9454 16 0.0336 0.2125 75 
redd1 0.1625  0.0233 89 0.8592 0.7764 84 0.4187 0.4868 82 
mo25 0.1020  0.3337 89 0.2192 0.0017 84 0.3210 0.9915 81 
mtor 0.9277  0.9107 87 0.3271 0.5877 84 0.7633 0.5098 82 
raptor 0.9657  0.8474 89 0.9279 0.6232 16 0.3983 0.2057 15 
rictor 0.9301  0.3865 88 0.5246 0.2748 82 0.0018 0.3968 80 
pras40 0.9974  0.8620 89 0.3899 0.6001 83 0.4677 0.6814 82 
pparβ 0.1493  0.8875 84 0.5968 0.6208 84 0.7212 0.2938 82 
pparγ 0.7598  0.5726 89 0.2478 0.6274 23 0.2891 0.0744 55 
rxr 0.1523  0.4325 79 0.4481 0.4998 83 0.1380 0.1043 81 
TABLE 4: SIGNIFICANCE AND N-VALUES FOR ALL GENES TARGETED BY THE 
MULTIPLEX IN LIVER, WHITE MUSCLE, AND VISCERAL ADIPOSE 
TISSUE OF PHENOTYPIC GROUPS 
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FIGURE 1: LIVER GENE EXPRESSION OF PHENOTYPIC GROUPS 
a) Phenotype effects on genes within fatty acid synthesis expressed in the liver; b) Phenotype 
effects on genes within β-oxidation expressed in the liver; c) Phenotype effects on genes within 
fatty acid transport expressed in the liver; d.) Phenotype effects on signaling factor genes 
expressed in the muscle. Values are LSmeans ± SEM and represent the fold change in gene 
abundance, relative to the normalized mean of three reference genes (β-actin, eF1a, and rplp2). 
Means without a common letter represents significant differences among the four phenotypic 
groups (P≤0.05). Abbreviations: LY/LF-low yield/low fat; LY/HF-low yield/high fat; HY/LF-
high yield/low fat; HY/HF-high yield/high fat. 
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FIGURE 2: WHITE MUSCLE GENE EXPRESSION OF PHENOTYPIC GROUPS 
a) Phenotype effects on genes within fatty acid synthesis and transport expressed in the muscle; 
b) Phenotype effects on genes within β-oxidation expressed in the muscle; c) Phenotype effects 
on signaling factor genes expressed in the muscle; d.) Phenotype effects on genes with high 
levels of expression in muscle. Values are LSmeans ± SEM and represent the fold change in 
gene abundance, relative to the normalized mean of three reference genes (β-actin, eF1a, and 
rplp2). Means without a common letter represents significant differences among the four 
phenotypic groups (P≤0.05). Abbreviations: LY/LF-low yield/low fat; LY/HF-low yield/high fat; 
HY/LF-high yield/low fat; HY/HF-high yield/high fat. 
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FIGURE 3: VISCERAL ADIPOSE TISSUE GENE EXPRESSION OF PHENOTYPIC 
GROUPS 
a) Phenotype effects on genes within fatty acid synthesis expressed in the visceral adipose tissue; 
b) Phenotype effects on genes within β-oxidation expressed in the visceral adipose tissue; c) 
Phenotype effects on genes within fatty acid transport in the visceral adipose tissue; d.) 
Phenotype effects on signaling factor genes expressed in the visceral adipose tissue. Values are 
LSmeans ± SEM and represent the fold change in gene abundance, relative to the normalized 
mean of three reference genes (β-actin, eF1a, and rplp2). Means without a common letter 
represents significant differences among the four phenotypic groups (P≤0.05). Abbreviations: 
LY/LF-low yield/low fat; LY/HF-low yield/high fat; HY/LF-high yield/low fat; HY/HF-high 
yield/high fat. 
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DISSERTATION CONCLUSION 
 
 Maturation is a dominant physiological process that causes a restructuring of metabolism. 
In 2N and 3N females, phenotypic differences occur at 21 M while differences in gene 
expression occur at 20 M. Diploid and triploid females also have differing fatty acid metabolisms 
during sexual maturation. Diploids are mobilizing lipid stores to support gonadogenesis while 
3Ns are synthesizing fatty acids to store excess energy. There is increased expression of β-
oxidation genes in 2N female muscle and visceral adipose tissue by 20 M, and these findings are 
consistent with increased pparβ expression.  On the other hand, 3N livers have increased 
expression of fatty acid synthesis genes at 20 M consistent with increased pparγ expression. 
Therefore, maturing diploid females appear to increase lipid utilization at 20 M and should be 
harvested prior to this point. In addition, immature male and female rainbow trout appear to have 
differing fatty acid metabolisms prior to maturation. Females have increased fillet PUFA content 
along with increased hepatic expression of fatty acid synthesis genes. Males have increased 
expression of β-oxidation genes within muscle. Differences in gene expression were also 
associated with altered expression within the mTOR signaling pathway.  These variations in gene 
expression may contribute to the compositional differences observed between genders and 
further supports the concept of culturing all-female trout for food production. Moreover, there is 
evidence that variation in β-oxidation gene expression could be responsible for differences 
observed in fillet yield and composition.  It may be possible to identify genes within fatty acid 
metabolism as potential markers for fillet quality traits in a study with greater differences in fat 
content. Overall, fatty acid metabolism is significantly altered by sexual maturation, polyploidy, 
and gender in rainbow trout. These factors should therefore be considered when culturing fish in 
order to optimize growth, fillet quality, and profitability.  
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APPENDIX 1 
 
 
FEEDING RATE STUDY TISSUE FATTY ACID COMPOSITIONS (mg/g sample) 
 
 
Table 1: Feeding Rate Study Muscle Fatty Acid Composition (mg/g sample)  
 
 Ration Effects    Ploidy Effects 
mg/g 0.25% Ration 0.5% Ration Satiation 
Ration 
P-value 
Family  
P-value 3N 
Ploidy 
P-value 
12:0 0.002±0.001 0.002±0.001 0.003±0.001 0.5875 0.0261 0.006±0.001 0.0098 
14:0 0.28±0.03 0.26±0.04 0.44±0.04 0.0039 0.0458 0.50±0.05 0.0155 
14:1 0.005±0.001 0.003±0.001 0.007±0.001 0.0260 0.1360 0.010±0.001 0.0033 
15:0 0.022±0.002 0.020±0.003 0.035±0.003 0.0011 0.0991 0.03±0.003 0.0258 
16:0 1.68±0.17 1.45±0.21 2.48±0.18 0.0020 0.0845 2.69±0.28 0.0243 
16:1 0.43±0.05 0.38±0.06 0.68±0.05 0.0030 0.0158 0.81±0.08 0.0120 
17:0 0.021±0.002 0.019±0.003 0.033±0.002 0.0013 0.2834 0.029±0.003 0.0659 
18:0 0.30±0.03 0.26±0.04 0.46±0.03 0.0015 0.1438 0.48±0.05 0.0310 
18:1n-9 1.37±0.15 1.24±0.19 2.12±0.16 0.0031 0.0353 2.05±0.26 0.1270 
18:2n-6 1.16±0.12 1.03±0.16 1.82±0.13 0.0013 0.0573 1.57±0.16 0.0807 
20:0 0.011±0.001 0.010±0.002 0.018±0.001 0.0046 0.0869 0.018±0.002 0.0381 
18:3n-6 0.024±0.004 0.025±0.005 0.040±0.005 0.0437 0.0818 0.039±0.004 0.1543 
20:1 0.43±0.05 0.33±0.06 0.61±0.05 0.0036 0.0171 0.59±0.03 0.0146 
18:3n-3 0.12±0.01 0.11±0.02 0.21±0.01 0.0003 0.0371 0.18±0.02 0.0501 
20:2 0.12±0.02 0.14±0.02 0.22±0.02 0.0026 0.0472 0.17±0.02 0.6003 
22:0 0.007±0.003 0.012±0.004 0.014±0.003 0.3980 0.5040 0.011±0.004 0.7299 
20:3n-6 0.10±0.01 0.09±0.02 0.15±0.01 0.0124 0.0037 0.12±0.02 0.3773 
22:1n-9 0.031±0.004 0.028±0.005 0.043±0.004 0.0655 0.0007 0.050±0.005 0.0074 
20:3n-3 0.019±0.003 0.016±0.004 0.023±0.003 0.4076 0.3182 0.019±0.002 0.5685 
20:4n-6 0.14±0.01 0.09±0.02 0.16±0.01 0.0110 0.0786 0.16±0.02 0.0566 
20:5n-3 0.38±0.03 0.24±0.04 0.45±0.03 0.0019 0.5054 0.37±0.04 0.0654 
24:1 0.047±0.005 0.035±0.006 0.059±0.005 0.0190 0.4753 0.055±0.007 0.1146 
22:6n-3 1.72±0.15 1.24±0.18 2.04±0.16 0.0122 0.4963 1.81±0.20 0.1282 
        
SAT 2.31±0.24 2.04±0.29 3.48±0.25 0.0021 0.0831 3.76±0.39 0.0244 
MUFA 2.32±0.25 2.02±0.31 3.52±0.27 0.0030 0.0237 3.56±0.39 0.0446 
PUFA 3.79±0.34 2.99±0.42 5.12±0.36 0.0028 0.1606 4.44±0.47 0.1031 
ω3 2.24±0.19 1.61±0.23 2.72±0.20 0.0066 0.4204 2.38±0.26 0.1075 
ω6 1.54±0.16 1.38±0.20 2.40±0.17 0.0013 0.0563 2.06±0.22 0.1083 
ω3: ω6 1.47±0.06 1.19±1.18 1.18±0.06 0.0046 0.0911 1.17±0.05 0.9606 
n 12 10 11   12  
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Table 2: Feeding Rate Study Liver Fatty Acid Composition (mg/g sample) 
 Ration Effects   Ploidy Effects 
 mg/g 0.25% Ration 0.5% Ration Satiation 
Ration 
P-value 
Family  
P-value 3N 
Ploidy 
P-value 
12:0 ND ND ND ND ND ND ND 
14:0 0.26±0.02
b 
0.24±0.02
ab 
0.18±0.02
a 
0.0321 0.4064 0.20±0.02 0.0515 
14:1 ND ND ND ND ND ND ND 
15:0 0.04±0.01 0.03±0.01 0.03±0.01 0.1113 0.2650 0.01±0.001* <0.0001 
16:0 2.64±0.16 2.57±0.19 2.47±0.17 0.7498 0.0933 2.57±0.17 0.9554 
16:1 0.32±0.03 0.26±0.04 0.29±0.04 0.5589 0.5217 0.57±0.06* 0.0158 
17:0 0.06±0.01 0.05±0.01 0.05±0.01 0.0708 0.0449 0.02±0.002* <0.0001 
18:0 1.36±0.09 1.36±0.11 1.10±0.09 0.1191 0.0927 0.87±0.07* 0.0009 
18:1n-9 1.49±0.13 1.36±0.16 1.45±0.14 0.8323 0.2349 2.18±0.20* 0.0337 
18:2n-6 0.88±0.07 0.78±0.09 0.78±0.07 0.5361 0.1906 0.77±0.06 0.9473 
20:0 0.01±0.002 0.01±0.003 0.01±0.002 0.9674 0.4345 0.03±0.003* 0.0021 
18:3n-6 0.03±0.003
b 
0.02±0.004
ab 
0.01±0.004
a 
0.0365 0.2380 0.03±0.004 0.0803 
20:1 0.51±0.04 0.59±0.06 0.42±0.05 0.0859 0.0225 0.50±0.04 0.1474 
18:3n-3 0.06±0.01 0.04±0.01 0.06±0.01 0.4159 0.3327 0.04±0.01 0.8635 
20:2 0.38±0.04 0.50±0.04 0.40±0.04 0.0922 <0.0001 0.32±0.04* 0.0381 
22:0 ND ND ND ND ND ND ND 
20:3n-6 0.45±0.06 0.51±0.07 0.34±0.06 0.1734 0.3161 0.36±0.04* 0.0405 
22:1n-9 ND ND ND ND ND ND ND 
20:3n-3 0.03±0.003 0.03±0.004 0.03±0.004 0.9943 0.2234 0.04±0.01 0.0882 
20:4n-6 0.75±0.13 0.59±0.16 0.62±0.13 0.6853 0.0545 0.40±0.05* 0.0077 
20:5n-3 0.69±0.09 0.43±0.11 0.58±0.09 0.1924 0.1309 0.40±0.05 0.4513 
24:1 0.18±0.01 0.19±0.02 0.21±0.01 0.2915 0.2452 0.25±0.02 0.1013 
22:6n-3 3.32±0.37 2.86±0.46 2.92±0.39 0.6751 0.0545 2.73±0.27 0.4831 
        
SFA 4.38±0.27 4.27±0.33 3.84±0.28 0.3787 0.1292 3.69±0.26 0.2187 
MUFA 2.51±0.21 2.41±0.26 2.37±0.22 0.8943 0.2115 3.50±0.29 0.0572 
PUFA 6.59±0.67 5.78±0.83 5.74±0.71 0.6310 0.0484 5.10±0.46 0.2296 
ω3 4.10±0.46 3.37±0.57 3.58±0.49 0.5735 0.0630 3.21±0.32 0.4934 
ω6 2.49±0.24 2.40±0.30 2.16±0.25 0.6403 0.0516 1.89±0.16 0.0528 
ω3: ω6 1.71±0.13 1.39±0.16 1.63±0.14 0.3153 0.7513 1.66±0.10 0.2054 
n 12 10 11   12  
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Table 3: Feeding Rate Study Visceral Adipose Tissue Fatty Acid Composition (mg/g 
sample) 
 Ration Effects   Ploidy Effects 
 mg/g 0.25% Ration 0.5% Ration Satiation 
Ration 
P-value 
Family  
P-value 3N 
Ploidy 
P-value 
12:0 0.19±0.02 0.20±0.02 0.21±0.02 0.8218 0.9194 0.27±0.02* 0.0239 
14:0 14.64±1.07
 
13.23±1.33 14.53±1.14 0.6804 0.7981 17.14±1.23 0.0727 
14:1 0.42±0.03 0.39±0.04 0.43±0.04 0.7611 0.7888 0.59±0.04* 0.0068 
15:0 1.71±0.13 1.59±0.16 1.81±0.13 0.5797 0.5428 1.59±0.15* 0.0439 
16:0 25.18±1.90 23.74±2.36 26.97±2.02 0.5905 0.6279 38.31±2.15* 0.0016 
16:1 40.42±3.16 37.69±3.92 42.64±3.35 0.6410 0.5020 52.54±3.50* 0.0338 
17:0 1.37±0.10 1.20±0.12 1.36±0.10 0.5067 0.5012 1.67±0.12* 0.0395 
18:0 8.66±0.50 6.92±0.62 8.06±0.53 0.1215 0.3347 11.12±0.58* 0.0012 
18:1n-9 67.14±4.40 57.05±5.46 64.32±4.67 0.3686 0.2480 72.27±5.02 0.1204 
18:2n-6 112.66±8.41 102.97±10.44 113.61±8.93 0.7090 0.6629 108.61±9.84 0.7418 
20:0 0.48±3.71 0.98±4.61 0.21±3.98 0.2279 0.2661 0.46±4.67 0.3441 
18:3n-6 1.88±1.18 1.57±0.22 1.84±0.19 0.5207 0.2596 2.36±0.16* 0.0278 
20:1 45.02±4.08
c 
19.6±5.06
a 
32.30±4.33
b 
0.0031 0.7065 33.22±5.10 0.1160 
18:3n-3 12.22±1.32 11.48±1.64 14.15±1.41 0.4357 0.7307 15.50±1.46 0.1306 
20:2 7.20±0.67 6.46±0.83 6.83±0.71 0.6583 0.1808 6.87±0.79 0.6870 
22:0 ND ND ND ND ND ND  ND 
20:3n-6 4.46±0.35 4.07±0.43 3.83±0.37 0.4750 0.0003 3.63±0.42 0.5874 
22:1n-9 ND ND ND ND ND ND ND 
20:3n-3 ND ND ND ND ND ND ND 
20:4n-6 2.94±0.31 3.06±0.38 2.78±0.33 0.8527 0.5977 3.47±0.36 0.4485 
20:5n-3 6.60±0.66 5.93±0.82 7.30±0.70 0.4640 0.6019 9.41±0.65* 0.0134 
24:1 1.41±0.41 1.73±0.51 1.06±0.44 0.6143 0.2164 1.23±0.53 0.7262 
22:6n-3 18.90±1.81 14.85±2.24 19.30±1.92 0.2878 0.8772 23.99±1.92* 0.0265 
        
SFA 52.24±5.39 56.69±6.69 52.91±5.72 0.8656 0.2245 71.09±6.67 0.1751 
MUFA 154.41±10.05 116.46±12.47 140.75±10.67 0.0841 0.3890 159.86±11.54* 0.0484 
PUFA 166.85±12.15 150.38±5.07 169.19±12.89 0.6093 0.6793 173.85±13.73 0.3556 
ω3 37.71±3.61 32.25±4.49 40.75±3.84 0.3764 0.9804 48.90±3.86* 0.0364 
ω6 129.14±9.48 118.13±11.76 128.44±10.06 0.7401 0.5528 124.95±11.18 0.7206 
ω3: ω6 0.29±0.02 0.30±0.02 0.32±0.02 0.5434 0.6410 0.39±0.02* 0.0227 
n 12 10 11   12  
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Table 4: Feeding Rate Study Diploid Gonad Fatty Acid Composition (mg/g sample) 
 Ration Effects 
mg/g 0.25% Ration 0.5% Ration Satiation 
Ration 
P-value 
Family  
P-value 
12:0 0.02±0.001 0.02±0.002 0.02±0.001 0.0574 <0.0001 
14:0 1.70±0.07 1.83±0.09 1.70±0.08 0.4532 0.0034 
14:1 0.03±0.002 0.03±0.002 0.03±0.002 0.1054 0.0051 
15:0 0.19±0.01 0.20±0.01 0.18±0.01 0.2945 0.0425 
16:0 10.87±0.33 11.14±0.43 10.25±0.37 0.2768 0.0801 
16:1 2.99±0.13 3.04±0.17 2.97±0.14 0.9483 0.0034 
17:0 0.17±0.005
b 
0.16±0.007
b 
0.15±0.006
a 
0.0178 0.2339 
18:0 2.99±0.09 3.29±0.12 3.16±0.10 0.1241 0.0527 
18:1n-9 9.53±0.31 10.14±0.42 9.19±0.36 0.5318 0.0003 
18:2n-6 6.25±0.24 6.49±0.32 5.98±0.27 0.4896 0.0008 
20:0 0.03±0.001 0.03±0.001 0.02±0.001 0.1430 0.0610 
18:3n-6 0.25±0.02
b 
0.17±0.02
a 
0.14±0.02
a 
0.0002 0.0974 
20:1 1.53±0.05 1.74±0.07 1.63±0.06 0.0705 0.0004 
18:3n-3 0.78±0.03 0.81±0.05 0.79±0.04 0.8817 0.0032 
20:2 0.97±0.05
a 
1.32±0.07
b 
1.22±0.06
b 
0.0008 0.0001 
22:0 0.02±0.004 0.03±0.005 0.02±0.004 0.1997 0.0051 
20:3n-6 1.19±0.09 1.30±0.13 1.22±0.11 0.7782 0.0089 
22:1n-9 0.07±0.003 0.08±0.004 0.07±0.004 0.0799 0.0011 
20:3n-3 0.11±0.005 0.12±0.007 0.11±0.006 0.2151 0.1606 
20:4n-6 1.48±0.06 1.33±0.08 1.32±0.06 0.1275 <0.0001 
20:5n-3 2.25±0.07
b 
1.94±0.09
b 
1.87±0.08
a 
0.0021 0.4930 
24:1 0.17±0.007 0.19±0.009 0.18±0.008 0.3854 0.0055 
22:6n-3 9.60±0.30 10.01±0.40 9.75±0.34 0.7290 0.6707 
      
SFA 15.96±0.45 16.68±0.60 15.48±0.51 0.3384 0.0371 
MUFA 14.45±0.48 15.41±0.64 14.18±0.55 0.3356 0.0003 
PUFA 22.91±0.65 23.51±0.88 22.40±0.73 0.6260 0.0260 
ω3 12.74±0.38 12.87±0.49 12.51±0.43 0.8552 0.4662 
ω6 10.16±0.33 10.64±0.44 9.89±0.38 0.4443 0.0010 
ω3: ω6 1.26±0.03 1.23±0.04 1.28±0.04 0.7108 0.0013 
n 12 10 11   
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PATHWAYS WITH MULITPLEX-PCR TARGET GENES HIGHLIGHED 
 
 
 
 
Figure 1: mTOR Signaling Pathway with Multiplex PCR Target Genes Highlighted 
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Figure 2: PPAR Signaling Pathway with Multiplex PCR Target Genes Highlighted 
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TABLE 5: Primer Sequences and Expected PCR Products for Multiplex-PCR Reactions 
 
Gene Primer Sequences (5'-3') PCR Product Length (bp) 
REFERENCE GENES   
βactin AGGTGACACTATAGAATAGATCCGGTATGTGCAAAGC 217 
 GTACGACTCACTATAGGGAGCTCGATGGGGTACTTCAGA  
Ef1a AGGTGACACTATAGAATATTAAGCAACCATGGGAAAGG 301 
 GTACGACTCACTATAGGGATACCTGCCGGTCTCAAACTT  
gapdh AGGTGACACTATAGAATAGGAATCAAAGTCGTTGCCAT 287 
 GTACGACTCACTATAGGGAAAGAGGCCTTGTCAATGCTG  
rplp2 AGGTGACACTATAGAATAACCGACGTTTCGTGTCTGTA 192 
 GTACGACTCACTATAGGGACCTTGTCTAGGCGCTCATCT  
TARGET GENES   
acat2 AGGTGACACTATAGAATAGGATTCAGAGGTGGTGCTGT 272 
 GTACGACTCACTATAGGGACTGGGTCTGGTGAGCGTATT  
acc AGGTGACACTATAGAATAGGACAAAGAAGCGGTAGTCG 152 
 GTACGACTCACTATAGGGAATGCGTAACTTTGCCCTGAC  
acdh AGGTGACACTATAGAATATGTTCCAGTCGTGTGTACCAG 379 
 GTACGACTCACTATAGGGAAGTGCTCAGGGTCACGAGAG  
acdhm AGGTGACACTATAGAATATCTGAACTCCTGTGCAACCA 369 
 GTACGACTCACTATAGGGACGTCCGTGTCGTAAAATCCT  
acdhvl AGGTGACACTATAGAATACTAGAGCCCACAAGGACTGC 167 
 GTACGACTCACTATAGGGAAGGCTACATGTGCACCATCA  
aco AGGTGACACTATAGAATAAGGCATCGAGAAGACCAAAA 177 
 GTACGACTCACTATAGGGAGGATCATCTGGGCACTCTTC  
acyl AGGTGACACTATAGAATACCCCATAAAGGAGCATGAGA 262 
 GTACGACTCACTATAGGGAGAGTTGAGCAGGAAGTTGGC  
akt2 AGGTGACACTATAGAATAGCAGAAAACGGTCGAAACTC 329 
 GTACGACTCACTATAGGGAGAGACAAGCTCTGGACGGAC  
apt1a AGGTGACACTATAGAATAGCACTGCAAAGGAGACATCA 188 
 GTACGACTCACTATAGGGAATCAAACAGACAGCCATGAA  
apt1b AGGTGACACTATAGAATAACACAGAACACAGAGGTTTAGCC 312 
 GTACGACTCACTATAGGGACTTAAATCTTATGGCGCGCTTT  
apt1c AGGTGACACTATAGAATAAATGTGCTCAGCGCAATATG 172 
 GTACGACTCACTATAGGGAATGGGCACCTTGAAGTAACG  
cpt1d AGGTGACACTATAGAATATTGACATGAAGAACCACCCA 252 
 GTACGACTCACTATAGGGAAGCTGGGGTAAGCACAGAAA  
cpt2 AGGTGACACTATAGAATAGATCCTGGCTGATAAGAGCG 207 
 GTACGACTCACTATAGGGACGTCGAGGGTTACGAAGAAG  
ehhadh AGGTGACACTATAGAATAAGCTGCTGGAGGTGGTGTAT 181 
 GTACGACTCACTATAGGGAGTATGGCTTCAACATCCGGT  
erk AGGTGACACTATAGAATAAACCCAAGATCCCTTGGAAC 268 
 GTACGACTCACTATAGGGATGAGCTCCTTCAGCTTCTCC  
fabp3 AGGTGACACTATAGAATACACATGGAACCTGAAGGACA 403 
 GTACGACTCACTATAGGGATAGGAGCGTGTGGAGACGAC  
fabp4 AGGTGACACTATAGAATAGGGGACAAAGTGGTCGTAAA 281 
 GTACGACTCACTATAGGGATACGCACTGCCACAATGTCT  
fas AGGTGACACTATAGAATAGCTATCCTGGCAGCCTACTG 142 
 GTACGACTCACTATAGGGACTGAGCCTTACACTCTGCCC  
cd36 AGGTGACACTATAGAATACTGTCACCCAGATTGGACCT 212 
 GTACGACTCACTATAGGGAGCTGGGATGTTGACTGTCCT  
gpat AGGTGACACTATAGAATAGGTCTCCCGCTTTATCTTCC 230 
 GTACGACTCACTATAGGGACCAAAAAGGTCCTCCTGTGA  
lpl AGGTGACACTATAGAATACTTGTGAAGTGCTCCCATGA 341 
 GTACGACTCACTATAGGGATCATGGGCTGCTCAGTGTAG  
magl AGGTGACACTATAGAATATCAGTTCATCCCCTTTCCTG 202 
 GTACGACTCACTATAGGGAGGCCTAAGGTCAAGACACGA  
me AGGTGACACTATAGAATACAAAAGACGAGGCTCTGAGG 197 
 GTACGACTCACTATAGGGAATGGCTGTGGGTTTGAGTTC  
mo25 AGGTGACACTATAGAATATGATGAACCTTCTTCGGGAC 222 
 GTACGACTCACTATAGGGAATTGAACTGTTCGTCCTCCG  
mtor AGGTGACACTATAGAATATCTCATTGGCTCAGCAGTGT 157 
 GTACGACTCACTATAGGGAACAGCATCTGACACGACACC  
pparα AGGTGACACTATAGAATACAGGGAGGTGGAGGACCCCC 410 
 GTACGACTCACTATAGGGAATACACGCCGTACTTCAGCAGA  
pparβ AGGTGACACTATAGAATAAGCTGGATGACAGTGACCTGGCC 137 
 GTACGACTCACTATAGGGATCCTGAATCTCCTCCACCTGCTTG  
pparγ AGGTGACACTATAGAATAGAAAGACCCACGGAAACTCA 257 
 GTACGACTCACTATAGGGAATGCTCTTGGCGAACTCTGT  
pras40 AGGTGACACTATAGAATAACCAGGGAGAAGGCCATAGT 238 
 GTACGACTCACTATAGGGATCACTCCTTCATCCCCTCAC  
raptor AGGTGACACTATAGAATACTCTTCACCTCCTGCCTCAC 293 
 GTACGACTCACTATAGGGAATAAACTGGCCACCAACAGG  
redd1 AGGTGACACTATAGAATAAAGGTCTTCATGGGGGAAAC 162 
 GTACGACTCACTATAGGGAACCCGGAGTCTGAGAGATCA  
rictor AGGTGACACTATAGAATACCTTTTTCTCCCCATTTCGT 234 
 GTACGACTCACTATAGGGAGTTTCCTCCGACACATTGGT  
Rxr AGGTGACACTATAGAATAGCATCTACAAGCCCTGCTTC 147 
 GTACGACTCACTATAGGGAGTTCTTCTGGATACTGCGCC  
scd1 AGGTGACACTATAGAATACAGTTGCTGCTGTGTGACCT 276 
 GTACGACTCACTATAGGGATGATGTGTTCGTGTGGGACT  
srebp1 AGGTGACACTATAGAATAACCCACAATGGCTACAAAGC 247 
 GTACGACTCACTATAGGGACTTGATAAACTGGGGCTGGA  
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Table 6: Genes within Fatty Acid Metabolism Targeted in GeXP-Multiplex PCR Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Role in Lipid 
Metabolism 
Gene         
Accession No. 
Standard Curve R2 values 
Gene Symbol Gene Name Liver Muscle Vis. AT 
Reference Genes            
β-actin  Beta-actin  NM_001124235  0.9991  0.9743  0.9950 
ef1a  Elongation factor 1-alpha  NM_001124339  0.9943  0.9773  0.9945 
gapdh  Glyceraldyhyde phosphate dehydrogenase  NM_001124246  0.9937  0.9864  0.9958 
rplp2 Acidic ribosomal protein P2  BT074359  0.9994  0.9858  0.9957 
Fatty Acid Synthesis  
gpat Glycerol-3-phosphate acyltransferase TAG Synthesis Salem et al., 2012  0.9903  0.9714  0.9887 
srebp1 Sterol regulatory element binding protein 1-like Transcription Factor Salem et al., 2012  0.9956  0.9538  --- 
acyl ATP Citrate Lyase Fatty Acid Synthesis Salem et al., 2012  0.9977  0.9966  0.9891 
acc Acetyl-CoA Carboxylase Fatty Acid Synthesis Salem et al., 2012  0.9995  0.9631  0.9924 
fas Fatty Acid Synthase Fatty Acid Synthesis Salem et al., 2012  0.9960  0.9614  0.9843 
scd1 Steroyl-CoA Desaturase (delta-9 desaturase) Fatty Acid Synthesis Salem et al., 2012  0.9991  0.9927  0.9834 
β-Oxidation 
magl Monoacylglycerol lipase ABHD12 Lipolysis EZ770803.1  0.9982 0.9706   0.9985 
cpt1a Carnitine Palmitoyltransferase a β-oxidation NM_001124735.1  0.9993  0.9462  0.9979 
cpt1b Carnitine Palmitoyltransferase b β-oxidation NM_001171855.1  0.9967  0.9872  0.9860 
cpt1c Carnitine Palmitoyltransferase c β-oxidation AJ619768  0.9930  0.9566  0.9969 
cpt1d Carnitine Palmitoyltransferase d β-oxidation AJ620356  0.9968  0.9931  0.9926 
cpt2 Mitochondrial carnitine palmitoyltransferase I alpha1a β-oxidation NM_001246330.1  0.9906  0.9648  0.9912 
acat2 Acetyl-CoA acyltransferase 2 (thiolase) β-oxidation EZ764956.1  0.9917  0.9755  0.9966 
acdh Acyl CoA DeHydrogenase β-oxidation EZ896350.1  ---  0.9740  0.9986 
acdhm Medium-chain specific acyl-CoA dehydrogenase β-oxidation EZ763374.1  ---  0.9162  0.9997 
acdhvl Acyl-CoA dehydrogenase, very long chain β-oxidation EZ911051.1  0.9994  0.9503  0.9921 
aco Acetyl-CoA Oxidase β-oxidation BX085367  0.9985  0.9845  0.9950 
ehhadh Enoyl-CoA, hydratase/3-hydroxyacyl CoA 
dehydrogenase/Peroxisomal bifunctional enzyme 
β-oxidation EZ838632 .1  0.9952  0.9777  0.9861 
Fatty Acid Transport 
fabp3 Fatty Acid Binding Protein 3 Fatty Acid Transport NM_001124713  0.9902  0.9826  0.9896 
fabp4 Fatty Acid Binding Protein 4 (aP2) Fatty Acid Transport JN413683.1  0.9905  0.9915  0.9922 
lpl Lipoprotein Lipase Fatty Acid Uptake AJ224693  0.9906  0.9745  0.9950 
cd36 Fatty Acid Translocase/Cluster of Differentiation 36 Fatty Acid Uptake NM_001124511  0.9956  0.9589  0.9917 
me Malic Enzyme Produces NADPH Salem et al., 2012  0.9956  0.9642  0.9979 
Signaling Factors 
erk Extracellular signal-regulated kinases Transcription Factor QI, 2012  0.8961  0.9861  0.9848 
akt2 a serine/threonine-specific protein kinase 2/β Transcription Factor Qi, 2012  ---  0.9768  0.9930 
redd1 REDD1—mTOR1 Repressor Transcription Factor Qi, 2012  0.9988  0.9314  0.9990 
mo25 MO25—induced by energy stress Transcription Factor Qi, 2012  0.9943  0.9840  0.9846 
mtor Mammalian target of rapamycin Transcription Factor EU179853  0.9912  0.9660  0.9865 
raptor Raptor Transcription Factor Qi, 2012  0.9861  0.9942  0.9883 
rictor Rictor Transcription Factor Qi, 2012  0.9957  0.9882  0.9913 
pras40 Proline-rich Akt substrate of 40 kilodaltons  Transcription Factor Salem et al., 2012  0.9941  0.9213  0.9967 
gpat Glycerol-3-phosphate acyltransferase TAG Synthesis Salem et al., 2012  0.9903  0.9714  0.9887 
pparα Peroxisome Proliferator-Activated Receptor α Transcription Factor NM_001197211.1  ---  0.9859  0.9962 
pparβ Peroxisome Proliferator-Activated Receptor β/δ Transcription Factor HM536191.1  0.9999  0.9488  0.9842 
pparγ Peroxisome Proliferator-Activated Receptor γ Transcription Factor NM_001197212.1  0.9964  0.9834  0.9916 
rxr Retinoid X Receptor  gamma variant a Transcription Factor NM_001246348.1  0.9993  0.9536  0.9860 
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Table 7: Fillet fatty acid compositions (% fatty acid) of immature male and female rainbow trout  
% FA Female Male p-value 
12:0 0.07±0.004 0.07±0.004 0.8275 
13:0 0.02±0.001 0.02±0.001 0.3135 
14:0 3.44±0.13 3.42±0.13 0.9330 
14:1 0.11±0.004 0.10±0.004 0.5233 
15:0 0.25±0.01 0.26±0.01 0.8266 
16:0 21.74±0.63 22.96±0.63 0.1818 
16:1 8.22±0.25 8.17±0.25 0.8787 
17:0 0.20±0.01 0.22±0.01 0.1810 
17:1 0.09±0.01 0.12±0.01 0.2234 
18:0 4.01±0.18
a 
5.01±0.18
b 
0.0103 
18:1n9 24.97±0.71 26.55±0.71 0.1296 
18:2n6 15.54±0.64
b 
13.63±0.64
a 
0.0464 
18:3n3 1.47±0.08
b 
1.22±0.08
a 
0.0366 
18:3n6 0.25±0.01 0.22±0.01
 
0.0976 
20:0 0.09±0.01
a 
0.11±0.01
b 
0.0342 
20:1 1.81±0.11 2.02±0.11 0.2087 
20:2 1.67±0.08 1.46±0.008 0.0720 
20:3n3 0.09±0.01 0.10±0.01 0.3565 
20:3n6 0.62±0.04 0.56±0.04 0.3536 
20:4n6 1.46±0.09 1.46±0.10 0.9686 
20:5n3 2.98±0.20 2.55±0.20 0.1463 
21:0 0.03±0.002 0.03±0.002 0.2689 
22:0 0.04±0.01 0.05±0.01 0.2864 
22:1n9 0.21±0.03 0.27±0.03 0.1227 
22:2 0.73±0.06 0.59±0.06 0.0956 
22:6n3 9.47±0.87 8.72±0.87 0.5427 
24:1 0.14±0.3
a 
0.21±0.03
b 
0.0212 
 
   
SFA 30.89±0.89 32.78±0.89 0.1441 
MUFA 44.01±2.80 49.89±2.80 0.1516 
PUFA 48.17±0.03 48.22±0.03 0.3014 
ω3 14.37±1.14 12.87±1.14 0.3618 
ω6 20.78±0.89 18.25±0.89 0.0592 
ω3: ω6 0.69±0.06 0.66±0.06 0.7248 
n 16 16  
Values are LSmeans ± SEM reported as mg of fatty acid per g of sample. Means without a 
common letter represents significant differences between 14-month male and female rainbow 
trout (P≤0.05). 
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Table 8: Fillet fatty acid compositions (% fatty acid) of immature female rainbow trout 
associated with fillet yield and crude fat content 
 
Values are LSMeans ± SEM. Means without a common letter represents significant differences 
among the four phenotypic groups (P≤0.05). Abbreviations: LY/LF-low yield/low fat; LY/HF-
low yield/high fat; HY/LF-high yield/low fat; HY/HF-high yield/high fat. 
 
 
 
 Phenotypic Group  
Fatty Acid 
(%) 
LY/LF LY/HF HY/LF HY/HF  Phenotype 
12:0 0.09±0.01 0.07±0.01 0.10±0.01 0.07±0.01  0.1812 
14:0 0.62±0.02 0.62±0.02 0.63±0.02 0.65±0.02  0.2832 
14:1 0.0006±0.0001 0.0005±0.0001 0.0006±0.0001 0.0007±0.0001  0.7396 
15:0 0.005±0.0003ab 0.004±0.0003a 0.005±0.0003b 0.004±0.0003a  0.0228 
16:0 28.6±0.6 30.2±0.6 29.2±0.6 29.9±0.6  0.3147 
16:1 3.5±0.1a 4.2±0.1b 3.3±0.1a 4.1±0.1b  <0.0001 
17:0 0.003±0.0001b 0.003±0.0001a 0.004±0.0001c 0.003±0.0001a  <0.0001 
18:0 1.4±0.04 1.3±0.04 1.3±0.04 1.4±0.04  0.5134 
18:1n-9 40.4±1.0a 44.7±1.0b 39.8±0.9a 44.2±0.9b  0.0002 
18:2n-6 16.1±0.5c 12.2±0.5a 16.0±0.5c 13.8±0.5b  <0.0001 
20:0 0.001±0.0001 0.001±0.0001 0.001±0.0001 0.001±0.0001  0.3752 
18:3n-6 0.004±0.0003 0.004±0.0003 0.004±0.0003 0.003±0.0003  0.2683 
20:1 0.35±0.01 0.32±0.01 0.34±0.01 0.33±0.01  0.6541 
18:3n-3 0.16±0.01
b
 0.11±0.01
a
 0.16±0.01
b
 0.14±0.01
b
  <0.0001 
20:2 0.11±0.02 0.09±0.02 0.11±0.02 0.08±0.02  0.4953 
20:3n-6 0.04±0.002
b
 0.03±0.002
b
 0.04±0.002
b
 0.03±0.002
a
  0.0332 
22:1n-9 0.005±0.0004 0.004±0.0004 0.004±0.0004 0.004±0.0004  0.6425 
20:3n-3 0.002±0.0001
b
 0.001±0.0001
a
 0.002±0.0001
ab
 0.002±0.0001
a
  0.0049 
20:4n-6 0.07±0.004
b
 0.05±0.004
a
 0.07±0.004
b
 0.05±0.004
a
  0.0021 
20:5n-3 0.60±0.03
b
 0.48±0.03
a
 0.62±0.03
b
 0.50±0.03
a
  0.0008 
24:1 0.006±0.001
b
 0.004±0.0005
a
 0.005±0.005
ab
 0.004±0.0005
a
  0.0170 
22:6n-3 8.0±0.7
b
 5.6±0.7
a
 8.3±0.7
b
 4.8±0.7
a
  0.0007 
       
SFA 29.6±0.3
a
 30.7±0.3
b
 29.8±0.3
a
 30.8±0.3
b
  0.0180 
MUFA 35.6±0.5
a
 38.2±0.5
b
 35.2±0.4
a
 38.0±0.4
b
  <0.0001 
PUFA 34.8±0.6
b
 31.0±0.6
a
 35.0±0.6
b
 31.2±0.6
a
  <0.0001 
ω3 15.6±0.5b 13.8±0.5a 16.0±0.5b 13.3±0.5a  <0.0001 
ω6 19.2±0.3b 17.3±0.3a 19.0±0.3b 17.9±0.3a  <0.0001 
ω3: ω6 0.82±0.03b 0.80±0.03b 0.85±0.03b 0.74±0.03a  0.0301 
n 22 22 24 24   
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TROUT GENOME PROJECT: CORRELATIONS WITH LIVER GENE EXPRESSION  
[Each table indicates the R
2
-value (top number) and p-value (bottom number) for each correlation.]  
 
 
 
Table 9: Correlations between Phenotypic Traits and Lipogenic Gene Expression in Liver 
 
 
 
 
Table 10: Correlations between Phenotypic Traits and β-Oxidation Gene Expression in Liver 
 
 
 
 
 
Table 11: Correlations between Phenotypic Traits and Signaling Factor Gene Expression in Liver 
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Table 12: Correlations between Fatty Acid Composition and Lipogenic Gene Expression in Liver 
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Table 13: Correlations between Fatty Acid Composition and β-Oxidation Gene Expression in Liver 
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Table 14: Correlations between Fatty Acid Composition and Signaling Factor Gene Expression in 
Liver 
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TROUT GENOME PROJECT: CORRELATIONS WITH MUSCLE GENE EXPRESSION  
[Each table indicates the R
2
-value (top number) and p-value (bottom number) for each correlation.]  
 
 
Table 15: Correlations between Phenotypic Traits and Lipogenic Gene Expression in Muscle 
 
 
Table 16: Correlations between Phenotypic Traits and β-Oxidation Gene Expression in Muscle 
 
 
Table 17: Correlations between Phenotypic Traits and Signaling Factor Gene Expression in Muscle 
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Table 18: Correlations between Fatty Acid Composition and Lipogenic Gene Expression in Muscle 
 
 
0.8765 
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Table 19: Correlations between Fatty Acid Composition and β-Oxidation Gene Expression in 
Muscle 
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Table 20: Correlations between Fatty Acid Composition and Signaling Factor Gene Expression in 
Muscle 
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TROUT GENOME PROJECT: CORRELATIONS WITH VISCERAL ADIPOSE TISSUE  
GENE EXPRESSION  
[Each table indicates the R
2
-value (top number) and p-value (bottom number) for each correlation.]  
 
Table 21: Correlations between Phenotypic Traits and Lipogenic Gene Expression in Visceral 
Adipose Tissue 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 22: Correlations between Phenotypic Traits and β-Oxidation Gene Expression in Visceral 
Adipose Tissue 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 23: Correlations between Phenotypic Traits and Signaling Factor Gene Expression in 
Visceral Adipose Tissue 
 
 
 
 
 
 
 
 
 
 
 
197 
 
Table 24: Correlations between Fatty Acid Composition and Lipogenic Gene Expression in Visceral 
Adipose Tissue 
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Table 25: Correlations between Fatty Acid Composition and β-Oxidation Gene Expression in 
Visceral Adipose Tissue 
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Table 26: Correlations between Fatty Acid Composition and Signaling Factor Gene Expression in 
Visceral Adipose Tissue 
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EXAMPLE SAS CODES 
 
 
 
 
Feeding Rate Study --- Ration Effects --- Example SAS Code 
options formdlim = '-'; 
 
options pageno=1 pagesize=60; 
Title 'Meg ration' ; 
 
data GeXP; 
input  sample $ month $ ID lot family $ ration $  ACAT2 ACC  ACDHM ACDHVL ACO
 ACYL AKT2 CPT1a CPT1b CPT1c CPT1d EHHADH ERK12 FABP3 FABP4 FAS FATCD36
 GPAT LPL MAGL MalicEnzyme MCPT1a MO25 mTOR PPARalpha PPARbeta
 PPARgamma PRAS40 Raptor REDD1 Rictor RxR SCD1 SREBP1 
; 
datalines; 
 
; 
proc glm data = GeXP; 
class month ploidy ; 
model ACAT2 ACC  ACDHM ACDHVL ACO ACYL AKT2 CPT1a CPT1b CPT1c CPT1d
 EHHADH ERK12 FABP3 FABP4 FAS FATCD36 GPAT LPL MAGL MalicEnzyme MCPT1a
 MO25 mTOR PPARalpha PPARbeta PPARgamma PRAS40 Raptor REDD1 Rictor
 RxR SCD1 SREBP1  = month ration month*ration; 
lsmeans month*ration /stderr pdiff; 
run; 
 
 
 
 
 
 
Feeding Rate Study --- Ploidy Effects --- Example SAS Code 
options formdlim = '-'; 
 
options pageno=1 pagesize=60; 
Title 'Meg ploidy' ; 
 
data GeXP; 
input  sample $ month $ ID lot family $ ploidy $  ACAT2 ACC  ACDHM ACDHVL ACO
 ACYL AKT2 CPT1a CPT1b CPT1c CPT1d EHHADH ERK12 FABP3 FABP4 FAS FATCD36
 GPAT LPL MAGL MalicEnzyme MCPT1a MO25 mTOR PPARalpha PPARbeta
 PPARgamma PRAS40 Raptor REDD1 Rictor RxR SCD1 SREBP1 
; 
datalines; 
 
; 
proc glm data = GeXP; 
class month ploidy ; 
model ACAT2 ACC  ACDHM ACDHVL ACO ACYL AKT2 CPT1a CPT1b CPT1c CPT1d
 EHHADH ERK12 FABP3 FABP4 FAS FATCD36 GPAT LPL MAGL MalicEnzyme MCPT1a
 MO25 mTOR PPARalpha PPARbeta PPARgamma PRAS40 Raptor REDD1 Rictor
 RxR SCD1 SREBP1  = month ploidy month*ploidy; 
lsmeans month*ploidy /stderr pdiff; 
run; 
 
 
 
201 
 
2N/3N Maturation Study --- Example SAS Code 
option LS=80 pagesize=60 nonumber; 
title 'ANOVA_2n3n_ALL TISSUES'; 
data genes; 
input tissue $ age ploidy $ family $ acat2 acc acdh acdhm acdhvl aco acyl akt2 cpt1a cpt1b cpt1c 
cpt1d ehhadh erk fabp3 fabp4 fas cd36 gpat lpl magl malenz cpt2 mo25 mtor ppara pparb pparg 
pras40 raptor redd1 rictor rxr scd1 srebp1; 
datalines; 
; 
proc mixed data=genes method=reml; 
class tissue age ploidy family; 
model srebp1 = tissue age ploidy tissue*ploidy tissue*age tissue*age*ploidy ; 
random family; 
lsmeans tissue age ploidy tissue*ploidy tissue*age tissue*age*ploidy ; 
run; 
 
 
 
Male verses Female Study --- Example SAS Code 
options ls=80; 
data MegMvFFA; 
input gender $ family $ c120 c130 c140 c141 c150 c160 c161 c170 c171 c180 c181n9 c182n6 c200 
c183n6 c201 c183n3 c210 c202 c220 c203n6 c221n9 c203n3 c204n6 c222 c205n3 c241 c226n3; 
datalines; 
 
; 
proc glm data=MegMvFFA ; 
class gender family; 
model c120 c130 c140 c141 c150 c160 c161 c170 c171 c180 c181n9 c182n6 c200 c183n6 c201 c183n3 
c210 c202 c220 c203n6 c221n9 c203n3 c204n6 c222 c205n3 c241 c226n3=gender; 
lsmeans gender /stderr pdiff; 
run; 
 
 
Trout Genome Study --- One-Way ANOVA --- Example SAS Code 
options ls=80; 
data MegTGFA; 
input group $ family $ c120 c130 c140 c141 c150 c160 c161 c170 c171 c180 c181n9 c182n6 c200 
c183n6 c201 c183n3 c210 c202 c220 c203n6 c221n9 c203n3 c204n6 c222 c205n3 c241 c226n3; 
datalines; 
 
; 
proc glm data=MegTGFA ; 
class group family; 
model c120 c130 c140 c141 c150 c160 c161 c170 c171 c180 c181n9 c182n6 c200 c183n6 c201 c183n3 
c210 c202 c220 c203n6 c221n9 c203n3 c204n6 c222 c205n3 c241 c226n3=group; 
lsmeans group /stderr pdiff; 
run; 
 
 
Trout Genome Project --- Correlations --- Example SAS Code 
options ls=80; 
data MegsFAandliver; 
input Group $ C12 C14 C141 C15 C16 C161 C17 C18 C181n9 C182n6 C20 C183n6 C201 C183n3 C202 C203n6 
C221n9 C203n3 C204n6 C205n3 C241 C226n3 SFA MUFA PUFA W3 W6 W3toW6 ACAT2 ACC ACDH ACDHM
 ACDHVL ACO ACYL AKT2 CPT1a CPT1b CPT1c CPT1d EHHADH ERK12 FABP3 FABP4
 FAS CD36 GPAT LPL MAGL MalEnz CPT2 MO25 mTOR PPARa PPARb PPARg
 PRAS40 Raptor REDD1 Rictor RxR SCD1 SREBP1 
; 
cards; 
 
; 
/*Proc sort; 
by group;*/ 
proc corr; 
/*by group;*/ 
run; 
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APPENDIX 11 
 
 
LIPID EXTRACTION AND FATTY ACID METHYLATION PROTOCOL 
Sample preparation:  
1. Intact muscle form—Fillets (excluding belly flap) are skinned, vacuum packed and kept at –20C.  
When lipid extraction is performed, frozen fillets are partially thawed and processed the same as 
powdered sample preparation. 
 
2. Powder form—Fillets are skinned, cut into small pieces (excluding belly flap), frozen with liquid N2, 
and powdered in a Waring blender for 1-2 min. TBHQ (0.1 g) is added before blending to prevent 
lipid oxidation.  Powdered samples are kept at –80C. 
 
Important: 
 Use 35-mL Teflon-lined screw cap glass centrifuge tubes 
 Check the condition of tubes and caps for methylation step—No chips or cracks 
 Work under hood 
 Use glass when working with chloroform or methanol 
 
Instruments: 
1. Hood 
2. 60C water bath or heating block 
3. 90C water bath or heating block 
4. Manifold and nitrogen gas 
5. Centrifuge 
6. Vortex 
 
Chemicals: 
1. Trizma/EDTA buffer: 
50 mM Trizma HCl: 7.880 g per 1000 mL dd water  
1 mM EDTA-disodium salt: 0.372 g per 1000 mL dd water  
Mix above stock solutions in a beaker, adjust pH to 7.4 with 5 M or 1 M NaOH, then filter using a 0.2 
micron filter storage unit. Buffer is stored at 4C. 
2. C:M:A (chloroform:absolute methanol: gracial acetic acid) 400:200:3 mL  
3. 2:1 (chloroform:methanol by volume) e.g. 400:200 mL  
4. 4:1 (chloroform:methanol by volume) e.g. 400:100  
5. 4% (w/v) H2SO4 in anhydrous methanol. Must prepare fresh.   
6. Chloroform 
7. Anhydrous Na2SO4 
8. 1-PS Phase separation filters (diameter 9 cm). This filter type takes water out off solution, thus 
filtered solution is water free. 
9. Glass wool 
10.  Iso-octane. Filter using a 0.45 micron filter storage unit. 
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Lipid extraction step: 
1. Weigh powdered sample in a 35-mL Teflon lined screw cap glass centrifuge tube.   
2. Add 5 mL Trizma/EDTA, then vortex for 60 sec. 
3. Add C19:0 (Nonadecanoic acid) as an internal standard at 0.3mg/ml. 
4. Add 20 mL C:M:A, then vortex vigorously twice (30 sec x 2). 
5. Hold tubes at room temperature for 10 min. 
6. Centrifuge at 900 x g (4000 rpm), 10C for 10 min. 
7. Transfer all lower layer with glass Pasteur pipet over 1-PS filter.  Collect filtered sample in a 35-mL 
Teflon lined screw cap glass centrifuge tube. (Pre-rinse filter paper 3 times with 5 mL 2:1 C:M each  
to remove trace silicone residue, and put away filtrate.) 
8. Add 10 mL 4:1 C:M to the upper layer, vortex for 15 sec, and centrifuge at 900 x g (4000 rpm), 10C 
for 10 min. 
9. Again transfer all lower layer over 1-PS filter. Rinse filter paper with 5 mL 2:1 C:M after the filtrate 
has gone. Take filter paper out, and rinse inside and outside of funnel with 1 pipett of 2:1 C:M.  
(Filtrated sample can be stored at 0-5C for 1-3 days.) 
10. Blow down under nitrogen gas to dry sample in 60C water bath. Nitrogen gas outlet should be close 
to liquid surface. (It takes around 60-75 mi. Completely dry sample does not have a smell of acetic 
acid.) 
 
 
Methylation step: 
1. Add 4 mL of 4% H2SO4 solution. (CAP THIGHTLY-NO LEAKING) 
2. Heat in water bath or heating block at 90C for 60 min. 
3. Cool in to room temperature then add 3 mL dd water (to stop reaction). 
4. Add 8 mL chloroform, then vortex for 30 sec. 
5. Centrifuge at 900 x g (4000 rpm), 10C for 10 min. 
6. Transfer the bottom layer (chloroform layer) through a Na2SO4 filled glass Pasteur pipet into 10-mL 
glass tube. Collect filtered sample in a 10-mL screw cap glass tube.  (Fill Pasteur pipet with 
glasswool first, then with around 1 inch of Na2SO4 layer. Pre-rinse with 1 pipett of chloroform and 
put away filtrate). Rinse the filter layer with a half pipett of chloroform to wash out sample that 
trapped in the filter layer. Before take the filter out, rinse the outside with a little bit of chloroform. 
7. Blow down under nitrogen gas in 60C water bath. Nitrogen gas outlet should be close to liquid 
surface. (It takes around 20-25 min.  Completely dry sample does not have a smell of chloroform.) 
8. Resuspend dried sample in 3 mL of filtered isooctane and keep at –20C or inject into GC. 
 
 
Calculations: 
RF = (Ax x Cis)/(Ais x Cx)   
 Ax   = area of fatty acid peak 
 Cx  = concentration of fatty acid 
Ais = area of internal standard 
 Cis = concentration of internal standard 
  
* The RF value is then used as a      
    correction factor for calculating  
    concentrations of each fatty acid. 
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APPENDIX 12 
 
 
GENOME LAB GeXP-MULTIPLEX GENETIC ANALYSIS SYSTEM PROTOCOL 
 
 
 
PRIMER DESIGN: 
Make a list of 30-40 genes of interest and obtain accession numbers and sequences. 
Insert genes as outlined in GeXP Chemistry Protocol.  
Design Multiplex as outlined in GeXP Chemistry Protocol. This will generate a list of primers. 
BLAST primers against NCBI Database. Ensure that the primers identify the desired gene and that the 
reverse primer does not bind a gene with the 5’ end (bp 20) with the forward primer binding the same 
gene. If the forward and reverse primers bind the same gene, the primer set must be redesigned. If either 
primer binds another gene of interest included in the multiplex, then the primer set must be redesigned.  
Once the primers have been determined to be desirable then the primers with the universal tag can be 
ordered.  
  
 
 
PRIMER OPTIZIMATION: 
Resuspend primers to 100µM concentrations in 10mM Tris-HCl pH8.0 
 
Reverse Primers: 
Make reverse plex by making a 1mL mixture of all reverse primers at a 500nM concentration. With 41 
primers, take 5µL of each 100µM reverse primer and add 795µL of 10mM Tris-HCl to make the final 
volume 1mL.  
 
Forward Primers: 
Dilute 100µM forward primers to 200nM individual solutions. Take 2µL of 100µM primer and add 
498µL of Tris-HCl. 
 
DNase Treatment: 
Take 2µg of RNA pool in 5 replicates. Add 2µL of DNase and 2µL of 10x Buffer then make the total 
volume of the reaction equal 20µL by adding water. The thermocycler should be set to run at 37
o
C for 1 
hr. To stop the reaction, add 2µL of STOP and run on the thermocycler at 60
o
C for 10 min.  
 
Kan(r) RNA Dilution: 
Dilute Kan to 1:50 with RNase/DNase free water (10µL in 490µL of water). 
 
Reverse Transcription Reaction: 
Dilute 20µL of DNase treated RNA pool in 80µL of RNase/DNase free water for a total volume of 
100µL.  Make master mix as outlined below. The total reaction volume should be 10µL. The 
thermocycler program is under the GeXP folder and is entitled “RT*”. The reaction is 48oC for 1min, 
42
o
C for 60min, 95
o
C for 5min, and 4
o
C hold.  
MasterMix: 
H2O           1.5µL 
5x RT        2.0µL 
RT             0.5µL 
Kan           2.5µL 
RevPlex   7.0µL 
RNA        0.5µL (H2O for NTC) 
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PCR Reaction: 
Make a master mix as outlined below. Then add 4.35µL of the master mix, 3.15µL of RT reaction 
products, and 2.5µL of primers. You can run singlet reactions or reactions with multiple primers. I ran 5 
forward primers in each well, so I added 0.5µL of each 200nM forward primer for a total reaction volume 
of 10µL.  The thermocycler program is under GeXP folder and entitled “PCR*”. 
Master Mix: 
MgCl2               2.0µL 
5x Buffer         2.0µL 
Polymerase    0.35µL 
 
Multiplex (Singlet Reactions): 
Dilute PCR products in strip tubes with 2µL of PCR products in 8µL of 10mM Tris-HCl.  
In a 96-well plate add: 
Diluted PCR products                1.0µL 
DNA Size Standard (400bp)     0.5µL 
Sample Loading Solution       38.5µL  
          40µL total 
Add 1 drop of mineral oil to the top of each well 
Fill appropriate wells on Buffer Microplate 2/3 full with Separation Buffer 
Ready for multiplex 
(The plate should be stored in the refrigerator until the machine is ready; the DNA standard is light 
sensitive.) 
Follow standard protocol for setting up the GeXP. 
 
Multiplex (Whole): 
Used PCR products of Reverse Plex + full Forward Plex 
Reverse Plex— made a 1mL mixture of all reverse primers at a 500nM concentration. With 41 
primers, take 5µL of each 100µM reverse primer and add 795µL of 10mM Tris-HCl to make 
the final volume 1mL. 
Forward Plex—combined 5µL of each 100µM forward primer (used 2µL in PCR reaction) 
Dilute PCR products in strip tubes with 2µL of PCR products in 8µL of 10mM Tris-HCl. 
In a 96-well plate add: 
Diluted PCR products                1.0µL 
DNA Size Standard (400bp)     0.5µL 
Sample Loading Solution      38.5µL  
          40µL total 
Add 1 drop of mineral oil to the top of each well 
Fill appropriate wells on Buffer Microplate 2/3 full with Separation Buffer 
Ready for multiplex 
(The plate should be stored in the refrigerator until the machine is ready; the DNA standard is light 
sensitive.) 
Follow standard protocol for setting up the GeXP. 
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RUNNING AN OPTIMIZED MULTIPLEX-PCR REACTION 
 
Reverse Primers: 
Combine all 100µM forward primers at 1.25µL except for β-actin (0.35 µL), FAS (0.625 µL), RibProt 
(0.125µL), and EF1a (0.125µL).  
 
Forward Primers: 
Make a 0.5 mL mixture of all forward primers at a 500nM concentration. With 41 primers, take 1µL of 
each 100µM reverse primer and add 460µL of 10mM Tris-HCl to make the final volume 500µL. 
 
DNase Treatment: 
Take 2µg of RNA and add 2µL of DNase and 2µL of 10x Buffer then make the total volume of the 
reaction equal 20µL by adding water. The thermocycler should be set to run at 37
o
C for 1 hr. To stop the 
reaction, add 2µL of STOP and run on the thermocycler at 60
o
C for 10 min.  
 
Reverse Transcription Reaction: 
Use undiluted DNase-Treated RNA.  Make master mix as outlined below. The total reaction volume 
should be 10µL. The thermocycler program is under the GeXP folder and is entitled “RT*”. The reaction 
is 48
o
C for 1min, 42
o
C for 60min, 95
o
C for 5min, and 4
o
C hold.  
MasterMix: 
H2O           2.75µL 
5x RT         2.0µL 
RT             0.5µL 
Kan [stock]         1.25µL 
RevPlex   1.0µL 
RNA          2.5µL (H2O for NTC) 
 
PCR Reaction: 
Make a master mix as outlined below. Then add 5.35µL of the master mix and 4.65µL of RT reaction 
products. The thermocycler program is under GeXP folder and entitled “PCR*”. The reaction is 
95
o
C for 10min, 95
o
C for 30 sec, 55
o
C for 30sec, 70
o
C for 1min, repeat steps 2-4 for an additional 
34 cycles (35 cycles total), and 4
o
C hold. 
Master Mix: 
MgCl2               2.0µL 
5x Buffer         2.0µL 
Polymerase     0.35µL 
ForPlex            1.0µL 
cDNA            4.65µL 
 
Multiplex: 
Use undiluted PCR products. 
In a 96-well plate add: 
PCR products                   1.0µL 
DNA Size Standard (400bp)      0.5µL 
Sample Loading Solution        38.5µL  
           40µL total 
Add 1 drop of mineral oil to the top of each well 
Fill appropriate wells on Buffer Microplate 2/3 full with Separation Buffer 
Ready for multiplex 
(The plate should be stored in the refrigerator until the machine is ready; the DNA Standard is light 
sensitive.) 
Follow standard protocol for setting up the GeXP. 
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STANDARD PROTOCOL FOR OPERATING GENOME LAB GeXP GENETIC ANALYSIS 
SYSTEM: 
 
1. Operation of the GenomeLab GeXP Genetic Analysis System 
 Power up the computer and analyzer.  If you hear a long buzz, lift lid, replace and restart. 
 Warm the capillary array and gel to room temperature for ~30 minutes. 
 Open the GenomeLab GeXp software. 
 Access personal database. Set as working database. Create a new project. 
 Select the Run Control Tab. A message will appear indicating a gel error. Hit OK.   
 Select the direct control tab. 
 Right click on the gel cartridge icon and select “Install gel cartridge.” Enter the lot number 
and hours.  Load gel cartridge and select “Done.” 
 Right click on the capillary array icon and select “remove manifold plug” and then “install 
capillary array.” Enter info and select done. 
 Replace all doors and close cover 
 Right click under direct control and perform manifold purge.  Change to 3Xs with 0.4 ml 
gel. 
 Select Fill Gel Capillary 3xs. 
 Perform an optical alignment instrument data options scan check. 
Monitor Baseline: Under Runmonitor baselineselect enableauto save 
To look at channels, Open data monitor. Click the Y axis and select 8K so that all are on the 
same scale. 
Channel C always runs higher than the others.  Do not want above 5K. 
Under Runmonitor baselineselect disableauto save. 
 Go to Main Menu and select Setup. Enter unknowns into plate map.  At the base of the 
column, select the method (Frag 3) from the pull-down options.  Save As 
 Select Run sample plates. Always remember to change project from default to project of 
interest  
 Select load the plate: 
o Load the plate-make sure it is properly aligned. Left side-rear. 
o Clean the water tray-replace with DIwater. 
o Add Separation buffer to corresponding wells of a 96 well buffer microplate (2/3 full) 
Replace cover.  
 Close the machine cover and start-plated loaded-load OK. 
 
 
2. After Completion of the Run: 
 Remove gel cartridge:  Rundirect control right click on iconremove gel cartridge.  
Remove the gel cartridge and return to 4°C.  Insert plug.  
 If the machine will not be used within a few days, remove the capillary array. 
Rundirect control right click on iconrelease capillary array 
Open both doors and remove covers.  Pull out the array with left hand while releasing the 
manifold plug with the right.  Place carefully on bench top. Fill caps with nano water and 
place on capillary.  Ensure the tips are in the water.  Place cap on manifold plug.  Place 
protective piece over window of manifold plug. Document usage on the outside of the box. 
Return to 4°C.     
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3. Fragment Analysis 
 Main menu FragmentsRaw DataSelect project 
 From List View, highlight to select your samples.  Use the right arrow to move the selected 
samples into the Raw Data Field hit Next. 
 Select “GeXP analysis” as parameter set and hit “next” and “analyze”.  Wait for analysis to 
complete and ensure that each sample analysis indicates “Pass.”  If not, this indicates a 
problem.   Select “Finish.” 
  A new window will open.  You will be prompted to Add Study? Select YES and save using 
a new study name. 
 Double click “Fragments List” under the Data Tab.  Deselect dyes 1-3.  Select and apply 
“mTOR/PPAR/FA Filter Set” under Exclusion filter.   Check box indicating “Show 
Excluded.”   
 Data is now ready to be reviewed. Verify that all expected peaks are present and that all 
peaks are identified as a single peak.  One peak area that is critical is ~165 nt.  We want to 
select for the second of the double peak even if the area is smaller.  This can be accomplished 
by tweaking the filter exclusions. 
 Export data for further analysis by selecting “transport fragments for GeXP” under the File 
pull-down menu.  Save to K drive. 
 
 
4. Analysis using Profiler Software 
 Open Profiler Software using “bcleveland” log-in info. 
 Select “Express Analysis”.  Log-in info is required at this step as well.   
 Under GeXP analysis tab, Create a new analysis.  Give a unique name to the analysis. 
Analysis set up window will open.  Select FA_15 from multiplex list. Save 
 Select GeXP import to pull in data from K drive using “Browse.” Add plate to the database. 
Save.  
 Under Plate Set up Tab, open plate and open sample layout.  Highlight wells and assign 
multiplex.  Save 
 Open GeXP analysis normalization.  Normalize to Kan peak. Select ALL under display 
normalized values. 
 Look over results to fine-tune.  Adjust peak binning to capture/eliminate peaks as needed. 
Save. 
 Open report View.  Select report format: Profile by gene.  Hit export data.  Must assign 
.TXT to the file name.  Save to K drive.  
 
 
5. Further analysis in Excel 
 Further analysis includes utilizing the standard curve generated for each gene and 
normalization prior to being further processed in GeNorm. 
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